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ABSTRACT  
Resveratrol and quercetin, two representative polyphenolics found in red wine, onions, 
and many other sources, have been well documented for having numerous health benefits 
such as antioxidant, anti-inflammatory, cardioprotective, and anticancer effects. Despite 
their health-related beneficial properties, their widespread use in lipophilic media such as 
lipid-based foods and cosmetic formulations is restricted due to their hydrophilicity. 
Moreover, phenolic compounds, including flavonoids, generally undergo extensive 
metabolism after consumption, thus they have low bioavailabilities. Even if these 
compounds can survive from metabolism, they can hardly penetrate lipophilic cell 
membrane bilayers. One possible solution to this problem is to modify their structures 
which can be carried out simply as a first approach via esterification. Esterification with 
fatty acids can enhance lipophilicity that would improve their use in different lipophilic 
media. Moreover, in the case of esterification with polyunsaturated fatty acids (PUFA), 
potential health benefits may be enhanced due to the presence of both phenolics and 
certain healthful PUFA such as those of the omega-3 family. For this reason, fatty acids 
of different chain length and degree of unsaturation (C3:0-C22:6) were employed as acyl 
donors. The resveratrol and quercetin derivatives so prepared were evaluated for their 
antioxidant activities in different systems, such as the 2,2-diphenyl-1-picrylhydrazyl 
(DPPH) radical scavenging assay; the 2,2'-azino-bis (3-ethylbenzothiazoline-6-sulphonic 
acid) (ABTS) radical cation scavenging assay; a bulk oil system; β-carotene bleaching 
assay; a hydroxyl radical-induced DNA scission assay, and the copper-induced low-
density lipoprotein (LDL) oxidation assay. Selected resveratrol derivatives were further 
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evaluated for their antioxidant activity and cell viabilities (A431, MCF7, HT-29, and 
AGS cells). All test compounds showed antioxidant activity in a system-dependent 
manner. The resveratrol and quercetin derivatives showed a decreased radical scavenging 
activity compared to their parent molecules. However, some derivatives exhibited a 
similar and/or a better antioxidant activity than resveratrol and quercetin themselves in 
different systems, such as in the bulk oil assay and copper-induced low-density 
lipoprotein (LDL) oxidation assays. In this work, both resveratrol and quercetin 
derivatives showed potential use in lipophilic systems, therefore they might serve as 
possible functional food ingredients as well as health promoting supplements. 
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CHAPTER 1 
Introduction 
Lipid oxidation is a major concern for the food industry, scientists and consumers alike.  
Attempts have been made to find the best way to minimize the risk of oxidation. In the 
early days, hydrogenation of unsaturated fatty acids was carried out to convert them to 
less unsaturated or more saturated fatty acids. The resultant products were used as 
shortening and margarine which were more stable than unsaturated fatty acids, thus 
leading to shelf life extension (Johnson, 2002). However, trans fat, a byproduct of 
hydrogenation, later became a significant concern due to the adverse health effects 
associated with the incidence of cardiovascular disease (Mozaffarian et al., 2006). 
Moreover, unsaturated fatty acids are known to be important in nutrition as well as 
biological systems (Watkins and German, 2002). For example, linoleic acid and α-
linolenic acid are essential fatty acids because human body cannot synthesise them. 
Addition of antioxidants has proven to be the most effective means to control oxidation 
(Shahidi and Ambigaipalan, 2015; Laguerre et al., 2015). The most widely used synthetic 
antioxidants such as butylated hydroxyanisole (BHA), butylated hydroxytoluene (BHT), 
propyl gallate (PG) and tertiary-butylhydroquinone (TBHQ) have been questioned due to 
their possible carcinogenic effects (Ito et al., 1986). Hence food scientists have found 
alternatives, mainly phenolic compounds from natural sources as functional food 
ingredients. So far, numerous phenolic compounds, mostly originating from plant sources, 
have been identified. Phenolic compounds have been known to have a great potential to 
serve as antioxidants with significant health benefits such as cardioprotective, anti-
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inflammatory, and anticancer effects. However, most effective phenolic compounds are 
hydrophilic compounds, therefore they may not be suitable for use in lipid-based systems 
(Laguerre et al., 2015). Besides, only a small fraction of phenolic compounds consumed 
may be absorbed and the rest is excreted in feces or in urine, as such or as their 
metabolites, hence we cannot take full advantage of their potential health benefits 
(Clifford, 2004). Thus, it is of interest to explore possible ways to overcome such 
problems, including structure modification. 
This study aimed to expand the potential application of phenolic compounds in food and 
lipophilic biological systems. To that end, two phenolic compounds, resveratrol and 
quercetin, were selected and esterified with 12 different fatty acids varying in chain 
length as well as in the degree of unsaturation. The central hypothesis of this study was 
that the lipophilised resveratrol and quercetin would have increased antioxidant activity in 
food and biological systems compared to the parent compounds. Because the 
lipophilisation would increase affinity between the phenolic compounds and lipophilic 
systems tested such as a bulk oil system and LDL oxidation inhibition assay, therefore 
lipophilisation would lead to enhanced antioxidant activity of resveratrol and quercetin.   
The general objective of this study was to investigate the effect of lipophilisation of 
resveratrol and quercetin on antioxidant activity and their application in a wide range of 
food and biological systems.   
The specific objectives of this study are summarised below. 
1) To prepare the lipophilised resveratrol and quercetin derivatives via esterification;  
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2) To identify the structure of lipophilised resveratrol and quercetin, derivatives; 
3) To evaluate the effect of lipophilised resveratrol and quercetin on antioxidant 
properties; 
4) To determine the effect of fatty acid chain length and degree of unsaturation of 
lipophilised resveratrol and quercetin on antioxidant properties, and 
5) To explore the additive, synergistic, or antagonistic effect arising from 12 different 
fatty acid esters of resveratrol and quercetin. 
This thesis consists of nine chapters. 
Chapters 1 and 2 describe the introduction and the related literature review. Chapter 3 
presents material and methods, whereas chapters 4-8 provide results and discussions. The 
titles of chapters 4-8 are summarised below. 
Chapter 4. Lipophilisation of resveratrol and effects on antioxidant activity            
Chapter 5. Antioxidant activity of resveratrol ester derivatives in food and biological 
model systems 
Chapter 6. Effect of lipophilisation of resveratrol on reactive nitrogen/oxygen species 
generation in murine macrophages and human cancer cell lines 
Chapter 7. Preparation of esterified quercetin derivatives and effects on antioxidant 
activity 
Chapter 8. Antioxidant activity of quercetin derivatives in food and biological model 
systems 
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Finally, Chapter 9 presents summary and recommendations. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
	   5	  
CHAPTER 2 
Literature review 
2.1 Phenolics 
2.1.1 Chemistry and classification 
Phenolic compounds consist of one (phenol) or more (polyphenol) hydroxyl groups 
attached to one or more aromatic hydrocarbon rings. They are widely distributed in plants 
and are present in several thousand different forms (Shahidi, 2002a). They can also 
incorporate other groups such as methoxy groups, fatty acids, and carbohydrates. They 
are important in the plant for growth regulation, wound healing, and for protection from 
sunlight, pathogens, and external predators (Shahidi and Yeo, 2016). They are also 
responsible for the colour and taste of foods.  
Phenolic compounds in plants are derived from phenylalanine and to a lesser extent from 
tyrosine. They are synthesized by phenylalanine ammonia lyase (PAL) and tyrosine 
ammonia lyase (TAL) to phenylpropanoids (C6-C3), which are trans-cinnamic acid and 
p-coumaric acid, respectively. (Figure 2.1; Shahidi, 2002b). These can be modified and 
form different types of phenolic compounds. Each phenolic compound has a different 
structure, however they can be classified, based on their basic carbon skeletons, into 
simple phenols (C6), phenolic acids (C6-C1, C6-C3), stilbenes (C6-C2-C6), and 
flavonoids (C6-C3-C6) (Pereira et al., 2009). Phenolic acids and flavonoids are the 
predominant phenolics found in food sources (Robbins, 2003). 
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Figure 2.1. Formation of phenylpropanoids from phenylalanine and tyrosine by ammonia 
lyase.   
 
Phenolic acids can be divided into hydroxybenzoic acid derivatives such as p-
hydroxybenzoic acid, protocatechuic acid, and gallic acid, as well as hydroxycinnamic 
acid derivatives such as coumaric acid, ferulic acid, and sinapic acid; these are varied by 
the location and number of hydroxyl groups attached to the aromatic ring (Figure 2.2).  
The production of stilbenes also starts from a phenylpropanoid pathway and subsequently 
undergoes condensation reaction of a p-coumaroyl-CoA and three malonyl-CoA 
(Vermerris and Nicholson, 2008). Phenolic compounds such as resveratrol and piceid 
belong to the class of stilbene derivatives (Shahidi and Ambigaipalan, 2015).  
 
 
H
NH3+-OOC
R
HOOC
R
R = H, phenylalanine
R = OH, tyrosine
Ammonia lyase
Phenylpropanoid
(R = H, cinnamic acid; 
 R = OH, coumaric acid)
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Figure 2.2. Phenolic acids (examples of hydroxybenzoic acid derivatives [top] and 
hydroxycinnamic acid derivatives [bottom]). 
 
Flavonoids consist of two benzene rings (A and B) linked by a 3-carbon heterocyclic 
pyrene ring (C) (Figure 2.3; Kumar and Pandey, 2013). More than 6500 flavonoid 
compounds have been identified (Harborne and Williams, 2000), which can be further 
categorized into flavones, flavan-3-ols, flavonols, anthocyanidins, and isoflavones 
COOH
OH
COOH
OH
OH
COOH
OH
OHHO
p-Hydrobenzoic acid Protocatechuic acid Gallic acid
COOH
OH
p-Coumaric acid
COOH
OH
OCH3
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COOH
OH
OCH3H3CO
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(Shahidi and Ambigaipalan, 2015). All phenolic acids and flavonoids may also be found 
as their glycosides. Most flavonoids are 3-O-glycosides (monoglycosides) and 3,7-di-O-
glycosides (diglycosides) (Shahidi and Naczk, 2004).  Flavan-3-ols consist of a C6-C3-
C6 basic carbon skeleton with a hydroxyl group attached to the C-3 position of the C ring. 
Flavan-3-ols include catechin, epicatechin, epicatechin gallate, and epigallocatechin 
gallate, and these are found in green tea. Flavones have a 2,3-double bond and a 4-keto 
group in the C ring. Flavones are mainly found in fruit skins (Kumar and Pandey, 2013). 
Isoflavones, which can be found in soybeans, have a similar structure to flavones, 
however the B ring of isoflavones is linked via carbon 3 of the C ring. Flavonols such as 
quercetin and kaempferol have an additional hydroxyl group linked to carbon 3 of the C 
ring of flavone. They are widely distributed in vegetables and fruits such as berries, 
onions, lettuce, and broccoli (Shahidi and Ambigaipalan, 2015). Meanwhile, 
anthocyanins, which can be found in flowers and fruits, play an important role in plant 
colour that can change with pH, being red in acidic solutions, blue to violet in neutral 
solutions, and green to yellow in alkaline solutions (Michaelis et al., 1936). Anthocyanins 
are abundant in blueberries, blackberries, cherries, pomegranates and eggplants (Shahidi 
and Naczk, 2004).  
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Figure 2.3. Structures of major classes of flavonoids.  
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2.1.2 Bioactivities and bioavailabilities  
It is of interest to the general public to learn about healthy intake of food in order to keep 
themselves in good health. There are notable volumes of epidemiological evidence that 
consumption of fruits and vegetables can decrease the risk of chronic diseases such as 
cancer, hypertension, and heart disease, therefore fruits and vegetables are generally 
considered as healthy foods (Van Duyn and Pivonka, 2000). Healthy food consumption is 
closely related to phenolic intake because food from plant sources such as fruits, 
vegetables, herbs, seeds, and cereals are important sources of phenolics. Phenolic 
compounds have been shown to have numerous anti-pathological activities such as 
antioxidant, anti-inflammatory, and antiulcer effects (Bravo, 1998), among others. 
Phenolic compounds display strong antioxidant activity, which prevents oxidation of 
biomolecules such as low density lipoprotein (LDL) cholesterol, DNA, and proteins, thus 
suppressing the development of cardiovascular disease and cancer. For example, 
catechins, abundant in green tea, can delay propagating lipid peroxyl radicals, DNA 
oxidation, and LDL cholesterol oxidation in vitro (Salah et al., 1995; Zhong and Shahidi, 
2012). Phenolics from olive oils could protect against reactive oxygen species (ROS) but 
also suppress xanthine oxidase activity, which can produce superoxide in vitro (Owen et 
al., 2000). Phenolic compounds also exert anti-inflammatory activity. Epigallocatechin 
gallate (EGCG) and its derivatives showed anti-inflammatory activity via inhibiting pro-
inflammatory mediators such as nitric oxide and prostaglandin (PGE2) in vitro (Zhong et 
al., 2012). This is exemplified for resveratrol, which also showed anti-inflammatory 
activity by reducing the production of nitric oxide and TNF-α (Bi et al., 2005). Phenolic 
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compounds also exert protective effects against coronary heart disease (CHD). Tresserra-
Rimbau et al. (2014) studied the association between polyphenol intake and the incidence 
of CVD in the Prevención con Dieta Mediterránea (PREDIMED) study. They divided 
7447 participants into three groups: Mediterranean diet supplemented with extra virgin 
olive oil (EVOO), Mediterranean diet supplemented with nuts or the control diet (low-fat 
diet). They reported that greater polyphenol intake leads to decreased risk of CVD. 
Hertog et al. (1993) studied the effects of flavonoid intake (25.9 mg/day) by 805 males 
(65-84 years old) for mortality from CHD and suggested that regular consumption of 
flavonoids might have protective effects on CHD. In addition, phenolic compounds are 
known to have anti-diabetic activity. Phenolics from Pakhanbhed, a traditional remedy for 
diabetes used by Nepalese, showed anti-diabetic potential by inhibiting rat intestinal α-
glucosidase as well as porcine pancreatic α-amylase (Bhandari et al., 2008). Besides, 
phenolics from muscadine (grapevine) exhibited anti-diabetic activities by inhibiting α-
glucosidase and pancreatic lipase (You et al., 2012). Phenolic compounds also show 
antimicrobial activity. For example, Rauha et al. (2000) reported that quercetin and 
naringenin effectively inhibited the growth of Staphylococcus aureus, which can cause 
food poisoning. According to Puupponen-Pimiä et al. (2001), phenolics from cloudberry, 
raspberry, and strawberry were able to inhibit the growth of Salmonella enterica. 
Although phenolics generally act as antioxidants, they can also behave as pro-oxidants 
which might be useful for their anticancer activity via apoptotic DNA fragmentation 
(Galati and O’Brien, 2004; Dai and Mumper, 2010). The action mechanism of anticancer 
drugs and γ-radiation treatment is highly related to apoptotic DNA fragmentation activity 
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via ROS (Hadi et al., 2000). This mechanism of action is similar to when phenolic 
compounds are binding and cleaving DNA then generating ROS in the presence of 
transition metal ions (Hadi et al., 2000). Juan et al. (2008) studied the anticancer activity 
of resveratrol in the colorectal carcinoma cell line (HP-29). They observed both anti-
proliferation activity and activation of caspase-3 in a dose-dependent manner as well as 
membrane permeability and DNA fragmentation. ROS level was also elevated. Phenolics 
such as secoiridoids from extra virgin olive oil showed inhibitory effects on proliferation 
in human breast cancer cells in vitro (García-Villalba et al., 2010). Phenolic extract from 
strawberries inhibited the growth of different human cancer cell lines such as oral (CAL-
27, KB), colon (HT-29, HCT-116), and prostate (LNCaP, DU145) (Zhang et al. 2008).  
Traditional Chinese medicinal herbs used for cancer treatment contain phenolic 
compounds from 0.22 to 50.3 g of gallic acid equivalents/100 g dry weight (Cai et al., 
2004). 
Despite the potential health benefits of phenolic compounds, it is extremely difficult to 
utilize them due to their low bioavailability and fast metabolism. Moreover, only limited 
information is available on the bioavailability of phenolics due to the variety, varying 
chemical structures and occurrence in specific plants (Bravo, 1998). Daily intake of 
phenolic compounds is varied from less than 100 mg to more than 2 g, depending on the 
food intake pattern (Clifford, 2004). However, generally only up to 10 % of the phenolic 
compounds consumed can be absorbed and the remaining 90 % goes to the colon where 
they are fermented by the gut microflora (Clifford, 2004). The absorption and metabolism 
of phenolics depend on their chemical structure, including degree of glycosylation, 
conjugation with other phenolic compounds, degree of polymerisation, and solubility 
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characteristics (Bravo, 1998; Kumar and Pandey, 2013). For example, flavonoids can 
either be absorbed in the intestine or go to the colon, whereas most of the flavonoid 
glycosides need to be hydrolysed to the aglycone form and then absorbed via passive 
diffusion (Kumar and Pandey, 2013; Manna et al., 2000). Absorption of phenolic 
compounds can also be affected by their affinity to the cell membrane. Murota et al. 
(2002) studied the cellular uptake of isoflavonoids and flavonoids by human intestinal 
Caco-2 cells. The highest affinity to the cell membrane was by flavonoid aglycones, 
whereas genistin and daidzin showed the least affinity to cell membranes. They suggested 
that this might be due to their lipophilicity, but earlier it was believed that mammals 
lacked β-glycosidases and hence absorption of phenolic glycosides in the intestine did not 
occur (Bravo, 1998). However, some phenolic glycosides may be absorbed in the 
intestine via glucose transporter (SGLT1) (Hollman et al., 1999) and/or hydrolysed by 
lactase-phlorizin hydrolase (β-glycosidase) on the brush border of the mammalian small 
intestine (Day et al., 2000). The phenolic glycosides, which did not absorb in the small 
intestine, are transported to the colon where they are hydrolysed by bacteria. The 
absorption in the colon can occur, however it is very limited compared to that in the small 
intestine (Kumar and Pandey, 2013). After absorption, phenolic compounds are 
metabolised via glucuronidation, sulphation, or methylation and this mostly occurs in the 
liver. Other organs such as the kidney and the intestine can also perform the conjugation 
of phenolic compounds (Bravo, 1998). The metabolites can either be secreted in the 
bile/urine or re-enter the intestine via the enterohepatic cycle (van Duynhoven et al., 2011; 
Chiou et al., 2014). Subsequently, phenolic compounds enter systemic circulation, 
however only small amounts (5-10%) can enter the plasma in the unchanged form 
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(Clifford, 2004). Manach et al. (2005) reviewed 97 bioavailability studies of phenolic 
compounds and reported that the absorption of gallic acid and isoflavones was the highest, 
whereas proanthocyanidins, epigallocatechin gallate (EGCG), and anthocyanin showed 
the least absorption. Hollman et al. (1999) reported that the absorption of quercetin 
glucosides, apart from rutin, was higher than quercetin itself. Moreover, the 
bioavailability of quercetin differs depending on the type of glycoside from the food 
source e.g. onions are a better source than apples or tea. The half-lives of quercetin 
metabolites ranged from 11 to 28 h, which means that continuous intake of 
quercetin/quercetin glycosides may lead to accumulation in the plasma (Manach et al., 
2005). Meanwhile, resveratrol can be absorbed well, however it has low bioavailability. 
Walle et al. (2004) studied the absorption, bioavailability, and metabolism of resveratrol 
after an oral dose of 25 mg in six human volunteers. Although 491 ± 90 ng/mL of 
resveratrol and its metabolites were detected in the plasma after 1 h of 25 mg oral dose, 
unchanged resveratrol was detected only in trace amounts of < 5 ng/mL; the half-lives 
ranged from 7 to 14 h. 
There are several strategies to improve the bioavailability of nutraceuticals such as 
encapsulation (microemulsion-based systems) and chemical modification (lipophilisation) 
(Davidov-Pardo and McClements, 2014; Ting et al., 2014; Torres et al., 2010). 
Encapsulation is a technique to trap one or more components within some form of a 
matrix (Davidov-Pardo and McClements, 2014). This technique can protect the 
ingredients from the environmental conditions which may cause chemical degradation 
during storage. However, this technique may need a high amount of encapsulant material 
or surfactant which can restrict its use due to sensory acceptability, economic or legal 
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issues (Davidov-Pardo and McClements, 2014). Another possible way is a chemical 
modification. This technique can improve the bioavailability via modifying chemical 
structures to more favourable forms to be absorbed. Since the nutraceuticals may lose 
their physiological or therapeutic benefits due to structural changes, the structural change 
has to be bio-reversible (Ting et al., 2014).  
 
2.2 Lipid oxidation and phenolics as antioxidants  
2.2.1 Lipid oxidation 
Lipids are one of the major food components, serving as a condensed source of energy, 
providing both favourable and objectionable flavour notes, and affecting the texture of 
products. They can also serve as structural components of cell membranes in biological 
systems (Shahidi and Zhong, 2010). However, lipids containing unsaturated fatty acids 
are prone to oxidation due to several factors such as the presence of heat, light, metal ions, 
enzymes, and photosensitizers; these can lead to food quality deterioration (Shahidi and 
Zhong, 2010). Lipid oxidation not only causes generation of off-flavours and decreases 
the nutritional value of foods, but it can also lead to the formation of toxic compounds 
(Shahidi and Zhong, 2015). Lipid oxidation in the human body can cause loss of structure 
and function of healthy cells, which eventually leads to ageing and non-communicable 
ailments such as cardiovascular disease and cancer (Percival, 1998). There are different 
types of oxidation mechanisms based on the specific factors that initiate lipid oxidation, 
namely autoxidation, photooxidation, thermal oxidation, and enzymatic oxidation. 
Among these, autoxidation is the most common oxidation process that follows a free 
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radical chain mechanism typically involving three steps of initiation, propagation, and 
termination (Figure 2.4).  
 
 
Figure 2.4. Mechanism of lipid oxidation involving initiation, propagation, and 
termination steps.   
 
In order to initiate autoxidation, the presence of initiators such as heat, light, or metal ions 
is necessary. Autoxidation is generally initiated by the abstraction of a hydrogen atom 
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low required dissociation energies. The dissociation energy of bis-allylic, allylic and alkyl 
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hydrogens are 65, 77, and 100 kcal/mol, respectively (Shahidi and Zhong, 2010). This 
process is called the initiation step of autoxidation. After losing its hydrogen atom, the 
alkyl radical formed is stabilised by delocalization (double bond shifting), along with 
possible formation of trans as well as conjugated double bonds of polyunsaturated fatty 
acids (Shahidi and Zhong, 2010). In the propagation step, the alkyl radical reacts with 
triplet oxygen (3O2) to form a peroxyl radical (Frankel, 1984). Subsequently, the lipid 
peroxyl radical abstracts a hydrogen atom from another lipid/fatty acid molecule and 
forms a hydroperoxide, known as the primary product of oxidation. As shown in Figure 
2.5, linoleic acid, for example, can produce a mixture of 9- and 13-hydroperoxides. 
Hydroperoxides are decomposed to alkoxyl radical (RO•), peroxyl radical (ROO•), and 
hydroxyl radical (•OH) and the radicals so produced can further participate in the 
oxidation process (Shahidi and Zhong, 2010). The O-O bond cleavage energy of 
hydroperoxides is 44 kcal/mol, which is easily achieved and yields secondary oxidation 
products such as aldehydes, ketones, alcohols, and hydrocarbons (Choe and Min, 2006). 
Most of the secondary oxidative products are responsible for off-flavours, and some of 
them such as alkanals and vinyl ketones have very low threshold values. Possible 
formation mechanisms of secondary oxidative products are shown in Figure 2.6. Finally, 
during the termination step the radicals produced are stabilised by binding to one other to 
form stable non-radical species. 
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Figure 2.5. Formation of hydroperoxides in the autoxidation of linoleic acid (adopted 
from Choe and Min, 2006). 
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Figure 2.6. Possible mechanisms of formation of secondary oxidation products.  
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2.2.2 Phenolic compounds as antioxidants  
Controlling lipid oxidation is of interest to the food industry for extending the shelf life 
and maintaining food quality of products. In addition, it is very important because the 
oxidation can affect biological systems. Free radicals, believed to be a major contributor 
to cause oxidative damage, can also attack different cells in the body, thus potentially 
causing a myriad of diseases such as cancer and cardiovascular ailments (Percival, 1998). 
Antioxidants, known as a most effective means to control oxidation, can delay the onset 
of oxidation or slow down its rate once it starts (Reische et al., 2002). Antioxidants can be 
classified into primary antioxidants as free radical chain breakers and secondary 
antioxidants such as metal ion chelators and singlet oxygen quenchers (Reische et al., 
2002).  
Phenolic compounds, which are primary antioxidants, can interfere and interrupt the free 
radical chain reaction by donating a hydrogen atom or transferring an electron to the free 
radicals (Equations 1,2, and 3) (Frankel, 1980; Shahidi and Ambigaipalan, 2015).  
 
 
 
In order to serve as an antioxidant, the resultant antioxidant radical (A•) must not be 
involved in further oxidation (Shahidi and Wanasundara, 1992). The phenoxyl radical 
produced is not readily available for further oxidation process, because it is stabilised by 
resonance. The stability of a phenoxyl radical may be enhanced by substitution with a 
bulky group in the ortho and para positions due to the steric hindrance where the radical is 
present (Gordon, 1990).  
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In terms of antioxidant activity, phenol itself is inactive, however substitution can 
increase its activity. Another hydroxyl group in the ortho or para position of phenol 
increases its antioxidant potential due to an intramolecular hydrogen bond (ortho position) 
and possible formation of quinone (para position) (Gordon, 1990). For example, the 
antioxidant activity of 1,2-dihydroxybenzene is higher than 2-methoxyphenol, because 2-
methoxyphenol is unable to form an intramolecular hydrogen bond (Gordon, 1990).  
Furthermore, substitution in the ortho or/and para position with an alkyl group or other 
electron donating groups such as amines (-NH2, -NHR, and -NR2) and ethers (-OR) 
improves the antioxidant activity via the inductive effect. Due to the increased electron 
density, the substituted phenolic antioxidant has a better reactivity toward lipid radicals 
(Rajalakshmi and Narasimhan, 1996). For example, the strong antioxidant activity of 
butylated hydroxyanisole (BHA) is closely related to the methoxylation (Gordon, 1990). 
Substitution in the para position with ethyl, propyl, or butyl groups increases the 
antioxidant activity compared to a methyl group. However, substitution with longer chain 
or electron withdrawing groups such as trihalides (-CF3, -CCl3) and nitro groups (-NO2) 
may decrease the antioxidant activity (Rajalakshmi and Narasimhan, 1996).   
Some phenolics may also act as chelators of metal ions such as those of ferrous and 
copper ions. Metal ions, which have two or more valence states can reduce the induction 
period and accelerate the rate of oxidation by producing radicals via interaction with 
intact lipid molecules or interaction with lipid hydroperoxides (Gordon, 1990; Reische et 
al., 2002). Metals can be involved in the oxidation process even at 10 ppb levels, hence 
all food should be considered in order to control metal ion-assisted oxidation. The most 
commonly used metal chelators are citric acid, phosphoric acid, and 
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ethylenediaminetetraacetic acid (EDTA). EDTA, which is the most powerful metal 
chelator, forms thermodynamically stable complexes with all metal ions, therefore it can 
effectively prevent oxidation during storage (Gordon, 1990). Some phenolic compounds 
can also chelate metal ions (Figure 2.7). 
 
	     
Figure 2.7. A possible mechanism of metal chelation of phenolic compounds (flavonol).  
	  
2.3 Resveratrol  
2.3.1 Resveratrol in foodstuffs  
Resveratrol, a stilbenoid (Figure 2.8), is present in grapes, especially grape skins, and is 
also expected to be present in grape products and processing by-products (Siemann and 
Creasy, 1992). According to Siemann and Creasy (1992), resveratrol itself had already 
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been reported to have lipid-lowering effects and wine also reduced serum lipid levels in 
humans, thus it was hypothesised that resveratrol in wine would have beneficial effects.  
 
Figure 2.8. Structures of representative stilbenoids. 
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Resveratrol has been known since 1940, however it was not of interest to scientists until 
1992, when it was used to explain the protective effects of red wines on CHD (Baur and 
Sinclair, 2006).  
Resveratrol is produced by the plant as a phytoalexin, which is believed to exert an 
important disease resistance mechanism in higher plants (Langcake and Pryce, 1977). It is 
synthesized in response to stress, injury, infection, or UV-irradiation (Soleas et al., 1997). 
However, resveratrol is not well distributed in the plant kingdom and its presence has 
been limited to a few edible plants. The primary source of resveratrol from edible plant 
parts is grape, wine, and to a lesser extent peanuts (Soleas et al., 1997). Siemann and 
Creasy (1992) studied the concentration of resveratrol in wine and found that resveratrol 
was present in red wines from less than 0.003 to 2.861 µmol/L and white wine from less 
than 0.001 to 0.438 µmol/L. In addition, they found that resveratrol concentration differed 
by geographical origins (e.g. New York and California). The concentration of resveratrol 
in wine may vary depending on the type of grape, fungal infection, growing methods, 
climatic factors, and wine processing. The level of resveratrol in wine is also affected by 
species. For example, Pinot Noir grapes have greater ability to synthesize resveratrol 
regardless of other factors such as soil and climate (Soleas et al., 1997). This might be 
due to its thin skin compared to other types of grapes. The thin skin makes it susceptible 
to damage from infection and UV-irradiation. Resveratrol plays an important role against 
fungal infection, therefore its concentration is higher in colder and moister growing 
climates (Siemann and Creasy, 1992; Kopp, 1998). As already mentioned, resveratrol is 
present in higher concentrations in red wine than white wine; a possible reason is the 
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different processing between red and white wines. After pressing of grapes for wine 
making, the skins remain in the red wine processing, whereas the skins are removed in the 
white wine processing (Siemann and Creasy, 1992).  
Resveratrol is also found in peanuts, but only in infected tissues. The level of resveratrol 
can be varied by stimuli, which can be a fungal infection or mechanical damage (Sanders 
et al., 2000). In addition, immature peanut kernels contain a high concentration of 
stilbenes, the capability of producing stilbene could be reduced with maturity (Sobolev 
and Cole, 1999). Sobolev and Cole (1999) reported that resveratrol concentrations in 
commercially available peanut products such as roasted peanuts, peanut butter, boiled 
peanuts were 0.055 ± 0.023, 0.324 ± 0.129, and 5.138 ± 2.849 µg/g, respectively. Sanders 
et al. (2000) studied the concentration of resveratrol in five different peanut cultivars and 
peanuts were stored for up to 3 years in cold temperatures. They found that the 
concentrations of resveratrol were 0.02-1.79 µg/g of peanuts. They suggested that the 
discrepancy in the concentration of resveratrol with other studies might be due to the 
different levels of fungal invasion.  
Medicinal herbs serve as another source of resveratrol. Burns et al. (2002) compared the 
concentration of resveratrol in wine, peanut products, and Itadori plants (Polygonum 
cuspidatum), which has been used as a traditional herbal remedy for heart disease and 
strokes. They reported that grapes and peanuts had a low concentration of stilbenes, 
however Itadori tea and red wine had a high concentration of resveratrol, suggesting that 
Itadori tea could serve as a good source of resveratrol for non-alcohol drinkers.  
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2.3.2 Resveratrol as an antioxidant  
As a phenolic compound, resveratrol has been of interest to many researchers to explore 
its antioxidant capacity. It has three hydroxyl groups, which makes it a good free radical 
scavenger. Gülçin (2010) reported that resveratrol exhibited the highest inhibition of lipid 
peroxidation, followed by BHA, BHT, trolox, and α-tocopherol (in decreasing order) at 
30 µg/mL. In reducing power assay, BHA showed the highest activity using ferric ion 
(Fe3+) and cupric ion (Cu2+). Resveratrol exhibited the second highest Fe3+ reducing 
power followed by trolox, BHT and α-tocopherol; BHT had the second highest Cu2+ 
reducing ability followed by resveratrol, α-tocopherol, and trolox. However, according to 
Pulido et al. (2000), resveratrol showed the lowest reducing power compared to tannic 
acid, selected flavonoids (quercetin, rutin, and catechin), selected phenolic acids (gallic 
acid, caffeic acid, and ferulic acid), and reference compounds (ascorbic acid, trolox, and 
BHA). They suggested that the lowest reducing power of resveratrol might be due to the 
lack of o-dihydroxy phenolic structures compared to flavonoids. Gülçin (2010) reported 
that resveratrol showed the highest superoxide anion radical scavenging activity, followed 
by BHT, BHA, trolox, and α-tocopherol. On the other hand, resveratrol had the lowest 
hydrogen peroxide scavenging ability (in the order of BHT > BHA > α-tocopherol > 
trolox > resveratrol). Gülçin (2010) also compared the scavenging activities of DPPH 
radical and ABTS radical cation. In the DPPH radical scavenging activity, BHA showed 
the highest radical scavenging activity, followed by BHT, resveratrol, trolox, and α-
tocopherol. However, resveratrol showed a slightly higher ABTS radical cation 
scavenging activity than BHA and BHT and this decreased in the order of trolox > α-
tocopherol. Gülçin (2010) explained that resveratrol had monophenol and diphenol 
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moieties which were linked by an ethylene bridge and donating hydrogen from the 
monophenol moiety could easily occur. Caruso et al. (2004) also reported that the para 
position was more stable after than the meta position upon donating a hydrogen atom, 
therefore donating hydrogen from 4'-OH was preferred. Hussein (2011) studied the 
hydroxyl radical scavenging activity of resveratrol and reference compounds such as 
trolox, ascorbic acid, BHT, and BHA; resveratrol showed the highest radical scavenging 
activity (resveratrol > trolox > ascorbic acid > BHT > BHA) which was concentration-
dependent in the range of 20-80 µg/mL. Hussein (2011) discussed that the antioxidant 
activity of phenolic compounds was related to their structural features such as 
substitutions, numbers of hydroxyl groups and their positions. Soares et al. (2003) studied 
the antioxidant activity of BHT, propyl gallate (PG), resveratrol, α-tocopherol, and 
ascorbic acid against ABTS radical cation, DPPH radical, and hydroxyl radical. BHT and 
resveratrol showed a higher ABTS radical cation scavenging activity than PG and 
ascorbic acid. However, resveratrol showed lower DPPH radical scavenging activity than 
BHT, PG, and ascorbic acid. In both ABTS radical cation and DPPH radical scavenging 
activity, α-tocopherol did not show any measurable radical scavenging activity, possibly 
due to the solvent (Tris-HCl buffer) used for dissolving the samples. BHT and resveratrol 
exhibited the highest inhibition of β-carotene oxidation against hydroxyl radical (H2O2 
and Fe2+). They also studied the survival of Saccharomyces cerevisiae against hydrogen 
peroxide, in which resveratrol was able to 100% protect yeast cells even at the highest 
concentration of hydrogen peroxide (33mM), whereas PG did not show any protective 
effect. Resveratrol also inhibited copper-catalyzed LDL oxidation. Frankel et al. (1993) 
reported that resveratrol inhibited hexanal formation of copper-catalyzed LDL oxidation 
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by 70-81%. They also reported that resveratrol exhibited a much higher inhibition of 
hexanal formation than α-tocopherol, whereas epicatechin and quercetin showed better 
efficacy than resveratrol. However, others have reported a higher inhibition of copper-
induced LDL oxidation for resveratrol compared to flavonoids due to a better ability to 
bind with copper (Frémont et al., 1999; Caruso et al., 2004). Belguendouz et al. (1998) 
studied the interaction of resveratrol with plasma lipoproteins and found that the 
concentration of resveratrol increased as lipid content of lipoprotein increased (high-
density lipoprotein < LDL < very low-density lipoprotein); they suggested that resveratrol 
had a lipophilic character. In addition, they studied the inhibition of formation of 
thiobarbituric acid reactive substances (TBARS) in unilamellar liposomes containing 
phospholipids and found that resveratrol was more effective than trolox but was as 
effective as α-tocopherol.  
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Figure 2.9. Resonance structures of resveratrol radical. 
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2.3.3 Other properties of resveratrol  
Resveratrol is speculated to play a role against atherosclerosis and CHD. One possible 
way to prevent heart disease is the inhibition of LDL cholesterol oxidation which may be 
achieved by resveratrol (Holvoet, 2004, Frankel et al., 1993). Inappropriate platelet 
aggregation can also cause heart disease due to thrombus formation and consequently 
blood vessel blockage (Baur and Sinclair, 2006). Pace-Asciak et al. (1995) reported that 
resveratrol and quercetin might protect the heart from diseases via blocking platelet 
aggregation and synthesis of eicosanoids such as thromboxane B2 (TxB2), 
hydroxyheptadecatrienoate (HHT), and 12-hydroxyeicosatetraenoate (12-HETE). They 
found that while resveratrol and quercetin inhibited platelet aggregation induced by 
thrombin and adenosine diphosphate (ADP) in a dose-dependent manner, ethanol was 
able to inhibit only thrombin-induced platelet aggregation. In addition, resveratrol was 
able to inhibit the synthesis of the three aforementioned eicosanoids, but the synthesis of 
12-HETE was less affected compared to other eicosanoids. Wang et al. (2002) also 
reported that resveratrol inhibited platelet aggregation induced by collagen as well as 
thrombin and ADP in a concentration-dependent manner in vitro. In addition, they found 
that resveratrol (4 mg/kg/day) was able to decrease platelet aggregation rate of high-
cholesterol fed rabbits from 61.0 ± 7.0 to 35.7 ± 6.3% (platelet aggregation rate of control 
rabbit, 39.5 ± 5.9%) without having any effect on serum lipid levels in vivo. Another way 
to decrease the risk of atherosclerosis related to blood pressure, serum total cholesterol 
and triacylglycerol levels is the caloric restriction (Fontana et al., 2004). The caloric 
restriction is consuming 60-70% calorie of normal diet without affecting any of the 
nutrients (Guarente and Picard, 2005). Resveratrol has been shown to activate Sir2, which 
	   31	  
is a key to regulate the beneficial effects of caloric restriction to extend the lifespan in 
yeast (Baur et al., 2006; Guarente and Picard, 2005) and SIRT1, which is the closest 
homologue to Sir2 based on amino acid sequence, among sirtuins in mammals (Baur and 
Sinclair, 2006; Howitz et al., 2003). Baur et al. (2006) studied the effects of resveratrol in 
mice fed a high-calorie diet. They categorized mice into three groups of standard diet, 
high-calorie diet, and high-calorie diet with 0.04% of resveratrol. Changes related to 
longer lifespan such as insulin sensitivity, motor function, and mitochondrial number 
were then monitored. They found that resveratrol could change the physiology of high-
calorie diet in mice towards standard diet mice and increase survival of mice on the high-
calorie diet.  
Anti-inflammatory effect of resveratrol has also been reported. Although inflammation is 
a normal reaction to the injury or infection, chronic inflammation can lead to various 
diseases such as cardiovascular ailment and cancer (Zhong et al., 2012; Steinberg, 2002). 
Immune cells such as neutrophils, macrophages, and monocytes can initiate inflammation 
in the damaged tissue via the release of various pro-inflammatory cytokines such as 
interleukin (IL)-1 and tumour necrosis factor (TNF)-α, and reactive oxygen/nitrogen 
species (ROS/RNS) (Zhong et al., 2012; Wiseman and Halliwell, 1996). In addition, 
cyclooxygenase (COX) may also play a crucial role in inflammation via producing pro-
inflammatory molecules (Simmons et al., 2004; Baur and Sinclair, 2006). According to 
Jang et al. (1997) resveratrol inhibited COX-1 such as cyclooxygenase activity and 
hydroperoxidase activity. However, resveratrol showed an inhibition only for 
hydroperoxidase activity of COX-2. They also reported that resveratrol was able to 
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reduce both acute and chronic phases of pedal edema. This effect was greater than 
phenylbutazone, an anti-inflammatory drug. Khanduja et al. (2004) studied the hepatic 
and pulmonary COX activity induced by N-nitrosodiethylamine (NDEA) via measuring 
the level of prostaglandins (PGE2, PGD2, and PGF2α) and reported that resveratrol 
significantly reduced the prostaglandin levels via inhibiting pulmonary COX activity. 
Although NDEA did not affect the hepatic COX activity to produce prostaglandins, 
resveratrol reduced its synthesis. Bi et al. (2005) reported that resveratrol was able to 
inhibit the generation of nitric oxide (NO) and TNF-α induced by LPS-stimulated 
microglia and suggested that it had a potent anti-inflammatory activity on microglia, brain 
macrophage. Furthermore, Tsai et al. (1999) reported that resveratrol inhibited the 
production of NO and reduced the amount of inducible NO synthase (iNOS) in the 
murine macrophage via suppression of iNOS mRNA.  
Resveratrol is known to have anticancer activity. Jang et al. (1997) stated that anticancer 
activity of resveratrol was related to several stages of carcinogenesis such as initiation, 
promotion, and progression. Resveratrol showed antioxidant and anti-mutagenic activity, 
which is related to tumour initiation. In addition, resveratrol was able to reduce 
inflammation (anti-promotion) and induce differentiation of human promyelocytic 
leukemia cell (anti-progression). According to Sgambato et al. (2001), resveratrol showed 
anti-proliferative activity on different types of cell lines such as rat fibroblast and mouse 
mammary epithelial cells as well as human breast, colon, prostate, and cervix cancer cells. 
Moreover, they reported that resveratrol was able to reduce nuclear DNA fragmentation. 
Patel et al. (2010) studied the level and anticancer activity of resveratrol and its 
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metabolites in the colorectal tissue of cancer patients. They gave 0.5 or 1.0 g of 
resveratrol for eight days to the twenty patients and took colorectal tissues and reported 
that the highest resveratrol concentration was 18.6 and 674 nmol/g for the 0.5 and 1.0 g 
dose, respectively. In addition, tumour cell proliferation was reduced by 5%. Aires et al. 
(2013) examined the anticancer activity of resveratrol metabolites (resveratrol-3-O-
sulphate, resveratrol-3-O-glucuronide, and resveratrol-4'-O-glucuronide) on human 
metastatic colon cancer cells. Among metabolites, only resveratrol-3-O-sulphate inhibited 
cell proliferation and accumulation of cells in the S phase. Surprisingly, the mixture of 
these three metabolites exerted a synergistic effect on cell proliferation, which was better 
than resveratrol itself. 
 
2.3.4 Antioxidant and biological activity of modified resveratrol  
It is a well-known fact that utilizing resveratrol for health benefits has limitations due to 
its fast metabolism (Walle et al., 2004; Yu et al., 2002). Many attempts have been made 
to increase the bioavailability of resveratrol, and this may be achieved by structure 
modification which may disturb glucuronidation and/or sulphation (Torres et al., 2010). 
Moreover, increased lipophilicity may enhance affinity with lipophilic cell membranes so 
that cellular uptake may be increased (Cardile et al., 2005). Torres et al. (2010) studied 
the antioxidant activity of resveratrol derivatives using trolox equivalent antioxidant 
capability (TEAC) assay and compared the results with trolox and α-tocopherol. They 
reported that resveratrol showed better antioxidant activity than trolox and α-tocopherol. 
They observed that the antioxidant activity of resveratrol derivatives decreased as the 
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acylation increased (resveratrol > monoesters > diester > triester). In addition, resveratrol 
with vinyl acetate showed better antioxidant activity than resveratrol with vinyl stearate 
(C2 > C18:0).  
Several biological activities of resveratrol derivatives have been reported. Fragopoulou et 
al. (2007) studied the effects of resveratrol and its acetylated derivatives (mono-, di-, and 
triester) on platelet aggregation. They reported that the diesters showed the highest 
inhibition of platelet aggregation, whereas resveratrol as well as its mono-, and triester 
exhibited similar inhibitions. Cardile et al. (2005) prepared resveratrol derivatives using a 
chemo-enzymatic synthesis and studied the cell growth inhibition activity on DU-145 
human prostate cancer cells as well as toxicity on non-tumourigenic human fibroblast 
cells. Resveratrol derivatives showed similar or better cell growth inhibition than the 
parent molecule. Moreover, resveratrol derivatives exhibited very low toxicity in non-
tumourigenic cells. Mazué et al. (2010) modified trans- and cis-resveratrol via 
hydroxylation and methylation and then examined their inhibitory activity on the 
proliferation of human colorectal tumour cells (SW 480). They reported that cis-3,5,4'-
trimethoxystilbene showed the highest inhibition of tumour cell growth after 48 h of 
treatment and this was much higher than both trans- and cis-resveratrol. Cichocki et al. 
(2008) studied the effect of pterostilbene on nuclear factor (NF)-κB, activator protein 
(AP)-1, COX-2, and iNOS induced by 12-O-tetradecanoylphorbol-13-acetate. They 
reported that pterostilbene showed equal or better inhibition than resveratrol in most of 
the assays and suggested that this might be due to the increased lipophilicity, which might 
elicit better bioavailability. Pan et al. (2007) studied the cytotoxic effect of pterostilbene 
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on COLO205, AGS, HL-60, and HepG2 cell lines and reported that pterostilbene (100 
µM) had the highest cytotoxic effect on AGS cells, among others. Moreover, they 
confirmed that the cytotoxic effect was due to the apoptotic cell death.  
 
2.4 Quercetin  
2.4.1 Quercetin in foodstuffs  
Quercetin is a flavonoid belonging to the flavonol subgroup. Flavonoids are widespread 
in the plant kingdom and are generally present in daily diet (Formica and Regelson, 1995). 
In addition, quercetin can be found in high concentrations in certain plant-based 
foodstuffs. Hertog et al. (1992) reported that quercetin in the edible portion of vegetables 
was usually present in less than 10 mg/kg, however onions, kale, broccoli, French beans, 
and slicing beans were found to contain high amounts of quercetin, at 284-486, 110, 30, 
32-45, and 28-30 mg/kg, respectively. In addition, they also studied the concentration of 
quercetin in fruit and reported that the average amount of quercetin was 15 mg/kg, but 
apple contained 21-72 mg/kg of quercetin depending on the variety. Hertog et al. (1993) 
expanded their study from vegetables and fruits to tea infusion, wine, and fruit juice. 
They reported that quercetin in white wine, beer, coffee, and chocolate milk was less than 
0.5 to 1.3 mg/L. Quercetin in fruit juices such as apple juice, grape juice, and grapefruit 
juice was less than 5 mg/L, whereas quercetin in fresh lemon juice and tomato juice was 
7.4 and 13 mg/L, respectively. Red wine contained quercetin at 4-16 mg/L and black tea 
infusion had 10-25 mg/L.  
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Figure 2.10. Quercetin and its glycosides found in plant-based foods.  
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Quercetin can also exist as a glucoside. According to Zielinska et al. (2008), the dominant 
flavonoids in the flesh of two onion varieties, Sochaczewska and Szalotka, were 
quercetin-4'-O-β-glucoside (61 and 54%), quercetin-3,4'-di-O-β-glucoside (37 and 44%), 
quercetin-3-O-β-glucoside (1.4 and 1.1%), and quercetin (1.1 and 0.7%). Hempel and 
Böhm (1996) reported that quercetin-3-O-glucuronides, quercetin-3-O-rutinosides, 
kaempferol-3-O-glucuronides, and kaempferol-3-O-rutinosides were the main flavonoid 
glycosides present in six varieties of yellow and green French beans. The total contents of 
quercetin glucosides and kaempferol glucosides were 19.1-183.5 and 5.6-14.8 µg/g, 
respectively. Stewart et al. (2000) studied the flavonol contents of 20 varieties of tomato 
and 10 commonly consumed tomato products. They reported that most flavonols were 
found in the tomato skin (98%) and the main quercetin conjugate was rutin. Among 
tomato products, tomato purée and tomato juice contained the highest level of quercetin 
and rutin. 
 
2.4.2 Quercetin as an antioxidant  
As shown in Figure 2.11, the antioxidant activity of flavonoids, as reflected in their 
radical scavenging activity, may increase if there is a 3',4'-dihydroxyl group in the B ring, 
and a 2,3-double bond and a 4-oxo moiety in the heterocycle (C ring); these allow for 
conjugation between A and B rings, and 3- and 5-hydroxyl groups in the A and C rings, 
respectively (Bors et al., 1990; Rice-Evans et al., 1996; Pulido et al., 2000). Quercetin, 
taxifolin, and catechin have a 5-hydroxyl group, however, taxifolin has no 2,3-double 
bond and catechin lacks both the 2,3-double bond and the 4-oxo moiety in the C ring. 
	   38	  
Quercetin (4.7 ± 0.1 mM) showed a roughly 2-fold higher radical scavenging activity 
compared to taxifolin (1.9 ± 0.0 mM) and catechin (2.4 ± 0.1 mM) in the TEAC assay. 
This might be due to the structural effect, which may allow the phenoxyl radical to be 
more stabilised via electron delocalization across the molecule (Rice-Evans et al., 1996). 
In addition, a 3-hydroxyl group in the C ring is important in terms of antioxidant activity. 
Compared to rutin (3-O-glycoside) or luteolin (lack of 3-OH), quercetin showed 
approximately 2 times more antioxidant activity than the other compounds (Rice-Evans et 
al., 1996). The influence of a 2,3-double bond on antioxidant activity can be limited when 
there is no ortho-diphenolic structure in the B ring. Kaempferol (lack of 3'-OH) exhibited 
similar antioxidant activity in the TEAC assay compared to aromadendrin (lack of both 
3'-OH and 2,3-double bond). The antioxidant activity of apigenin (lack of 3'-OH) and 
chrysin (lack of 3'-OH and 4'-OH), both with similar antioxidant activity to kaempferol, 
also supported the effect of ortho-diphenolic structural effect in antioxidant activity 
(Rice-Evans et al., 1996). The effect on the antioxidant activity of an ortho-diphenolic 
structure might be due to the possible formation of either semiquinone or quinone, which 	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Figure 2.11. Important parts of quercetin for radical scavenging activity.  
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could stabilise the electron (Bors et al., 1990). Pulido et al. (2000) examined the solvent 
effect (methanol vs. distilled water) toward ferric reducing/antioxidant power (FRAP) 
assay using tannic acid, flavonoids (quercetin and catechin), phenolic acids (gallic acid 
and caffeic acid,), and reference compounds (ascorbic acid and trolox). Test compound 
with ferrous ion in methanol showed higher FRAP values than test compound with 
ferrous ion in distilled water, however the order of FRAP values was the same. Quercetin 
exhibited the highest FRAP value among all tested samples. Quercetin also showed 
inhibition against LDL cholesterol oxidation and it was 2-fold more effective than 
resveratrol (Frankel et al., 1993). Frémont et al. (1999) compared to inhibition against 
LDL cholesterol oxidation induced by copper and AAPH (radical initiator) using 
quercetin, resveratrol, catechin, epicatechin, and trolox. While quercetin showed the 
highest inhibition in the presence of AAPH, resveratrol exhibited the best protection in 
the presence of copper. Meyer et al. (1998) compared inhibition activity of catechin, 
cyanidin, caffeic acid, quercetin, and ellagic acid against LDL oxidation and reported that 
the inhibition was in the order of catechin > cyanidin ≈ caffeic acid > quercetin > ellagic 
acid. Huber et al. (2009) studied the antioxidant activity of quercetin and its glycosides 
(quercetin-3-O-glucoside, quercetin-3-O-galactoside, quercetin-3-O-rhamnoside, and 
quercetin-3-O-rutinoside) in omega-3 polyunsaturated fatty acids and bulk fish oil 
compared with that of BHT and α-tocopherol. They reported that quercetin showed 
similar or better antioxidant activity than quercetin glycosides in the oil-in-water 
emulsion system and also displayed better antioxidant activity compared to α-tocopherol. 
On the other hand, quercetin and quercetin-3-O-glucoside showed better antioxidant 
activity than BHT in bulk oil. Zielinska et al. (2008) reported that the antioxidant activity 
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of quercetin and its glycosides evaluated by TEAC assay was in the order of quercetin > 
quercetin-3-O-β-glucoside > quercetin-4'-O-β-glucoside > quercetin-3,4'-di-O-β-
glucoside. Zhang et al. (2011) observed that quercetin exhibited better reduction 
potential than curcumin at pH 3, 7, and 9.5. In examining the total antioxidant 
capacity using phosphomolybdenum, quercetin showed 3.5 times stronger effect 
compared to curcumin. In addition, they reported that quercetin was able to reduce 
NO and ROS production induced by LPS in the human acute monocytic leukemia cell. 
Gordon and Roedig-Penman (1998) studied the antioxidant activity of quercetin and 
myricetin in a small unilamellar liposome and α-tocopherol was employed as a reference. 
Myricetin showed the highest antioxidant activity, followed by quercetin > α-tocopherol 
at pH 5.4 and a phospholipid concentration of 0.01 mol/mol. They also compared the 
effect of cupric chloride and ferric chloride on oxidation and found that cupric chloride 
could cause more oxidation than ferric chloride. While quercetin showed better 
antioxidant activity than myricetin in the presence of cupric chloride, myricetin exhibited 
a greater antioxidant activity than quercetin in the presence of ferric chloride. Mira et al. 
(2002) studied the metal chelation of the following flavonoids: flavonols (quercetin, 
kaempferol, myricetin, and rutin); flavones (apigenin and luteolin); a flavanol (catechin); 
flavanones (taxifolin, naringenin, and naringin); and isoflavones (daidzein and genistein). 
The result showed that all flavonoids had a better reducing activity for Cu2+ than Fe3+. 
They reported that only myricetin and quercetin were able to reduce Fe3+, concluding that 
this might be due to the presence of ortho-diphenolic structure in the B ring and 3-OH, 
2,3-double bond, and 4-oxo group in C ring. In Cu2+ reducing study, myricetin showed 
the highest reducing activity followed by taxifolin, catechin, quercetin > rutin > naringin 
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> luteolin, kaempferol. They suggested the reducing activity of Cu2+ might depend on the 
number of hydroxyl groups of flavonoids. According to Mira et al. (2002), a 2,3-double 
bond in the flavonoids renders the molecule more planar and more rigidity so that the A 
and C rings can be in a more coplanar position. Hence the 3-OH, 4-oxo, and 5-OH group 
of flavonoids can be closer to each other. Mira et al. (2002) studied the metal chelation 
via a spectrophotometric method and observed the occurrence of bathochromic shifts in 
the interaction between flavonoids and metal ions. The peaks of Cu2+ with kaempferol, 
luteolin, and apigenin from spectra were around 408 nm at both pH 5.5 and 7.4. This 
implied that the metal chelation might occur at the same site, possibly between the 5-OH 
and 4-oxo group. On the other hand, the peaks of Cu2+ with myricetin or quercetin at pH 
7.4 from the spectra were around 436 nm. This might be due to the 3 possible metal 
chelating sites of these two flavonoids, thus myricetin and quercetin had the peaks at the 
longer wavelength. However, the spectral peaks of Cu2+ with myricetin or quercetin at pH 
5.5 were around 412 nm, which is similar to kaempferol, luteolin, and apigenin. This 
result implies that myricetin and quercetin might have more metal chelating sites at pH 
7.4 than at pH 5.5. In fact, metal chelation ability of catechol (orthodiphenolic structure) 
can be enhanced by the increase of pH. Leopoldini et al. (2006) reported that metal 
chelation between 4-oxo and 5-OH showed minimum energy (0.0 kcal/mol), whereas 
metal chelation between 3′-OH and 4′-OH showed the highest energy (12.3 kcal/mol).  
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Figure 2.12. Possible sites of quercetin for cupric ion chelation.  
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on CHD via blocking platelet aggregation induced by thrombin and ADP as well as 
eicosanoid synthesis (12-hydroxyeicosatetraenoate). Egert et al. (2009) studied the effect 
of quercetin on blood pressure, lipid metabolism, oxidative stress, inflammation, and 
body composition in 93 overweight or obese subjects. They found that the quercetin 
treatment group decreased both systolic blood pressure by 2.6 mmHg (P < 0.01) and 
plasma concentration of atherogenic oxidized LDL, compared to the placebo group. 
However, quercetin did not alter total cholesterol, triacylglycerol (TAG), LDL: HDL ratio, 
and TAG: HDL ratio.  
Quercetin has also been shown to have anticancer activity. Lu et al. (2006) studied the 
anticancer activity of quercetin and myricetin by inhibiting mammalian thioredoxin 
reductase and found that both quercetin and myricetin showed powerful inhibitory 
activity on mammalian thioredoxin reductase. They suggested that one of the anticancer 
mechanisms of quercetin might be due to enzyme inhibition. Agullo et al. (1994) studied 
the cytotoxic effect of quercetin on colon carcinoma (HT-29, Caco-2 cells) and reported 
its cytotoxicity on active proliferating cells in a dose-dependent manner.  
According to Vessal et al. (2003), quercetin showed antidiabetic effects in diabetic rats 
induced by streptozocin. While quercetin was able to reduce plasma glucose level of 
diabetic rats, it was unable to reduce plasma glucose level in normal rats. Plasma 
cholesterol and triacylglycerol levels in diabetic rats decreased significantly. Furthermore, 
they reported that quercetin was able to increase hepatic glucokinase activity. Coskun et 
al. (2005) studied the protective effect of quercetin on oxidative stress and β-cell damage 
in diabetic rat pancreas induced by streptozotocin. Quercetin was able to reduce the level 
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of malondialdehyde and NO production and increase antioxidant enzyme activity. 
Furthermore, quercetin increased insulin staining and preserved islet cells in diabetic rats.  
 
2.4.4 Antioxidant and biological activity of modified quercetin  
Low bioavailability of quercetin has been an issue of concern to many scientists. Many 
attempts have been made to enhance its bioavailability while maintaining its beneficial 
effects; a possible way is by structure modification. Mainini et al. (2013) prepared 
quercetin triesters, tetraesters, and pentaesters using stearic, oleic, linoleic, and linolenic 
acids and evaluated antioxidant activity of quercetin esters by TEAC and DPPH radical 
scavenging assays. They reported that quercetin showed the highest antioxidant activity in 
both assays. Among esters, triesters exhibited a stronger antioxidant activity than 
pentaesters. Guardia et al. (2001) studied the effect of rutin (quercetin-3-O-glycoside), 
quercetin, and hesperidin on acute and chronic inflammation in the rat. They induced 
arthritis in the rat using carrageenan; phenylbutazone was a positive control. They 
reported that rutin and quercetin were able to decrease inflammation in the acute phase 
and rutin showed the most potential in the chronic phase. Montenegro et al. (2007) 
prepared quercetin-3-O-acyl esters and evaluated their water stability, solubility, 
susceptibility to enzymatic hydrolysis, and permeability. They observed quercetin with 
acetic acid and caproic acid not stable in water. Some esters (quercetin with propionic 
acid, butyric acid, and lauric acid) showed more susceptibility to hydrolysis by human 
plasma. Furthermore, quercetin with propionic acid and butyric acid not only had a better 
solubility in water than quercetin itself but also exhibited greater permeability than the 
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parent molecule. Hence, they suggested that quercetin with propionic acid and butyric 
acid could serve as quercetin prodrugs. Biasutto et al. (2007) studied the effect of 
esterification on transepithelial transport by measuring permeation of three different 
epithelial cell monolayers, namely MDCK-1, MDCK-2, and Caco-2 cells. They reported 
that all types of cells extensively metabolized the parent molecule. Some esters 
(pentaacetylquercetin, 3′-t-butyl-oxycarbonyl-D-alanine tetraacetylquercetin ester, 3′-[4-
(t-butyl-oxycarbonyl-amino)butanoic acid] tetraacetylquercetin ester, and 3′-[6-(t-butyl-
oxycarbonyl-amino)hexanoic acid] tetraacetylquercetin ester) passed through monolayer 
and underwent partial deacylation. They suggested that ester derivatives might provide a 
useful means to increase the level of systemic aglycone. 
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CHAPTER 3 
Materials and methods 
Part of this chapter has been published in J. Agric. Food Chem. (2017), 65, 8617-8625 
and Food Chem. (2018), 261, 267-273.  
3.1 Materials  
The materials reported in this chapter are for all studies performed in this thesis. 
Resveratrol and DHA single cell oil (DHASCO) were procured from DSM (Columbia, 
MD, USA). EPA ethyl ester was a product of Mochida Pharmaceutical CO., LTD. (Tokyo, 
Japan) and was kindly provided by Professor Kazuo Miyashita. Potassium hydroxide was 
purchased from BDH Inc. (Toronto, ON, Canada). Silica gel and flexible thin layer 
chromatography (TLC) plates with silica gel 60A (2.5 × 7.5 cm) were bought from 
Selecto Scientific (Suwanee, GA, USA). Deuterated dimethyl sulphoxide (DMSO-d6) 
containing tetramethylsilane (TMS) was purchased from Cambridge Isotope Laboratories, 
Inc. (Andover, MA, USA). Acyl chlorides (propionyl chloride, butyryl chloride, caproyl 
chloride, capryloyl chloride, capryl chloride, lauroyl chloride, myristoyl chloride, 
palmitoyl chloride, stearoyl chloride, and oleoyl chloride), 2,2-diphenyl-1-picrylhydrazyl 
(DPPH) radical and 2,2'-azino-bis (3-ethylbenzothiazoline-6-sulphonic acid) (ABTS), 
trolox, and 2,2'-azobis(2-amidinopropane) dihydrochloride (AAPH), were obtained from 
Sigma-Aldrich Canada Ltd (Oakville, ON, Canada). Hydrogen chloride, phosphate 
buffers (sodium phosphate monobasic and sodium phosphate dibasic), sodium chloride, 
and other solvents were procured from Fisher Scientific Ltd (Ottawa, ON, Canada). 
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SensoLyte 520 HCV fluorimetric Protease Assay Kit (lot #1028) and HCV NS3/4A 
protease (lot# 103-075), bought from Anaspec. Com. (San Jose, CA, USA).  
The RAW 264.7 cells, derived from murine macrophages, were procured from the 
American Type Culture Collection (Rockville, MD, USA). Heat-inactivated fetal calf 
serum was purchased from GIBCO (Grand Island, NY, USA). LPS (Escherichia coli 
O127:E8, molecular weight, 60 kDa) was purchased from Sigma Chemical Co. (St. 
Louis, MO, USA). Both the human AGS and MCF7 cell lines were isolated from gastric 
adenocarcinoma (ATCC CRL-1739) and breast adenocarcinoma (ATCC HTB-22). Fetal 
bovine serum (FBS) was bought from Biological Industries (Cromwell, CT, USA). 
Alpha-glucosidase (from Bacillus stearothermophilus, Lot# SLBP7209V), tert-
butylhydroperoxide (t-BOOH) and dichlorofluorscein-2',7'-diacetate (DCFH-DA) and all 
other chemicals, not mentioned which were used, were purchased from Sigma-Aldrich 
(Oakville, ON, Canada). 
 
3.2 Methods 
3.2.1 Lipophilisation of resveratrol and effects on antioxidant activities 
3.2.1.1 Preparation of EPA and DHA   
EPA was produced from its ethyl ester via saponification. Preparation of DHA from 
DHASCO was carried out as described by Wanasundara and Shahidi (1999). DHASCO 
(30 g) was saponified using potassium hydroxide (6.9 g), water (13.2 mL), and 95% 
aqueous ethanol (79.2 mL) under reflux conditions and under a nitrogen atmosphere at 62 
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± 2 °C. Water (60 mL) and hexane (100 mL x2) were subsequently added, mixed, and 
separated; the hexane layer was discarded to remove unsaponifiable matter. The pH of the 
aqueous layer was adjusted to 1 with 3.0 M HCl. Hexane (50 mL x4) was subsequently 
added to extract the liberated free fatty acids which were then passed through a layer of 
anhydrous sodium sulphate.  The hexane was subsequently removed by using a rotary 
evaporator. The free fatty acids obtained were stirred with 20% urea in 95% aqueous 
ethanol (150 mL, w/v) at 60 °C. When a clear solution resulted, the mixture was kept for 
24 h at 4 °C to allow the formation of urea-complexed crystals. The crystals were 
removed by suction filtration followed by the addition of an equal volume of the water to 
non-urea complexed fraction (NUCF) and the pH was adjusted to 4-5 with 6.0 M HCl. An 
equal volume of hexane was added and stirred for 1 hour. The hexane layer was passed 
through anhydrous sodium sulphate and the hexane subsequently removed by rotary 
evaporation. The identity and relative purity of the DHA so obtained were confirmed by 
gas chromatography-mass spectrometry (GC-MS) of its fatty acid methyl ester (FAME). 
3.2.1.2 Preparation of resveratrol derivatives    
Preparations of resveratrol derivatives were carried out according to Zhong and Shahidi 
(2011). EPA and DHA were converted to eicosapentaenoyl chloride and docosahexaenoyl 
chloride with thionyl chloride. The mole ratio between PUFA and thionyl chloride was 
1:2. Resveratrol was dissolved in ethyl acetate and then pyridine was added at a mole 
ratio of 1:1. Acyl chlorides (propionyl chloride, butyryl chloride, caproyl chloride, 
capryloyl chloride, capryl chloride, lauroyl chloride, myristoyl chloride, palmitoyl 
chloride, stearoyl chloride, oleoyl chloride, eicosapentaenoyl chloride, and 
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docosahexaenoyl chloride) were added dropwise to a solution of resveratrol in ethyl 
acetate. The reaction proceeded under reflux heating and a blanket of nitrogen at 50 °C. 
Upon completion of the reaction, the mixture was allowed to stand until it reached room 
temperature and was then washed 3 times with distilled water (60 °C). The ethyl acetate 
layer was then passed through a layer of anhydrous sodium sulphate followed by the 
removal of the solvent. 
3.2.1.3 Purification of resveratrol derivatives 
The resveratrol derivatives were purified using column chromatography on silica gel. The 
solvent ratios used were gradients of hexane / ethyl acetate / formic acid (90/ 10/ 2; 80/ 
20/ 2; 70/ 30/ 2; 60/ 40/ 2: v/v/v). Each fraction was collected and monitored by TLC 
(hexane / ethyl acetate / formic acid: 3/ 3/ 0.12: v/v/v). Each purified compound was 
procured following solvent removal. 
3.2.1.4 Identification of resveratrol derivatives 
The chemical structures of resveratrol derivatives were determined by high-performance 
liquid chromatography-diode array detector-mass spectrometry (HPLC-DAD-MS) using 
an Agilent 1100 HPLC unit (Agilent Technologies, Palo Alto, CA, USA). A C18 column 
(4.6 mm × 250 mm × 5 µm with guard column; Sigma-Aldrich, Oakville, ON, Canada) 
was used for separation. The mobile phase was methanol/ 5% acetonitrile in water at 
different ratios (60:40-95:5, v/v; see results and discussion) varying from 0 to 70 min at 
0.8 mL/min and the compounds were detected at 306 nm. 
	   51	  
Proton nuclear magnetic resonance (1H-NMR) spectroscopy, carbon-13 nuclear magnetic 
resonance (13C-NMR) spectroscopy, correlation spectroscopy (COSY), single-quantum 
correlation (HSQC) spectroscopy, nuclear Overhauser effect spectroscopy (NOESY), and 
heteronuclear multiple-bond correlation (HMBC) spectroscopy were performed to 
identify their molecular structures. All NMR data were collected on a Bruker Avance 300 
MHz (Bruker Biospin Co., Billerica, MA, USA) and data interpretation was performed 
with Topspin 3.0 with ICON. The compounds were dissolved in perdeuterated dimethyl 
sulphoxide (DMSO-d6) containing tetramethylsilane (TMS). The results were confirmed 
by comparing the chemical shifts of resveratrol and its derivatives. 
3.2.1.5 Determination of lipophilicity 
The lipophilicity of resveratrol derivatives was computationally obtained by using 
ALOGPS 2.1. established by Tetko et al. (2005). The structures of resveratrol derivatives 
in simplified molecular input line entry (SMILE) format were drawn using ChemDraw 
Std 14.0.  
3.2.1.6 DPPH radical scavenging assay 
The antioxidant activities of the parent resveratrol molecule and its derivatives were 
determined according to their DPPH scavenging capacity using electron paramagnetic 
resonance (EPR) according to Madhujith and Shahidi (2006) with slight modification. 
Trolox in ethanol was used as a standard (0-750 µM) and resveratrol derivatives (500 µM) 
were also dissolved in ethanol. Test compounds (0.10 mL) were added to 0.90 mL of 
DPPH (0.20 mM) in ethanol. The mixtures were mixed well and placed in the dark for 30 
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min. The DPPH radical scavenging capacities were expressed as micromoles of trolox 
equivalents (TE) per micromole of test compound. 
3.2.1.7 ABTS radical cation scavenging assay  
The ABTS radical cation scavenging assay of resveratrol and its derivatives was 
conducted according to the method described by Miller et al. (1993) and as reported by 
Ambigaipalan et al. (2015) with slight modifications.  
A mixture of 1.25 mM ABTS and 1.25 mM AAPH was prepared in a 0.1 M phosphate 
buffer containing 0.15 M sodium chloride (pH 7.4) and subsequently heated for 20 min at 
60 °C to prepare the ABTS radical cation solution. The container was covered with 
aluminum foil and stored at room temperature. The samples to be tested (500 µM in 
ethanol, 40 µL) and blank (ethanol, 40 µL) were mixed with the ABTS radical cation 
solution (1.96 mL). The absorbance of the mixture was read after 6 min at 734 nm. ABTS 
radical cation scavenging ability was expressed as micromoles of trolox equivalents per 
micromole of test compound.  
 
3.2.2 Antioxidant activity of resveratrol ester derivatives in food and biological 
model systems 
3.2.2.1 Preparation of resveratrol derivatives 
Resveratrol derivatives were prepared as described in section 3.2.1.1 and 3.2.1.2 (Oh and 
Shahidi, 2017). Briefly, resveratrol was esterified with acyl chlorides of propionic acid 
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(C3:0), butyric acid (C4:0), caproic acid (C6:0), caprylic acid (C8:0), capric acid (C10:0), 
lauric acid (C12:0), myristic acid (C14:0), palmitic acid (C16:0), stearic acid (C18:0), 
oleic acid (C18:1), eicosapentaenoic acid (C20:5, EPA), and docosahexaenoic acid 
(C22:6, DHA). The chemical structures of resveratrol derivatives, after HPLC separation, 
were determined by MS and different types of NMR. The mono- and diesters of crude 
products were used to assess their antioxidant potential in selected food and biological 
model systems. 
3.2.2.2 Antioxidant activity of resveratrol derivatives in oil-in-water emulsion (β-
carotene bleaching assay)  
The β-carotene bleaching assay was used to determine antioxidant activity of resveratrol 
and its derivatives in the oil-in-water emulsion according to Zhong and Shahidi (2012). 
An aliquot (1.2 mL) of β-carotene (10 mg) dissolved in 10 mL of chloroform was 
transferred into a flask containing linoleic acid (40 mg) and Tween 40 (400 mg). A blank 
was also prepared (40 mg of linoleic acid + 400 mg of Tween 40 without β-carotene). 
Chloroform was removed under a stream of nitrogen and then 100 mL of oxygenated 
distilled water were added and stirred vigorously. One millimole of resveratrol and its 
derivatives in 100% ethanol (0.5 mL) as well as the control (0.5 mL, 100% ethanol) were 
mixed with aliquots (4.5 mL) of the above emulsion. Each sample blank (40 mg of 
linoleic acid + 400 mg of Tween 40 + 0.5 mg of samples without β-carotene) was also 
prepared. The absorbance of the contents of each tube was read immediately at 470 nm 
and then incubated in a shaking water bath at 50 °C. The UV-vis absorbance was read 
over a 105 min period at 15 min intervals. The antioxidant activity of resveratrol and its 
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derivatives in the oil-in-water emulsion was subsequently calculated using the following 
equation. 
Antioxidant activity (%) = [1-(S0-St)/(C0-Ct)]*100 
where S0 and St are corrected absorbance values for test compounds measured at zero 
time and after incubation, respectively; while C0 and Ct are corrected absorbance values 
for the control at zero time and after incubation, respectively.  
3.2.2.3 Antioxidant activity of resveratrol derivatives in bulk oil 
Stripped corn oil, which is free of minor compound, was prepared according to a 
simplified stripping method.  The stripped oil (1 g) was weighed into 10 mL clear glass 
vials and loosely capped in order to induce oil oxidation. Resveratrol and its derivatives 
(75 µM, 100 µL) in ethanol were added, and the solvent was then removed under a stream 
of nitrogen. The vials were wrapped in aluminum foil to protect samples from light and 
stored in a forced air oven (Precision Scientific Co., Chicago, IL, USA) at 60 ± 0.5 °C. 
Samples were withdrawn on day 0, 1, 3, and 6 for analyses. Conjugated dienes and p-
anisidine values were used for monitoring oxidative products according to the AOAC 
(Conjugated dienes, 1980; p-anisidine values, 1990) methods.  
3.2.2.4 Antioxidant activity in a meat model system (thiobarbituric acid reactive 
substances, TBARS)  
A ground meat model system was used to determine the antioxidant activity of resveratrol 
and its derivatives (Wettasinghe and Shahidi, 1999). Forty grams of ground pork were 
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mixed with 10 mL of deionized water in Mason jars. One millilitre of test compounds (1 
mM) or a positive control (bytylated hydroxytoluene, BHT, 1 mM) was added directly to 
the meat. A blank with no antioxidant was also prepared. The meat samples were mixed 
and cooked for 40 min in a water bath at 80 °C with intermittent stirring. The contents 
were transferred into plastic bags and stored for 7 days at 4 °C. Meat samples were 
analyzed on day 0, 3, 5, and 7 for their oxidative state using the TBARS test as described 
by Shahidi and Hong (1991) with slight modification. Trichloroacetic acid (10 %, w/v, 
2.5 mL) was added to meat samples (1 g) in centrifuge tubes which were then vortexed 
for 2 min. Subsequently, TBA reagent (0.02 M, 2.5 mL) was added and vortexed again 
for 30 sec. After centrifugation at 3000g for 10 min, the supernatants were filtered 
through a Whatman No.3 filter paper. The samples were kept in a water bath at 95 °C for 
45 min, then cooled to room temperature. A precursor of malondialdehyde (MDA), 
1,1,3,3-tetramethoxypropane, was used for constructing a standard curve. The absorbance 
of pink TBA-MDA adducts was read at 532 nm. TBARS values were calculated using the 
standard curve and expressed as milligrams of MDA equivalents per kilogram of sample. 
3.2.2.5 Hydrogen peroxide (H2O2) scavenging activity 
 The H2O2 scavenging activity of resveratrol and its derivatives was determined according 
to the method explained by Chandrasekara and Shahidi (2011) with slight modification. 
The standard (ascorbic acid) and test compounds were dissolved in 100% ethanol (1 mM, 
0.4 mL) were added to 0.6 mL of 40 mM H2O2 (in 45 mM sodium phosphate buffer 
solution, pH 7.4) and 1 mL of buffer solution. The absorbance was read at 230 nm after 
40 min of incubation at 30 °C. Blanks were run for each sample; buffer solution was 
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added instead of H2O2. A standard curve was prepared with ascorbic acid (AA). The 
results were expressed as micromoles of AA equivalents per micromoles of each 
compound. 
3.2.2.6 Inhibition of copper-induced low-density lipoprotein (LDL) oxidation  
The inhibition of LDL oxidation induced by copper was determined according to 
Chandrasekara and Shahidi (2012). Human LDL was dialyzed in 10 mM phosphate 
buffer (pH 7.4, 0.15 M NaCl) using a dialysis tube (molecular weight cutoff of 12−14 
kDa; Fisher Scientific, Nepean, ON, Canada) at 4 °C under a nitrogen blanket in the dark 
for 12 h. Diluted LDL (0.04 mg LDL/ mL, 0.8 mL) was mixed with resveratrol and its 
derivatives (5 µM, 100 µL). The samples and cupric sulphate (CuSO4) were pre-incubated 
at 37 °C for 15 min. The reaction was initiated by adding CuSO4 (50 µM, 100 µL) and 
measured immediately at 234 nm. The samples were then incubated at 37 °C for 8 h. The 
formation of conjugated dienes (CD) was monitored at 234 nm using a diode array 
spectrophotometer (Agilent, Palo Alto, CA, USA). The blanks were run for each sample 
by replacing LDL and CuSO4 with phosphate buffer for background correction.  
3.2.2.7 Inhibition of hydroxyl radical-induced DNA scission  
Inhibitory activity of resveratrol and its derivatives against DNA scission induced by 
hydroxyl radical was determined according to the method described by Ambigaipalan and 
Shahidi (2015) with slight modification. Supercoiled pBR 322 DNA (50 µg/mL) was 
dissolved in 10 mM phosphate buffer (pH 7.4), and resveratrol and its derivatives 
dissolved in ethanol were diluted with phosphate buffer. In an eppendorf tube, test 
compound (12.5 µM, 2 µL), phosphate buffer (2 µL), DNA (50 µg/mL, 2 µL), FeSO4 (0.5 
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mM, 2 µL), and H2O2 (1 mM, 2 µL) were added. A control (DNA with radicals) and a 
blank (DNA only) were also prepared. After incubation at 37 °C for 1 h, 1 µL of the 
loading dye (0.25% bromophenol blue, 0.25% xylene cyanol, and 50% glycerol) was 
added. The mixture was loaded onto 0.7% agarose gel (50 mL). The gel was prepared in 
Tris−acetic acid−EDTA (ethylenediaminetetraacetic acid) buffer (TAE, 40 mM, pH 8.5) 
with SYBR safe gel stain (5 µL). Electrophoresis was performed at 80 V for 90 min in 
TAE buffer using a horizontal mini gel electrophoresis system (Owl Separation Systems 
Inc., Portsmouth, NH, USA) with a 300 V power supply (VWR International Inc., West 
Chester, PA, USA). The DNA bands were visualized under UV light using the Alpha-
Imager gel documentation system (Cell Biosciences, Santa Clara, CA, USA) and the data 
processing was performed with the Chemi-Imager 4400 software (Cell Biosciences). The 
retention of supercoiled DNA strand (%) was calculated according to the following 
equation:  
DNA retention (%) = (DNAsample / DNAblank) * 100 
 
3.2.3 Effect of lipophilisation of resveratrol on reactive nitrogen/oxygen species 
generation in murine macrophages and human cancer cell lines 
3.2.3.1 Preparation of resveratrol esters  
Resveratrol derivatives were prepared as described in sections 3.2.1.1 and 3.2.1.2 (Oh and 
Shahidi, 2017). Resveratrol was lipophilised with propionyl chloride and 
docosahexaenoyl chloride. The monoesters were identified by HPLC-MS and several 
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types of NMR (1H NMR, 13C NMR, COSY, HSQC, NOESY, and HMBC). Resveratrol 
and its esters were subjected to NO production, cell viability, and ROS generation.  
3.2.3.2 Cell culture 
The RAW 264.7 cells, derived from murine macrophages, were cultured in Dulbecco’s 
minimal essential medium (DMEM) containing 10% endotoxin-free, heat-inactivated 
fetal calf serum, 100 units/mL penicillin, and 100 µg/mL streptomycin. Human hepatoma 
carcinoma cells (HepG2) in DMEM containing 10% FBS and 100 units/mL penicillin and 
streptomycin were maintained in humidified atmosphere of 5% CO2 at 37 °C. The AGS 
cell lines in DMEM-F12 were grown at 37°C in 5% CO2 atmosphere. A431 cell lines and 
MCF7 cell lines were grown in DMEM supplemented with 10% heat-inactivated fetal 
calf serum, 100 units/mL of penicillin, and 100 µg/mL of streptomycin. Those cell lines 
were kept at 37°C in a humidified atmosphere of 5% CO2. 
3.2.3.3 Nitrite assay  
The cells were seeded into 24 well plates, after reaching a density of 1×106 cells/mL and 
were activated by changing their medium to serum-free DMEM without phenol red 
containing lipopolysaccharide (LPS; Zhong et al., 2012). The RAW 264.7 cells were 
treated with different concentrations of compounds and LPS or LPS only for 24 h. The 
supernatants (100 µL) were mixed with the Griess reagent (100 µL, 1% sulphanilamide in 
5% phosphoric acid and 0.1% naphthylethylenediamine dihydrochloride in water) in 
duplicate on 96-well plates. The absorbance was then read at 570 nm with an ELISA 
reader. Sodium nitrite (NaNO2) was employed as a standard. 
	   59	  
3.2.3.4 Determination of cytotoxicity and ROS generation on human hepatoma 
carcinoma (HepG2) cells   
The cell viabilities and cytotoxic properties of resveratrol and its esters were evaluated by 
using MTT assay (Mosmann, 1983). The 5000 cells were seeded each well in 96-well 
plate and incubated for 16 hours. After that, the samples (10 µg/mL) were added to each 
well and incubated for 24 or 48 hours and 20 µL MTT (5 mg/mL) were then added and 
continued incubating for 3 hours. The medium was then removed and DMSO (100 µL) 
was added to dissolve the crystals. The absorbance was measured at 570 nm.  
HepG2 cells were seeded in 96-well black plate (at a rate of 30000 cells per well) and 
incubated for 14 h (Wang et al., 2016). After that, the samples at various concentrations 
were added and incubated for 4 h, and then the medium was removed. The cells were 
washed with PBS, added 10 µM DCFH-DA, and continued incubating for 30 min. After 
removing the medium, the cells were washed with PBS again and 400 µM tert-butyl 
hydroperoxide (t-BOOH) was added with subsequent incubation for 90 min. For control, 
FBS-free medium was added instead of t-BOOH. The cells were washed with PBS and 
the fluorescence (excitation 485 nm and emission 535 nm) was then measured.  
3.2.3.5 Cell viability of A431, MCF7, HT-29, and AGS  
Resveratrol and its esters were dissolved in dimethyl sulphoxide (DMSO). Cell viability 
of various cancer cell lines was assessed by 3-(4, 5-dimethylthiazol-2-yl)-2, 5-
diphenyltetrazoliumbromide (MTT) assay (Mosmann, 1983). The cells were plated at a 
density of 2×105 cells/mL into 96 well plates and incubated for 24 h. The cells were then 
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pretreated with test compounds at different concentration for 24 h. The final 
concentration of DMSO in the culture medium was <0.05% (v/v). MTT (100 µL) was 
added, and the cells were incubated for a further 1 h. Then the medium was aspirated and 
100 µL of DMSO was added to dissolve the MTT-formazan crystals formed by 
metabolically viable cells. Cell viability was scanned with an enzyme-linked 
immunosorbent assay reader with a 570 nm filter.  
 
3.2.4 Preparation esterified quercetin derivatives and effects on antioxidant activity 
3.2.4.1 Preparation of EPA and DHA 
Saponification of EPA ethyl ester was carried out to prepare EPA. DHA was prepared 
from DHASCO via urea complexation as described by Wanasundara and Shahidi (1999). 
For saponification, DHASCO was stirred with potassium hydroxide, water, and 95% 
aqueous ethanol at 62 ± 2 °C under reflux condition and a nitrogen blanket. In order to 
remove unsaponified materials, water and hexane were mixed then the hexane was 
discarded. Hydrochloric acid (HCl, 3 M) was added to the aqueous layer to adjust to pH 1 
and then hexane was added to extract the liberated free fatty acids. The solvent was 
subsequently passed through a layer of anhydrous sodium sulphate then removed by a 
rotary evaporator.  
The free fatty acids were mixed with 20% urea in 95% aqueous ethanol (w/v) and this 
was heated at 60 °C until a clear solution resulted. The clear solution was then in the cold 
room (4 °C) for 24 h to form urea complexed crystals, subsequently suction filter was 
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carried out to remove the crystals. The resultant solution was added an equal volume of 
water and the pH was adjusted to 4-5 with 6 M HCl. An equal volume of hexane was 
added and mixed. The solvent was then passed through anhydrous sodium sulphate and 
subsequently removed by rotary evaporation.  
3.2.4.2 Preparation of quercetin derivatives    
Preparation of quercetin derivatives was conducted according to Zhong and Shahidi 
(2011). Eicosapentaenoyl chloride and docosahexaenoyl chloride was prepared with 
thionyl chloride as well as EPA and DHA. Quercetin (in ethyl acetate) was stirred with 
pyridine at a molar ratio of 1:1. Then acyl chlorides (propionyl chloride, butyryl chloride, 
caproyl chloride, capryloyl chloride, capryl chloride, lauroyl chloride, myristoyl chloride, 
palmitoyl chloride, stearoyl chloride, oleoyl chloride, eicosapentaenoyl chloride, and 
docosahexaenoyl chloride) were added dropwise under a blanket of nitrogen at 50 °C 
while stirring constantly. After the reaction was completed, the mixture was cooled down 
to room temperature and washed 3 times with distilled water (60 °C). The ethyl acetate 
layer was subsequently passed through a layer of anhydrous sodium sulphate. The 
product mixture was obtained by the removal of the solvent.  
3.2.4.3 Identification of quercetin derivatives 
The chemical structures of quercetin derivatives were determined by high-performance 
liquid chromatography-electrospray ionization-time of flight-mass spectrometry (HPLC-
ESI-TOF-MS) using an Agilent 1260 HPLC unit (Agilent Technologies, Palo Alto, CA, 
USA). A C18 column (4.6 mm × 250 mm × 5 µm; Sigma-Aldrich, Oakville, ON, Canada) 
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was used. The mobile phase was methanol/ 5% acetonitrile in water at 80:20-90:10 (v/v) 
and the runtime varied from 0 to 100 min at 1 mL/min. The compounds were detected at 
370 nm. The compounds were than dissolved in perdeuterated dimethyl sulphoxide 
(DMSO-d6) containing tetramethylsilane (TMS) in order to record their proton nuclear 
magnetic resonance (1H NMR, Bruker Avance 300 MHz; Bruker Biospin Co., Billerica, 
MA, USA) for structure identification. The results were compared with the chemical 
shifts of quercetin and literature values. 
3.2.4.4 Separation of quercetin and its derivatives 
Intact quercetin was removed from different mixtures of quercetin and derivatives using 
column chromatography on silica gel. The gradients of hexane / ethyl acetate / formic 
acid (90: 10: 2, 80: 20: 2, 70: 30: 2, 60: 40: 2, v/v/v) were employed and each collected 
fraction was monitored by TLC (hexane / ethyl acetate / formic acid, 3: 3: 0.12, v/v/v).  
3.2.4.5 Determination of lipophilicity 
The lipophilicity of quercetin derivatives was theoretically calculated by using ALOGPS 
2.1. established by Tetko et al. (2005). The simplified molecular input line entry (SMILE) 
system of quercetin derivatives was obtained from ChemDraw Standard 16.0.  
3.2.4.6 ABTS radical cation scavenging assay  
The procedure of ABTS radical cation scavenging assay followed was described by 
Miller et al. (1993) as described by Ambigaipalan et al. (2015) with slight modifications.  
Solutions of ABTS (2.5 mM) and AAPH (2.5 mM) in a 0.1 M phosphate buffer 
containing 0.15 M sodium chloride (pH 7.4) were mixed at a ratio of 1:1 (v/v). The 
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mixture (ABTS radical cation) was then heated for 20 min at 60 °C and subsequently 
stored in the dark at room temperature. Quercetin and its derivatives (0.5 mg/mL) were 
dissolved in ethanol. The compounds and a blank (40 µL) were vortexed with the ABTS 
radical cation solution (1.96 mL). Six minutes later, the samples were measured at 734 
nm. The ABTS radical cation scavenging ability of quercetin and its derivatives was 
expressed as mmoles of trolox equivalents per mg of sample.  
 
3.2.5 Antioxidant activity of quercetin derivatives in food and biological model 
systems  
3.2.5.1 Preparation of quercetin derivatives 
Quercetin derivatives were prepared as described in 3.2.4.1 and 3.2.4.2. Briefly, quercetin 
was esterified with 12 different fatty acids, propionic acid (C3:0), butyric acid (C4:0), 
caproic acid (C6:0), caprylic acid (C8:0), capric acid (C10:0), lauric acid (C12:0), 
myristic acid (C14:0), palmitic acid (C16:0), stearic acid (C18:0), oleic acid (C18:1), 
eicosapentaenoic acid (C20:5, EPA), and docosahexaenoic acid (C22:6, DHA), after the 
fatty acids were converted to their corresponding acyl chlorides. The chemical structures 
of quercetin derivatives were determined by HPLC-MS and 1HNMR. Intact quercetin 
from the crude product mixture was removed and used to evaluate their antioxidant 
potential in selected food and biological model systems. 
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3.2.5.2 DPPH radical scavenging assay  
The DPPH scavenging capacity of quercetin and its derivatives was determined according 
to Madhujith and Shahidi (2006) with slight modifications. The samples (40 µL, 0.5 
mg/mL, in ethanol) were mixed with 60 µL of ethanol and 0.9 mL of DPPH (0.2 mM, in 
ethanol), kept in the dark for 30 min and monitored using electron paramagnetic 
resonance (EPR). The DPPH scavenging capacities of quercetin and its derivatives were 
expressed as mmoles of trolox equivalents (TE) per mg of sample. 
3.2.5.3 Hydroxyl radical scavenging assay 
The hydroxyl radical scavenging capacity of quercetin and its derivatives was evaluated 
according to Chandrasekara and Shahidi (2011) with modifications. The samples in 
ethanol were diluted with 75 mM phosphate buffer (pH 7.2) and added with H2O2 (200 
µL, 10 mM), DMPO (400 µL, 17.6 mM), and FeSO4 (200 µL, 10 mM). After 3 min, the 
sample was recorded using EPR spectrometer. The hydroxyl radical scavenging activity 
of quercetin and its derivatives was expressed as micromoles of catechin equivalents per 
milligram of sample.   
3.2.5.4 Reducing power  
The antioxidant activities of quercetin and its derivatives were determined according to 
their reducing power according to Zhong et al. (2012) with slight modification. The 
sample (1 mL, 0.5 mg/mL in 100% ethanol) was added 0.2 M phosphate buffer solution 
(2.5 mL, pH 6.6) and 1% potassium ferricyanide solution (2.5 mL), then incubated at 
50 °C for 20 min. Subsequently, 10% trichloroacetic acid (2.5 mL) was added. An aliquot 
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of the mixture (2.5 mL) was transferred to a tube and mixed with distilled water (2.5 mL) 
and 0.1% ferric chloride solution (0.5 mL). The absorbance of the mixture was then read 
at 700 nm. Reducing power was expressed as µmoles of ascorbic acid equivalents per mg 
of quercetin and its derivatives.  
3.2.5.5 Antioxidant activity of quercetin derivatives in oil-in-water emulsion (β-
carotene bleaching assay)  
An oil-in-water emulsion system was used to determine antioxidant activity of quercetin 
and its derivatives according to Zhong and Shahidi (2012). Linoleic acid (40 mg), Tween 
40 (400 mg), and an aliquot (1.2 mL) of β-carotene in chloroform (10 mg/10 mL) were 
transferred to a flask. A blank without β-carotene was also prepared. The flask was under 
a stream of nitrogen in order to remove chloroform then oxygenated distilled water (100 
mL) was added and stirred vigorously. Aliquots (4.5 mL) were added to the samples in 
ethanol (0.5 mL, 0.25 mg/mL) and the control. Samples without β-carotene were also 
prepared. The reading at 470 nm was monitored immediately and subsequently the tubes 
were placed in a shaking water bath at 50 °C. The measurements were conducted every 
15 min over 105 min period. The antioxidant activity of quercetin and its derivatives was 
calculated as follows: 
Antioxidant activity (%) = [1-(S0-St)/(C0-Ct)] × 100 
where S0 and St are corrected values for the sample measured at zero time and after 
incubation, respectively, while C0 and Ct are corrected values of the control at zero time 
and after incubation, respectively.  
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3.2.5.6 Antioxidant activity of quercetin derivatives in bulk oil 
Stripped corn oil was prepared according to a simplified stripping method.  The stripped 
oil (1 g) was weighed into test tube. Quercetin and its derivatives (12.5 µg/mL, 100 µL) in 
ethanol were added and stored in a forced air oven (Precision Scientific Co., Chicago, IL, 
USA) at 60 ± 0.5 °C. The samples were taken on day 0, 2, 4, 6, and 8 for analyses. 
Conjugated dienes and p-anisidine values were monitored according to the AOAC 
(Conjugated dienes, 1980; p-anisidine values, 1990) methods.  
3.2.5.7 Inhibition of copper-induced low-density lipoprotein (LDL) oxidation  
The inhibition of LDL oxidation induced by copper was determined following the method 
described by Chandrasekara and Shahidi (2012). Human LDL obtained from Sigma was 
dialyzed in 10 mM phosphate buffer (pH 7.4) containing 0.15 M NaCl using a dialysis 
tube (molecular weight cutoff of 12−14 kDa; Fisher Scientific, Nepean, ON, Canada) at 4 
°C under a nitrogen atmosphere in the dark for 12 h. The dialyzed LDL was then diluted 
to 0.04 mg LDL/ mL. An aliquot of diluted LDL (0.8 mL) was added with the sample (5 
µg/mL, 100 µL). The blanks (without LDL and CuSO4) were run for each sample for 
background correction. The mixture and cupric sulphate (CuSO4) were then pre-incubated 
at 37 °C for 15 min. The oxidation was initiated by the addition of 100 µL of CuSO4 (50 
µM, 100 µL) and formation of conjugated dienes (CD) was measured immediately at 234 
nm for 0 h. The samples were then kept at 37 °C for 12 h and the absorbance read again at 
234 nm.  
3.2.5.8 Inhibition of hydroxyl radical-induced DNA scission  
Inhibitory activity of quercetin and its derivatives against DNA scission induced by 
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hydroxyl radical was determined according to Ambigaipalan and Shahidi (2015) with 
modification. Supercoiled pBR 322 DNA was diluted to 50 µg/mL using 10 mM 
phosphate buffer (pH 7.4). The sample (0.5 mg/mL) dissolved in ethanol was also diluted 
200 times with phosphate buffer. Sample (2 µL), phosphate buffer (2 µL), DNA (2 µL), 
0.5 mM FeSO4 (2 µL), and 1 mM H2O2 (2 µL) were mixed and incubated at 37 °C for 1 h. 
DNA with radical (control) and DNA only (blank) were also prepared. During incubation, 
50 mL of 0.7 % agarose gel in Tris−acetic acid− ethylenediaminetetraacetic acid (TAE) 
buffer (40 mM, pH 8.5) with SYBR safe gel stain (5 µL) was prepared and placed in a 
horizontal mini gel electrophoresis system (Owl Separation Systems Inc., Portsmonth, 
NH, USA) filled with TAE buffer. After incubation, loading dye (1 µL, mixture of 0.25% 
bromophenol blue, 0.25% xylene cyanol, and 50% glycerol) was added. The sample 
prepared was loaded onto the agarose gel, which was then subjected to electrophoresis at 
80 V for 2 h using with a 300 V power supply (VWR International Inc., West Chester, 
PA, USA). The visualization of DNA bands was achieved by Alpha-Imager gel 
documentation system (Cell Biosciences, Santa Clara, CA, USA) and the data processing 
was conducted by the Chemi-Imager 4400 software (Cell Biosciences). The inhibition of 
supercoiled DNA strand oxidation (%) was calculated according to the following 
equation:  
Inhibition (%) = (DNAsample / DNAblank) * 100 
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3.3 Statistical analysis 
Tukey’s honest significant difference (HSD) test was performed with one way analysis of 
variance (ANOVA) to calculate the significance of differences using SPSS 16.0 for 
Windows (SPSS Inc., Chicago, IL, USA) for Chapters 4, 5, 7, 8 (P < 0.05). For Chapter 6, 
t-test was employed (P < 0.05). All determinations were repeated three times using the 
same combined starting materials and mean values and standard deviations were reported. 
Values with different letters were significantly different at P < 0.05 as performed by 
ANOVA or t-test. 
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CHAPTER 4 
Lipophilisation of resveratrol and effects on antioxidant activity 
 
This chapter has mainly been published in J. Agric. Food Chem. (2017), 65, 8617-8625.  
4.1 Introduction 
Resveratrol, as a stilbenoid, has a C6-C2-C6 structure with three hydroxyl groups. It serves 
as a UV-protectant and acts as a phytoalexin in plants (Vermerris and Nicholson, 2008). 
Resveratrol is speculated to play a role in human health due to its biomedical aspects due 
to its potential ability to prevent oxidation, inflammation, cardiovascular disease, and 
cancer, which were observed in vitro (Jang et al., 1997; Wang et al., 2002; Donnelly et al., 
2004). However, its application to biological systems is a real challenge because of its 
fast metabolism in the body (Walle et al., 2004). Moreover, the hydrophilicity of phenolic 
compounds restricts their application in lipophilic systems, therefore resveratrol may 
exhibit reduced antioxidant activity in oily foods, drugs, and cosmetics (Zhong and 
Shahidi, 2011; Laguerre et al., 2013). Thus, structure modification was carried out to 
increase lipophilicity of resveratrol using different fatty acids with varying chain lengths 
and degrees of unsaturation (Baur and Sinclair, 2006; Torres et al., 2010; Zhong and 
Shahidi, 2011).  
Polyunsaturated fatty acids (PUFAs), such as eicosapentaenoic acid (EPA, C20:5n-3) and 
docosahexaenoic acid (DHA, C22:6n-3), have their own reported health benefits, such as 
anticancer and cardioprotective effects (Tapiero et al., 2002). Therefore, it is of interest to 
examine structurally-modified resveratrol with PUFA, since they may display an additive, 
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synergistic or antagonistic effect when present in the same molecule (Zhong and Shahidi, 
2011; Zhong et al., 2012; Zhong and Shahidi, 2012). Moreover, short-chain fatty acids, 
such as propionic acid (C3:0) and butyric acid (C4:0), may inhibit cholesterol synthesis 
and prevent colon cancer (Wong et al., 2006). Medium-chain fatty acids such as caprylic 
acid (C8:0), capric acid (C10:0) and lauric acid (C12:0), are also of interest because they 
can directly serve as an energy source (Bach and Babayan, 1982). Saturated fatty acids, 
such as myristic acid (C14:0), palmitic acid (C16:0) and stearic acid (C18:0), are most 
stable in terms of oxidative processes. Thus, esterification of resveratrol with such fatty 
acids may increase both the lipophilicity and stability of the final products. By using 
different fatty acids, one can explore which degree of lipophilicity provides the optimum 
condition for best effects in test systems, both in vitro and in vivo. 
In this work, resveratrol was structurally modified via esterification in order to improve 
its application in food and biological systems. Lipophilised resveratrols were obtained by 
acylation of resveratrol with C3:0-C22:6 fatty acyl chlorides, namely propionyl chloride 
(C3:0) to docosahexaenoyl chloride (DHA, C22:6n-3).    
4.2 Preparation of resveratrol derivatives 
There have been several attempts to improve the biological effects and performance of 
resveratrol by modifying its structure. Chao et al. (2010) methylated resveratrol to 
examine possible enhancement of its neuroprotective effects. Biasutto et al. (2008) used 
membrane-permeable lipophilic triphenylphosphonium cation to improve 
pathophysiological relevance of resveratrol. In this study, fatty acyl chlorides with 
varying chain length and degree of unsaturation (C3:0 to C22:6), were employed to 
	   72	  
expand the application of resveratrol in food and non-food commodities. To the best of 
our knowledge, this is the first work incorporating short-, medium-, and long-chain fatty 
acids, especially the omega-3 PUFA into the resveratrol molecule.  
To prepare resveratryl docosahexaenoate (RDHA), as an example, DHA was esterified 
with resveratrol, and the esterification was monitored using TLC. Following esterification, 
two monoesters, two diesters, and one triester were produced. The crude products of 
RDHA were identified using HPLC-MS and the esterification yield was 37.7%. On the 
other hand, the yield of RC3:0 was 74%. The structural characteristic of DHA (long 
carbon chain and nonlinear) may be responsible for its low incorporation. Zhong and 
Shahidi (2011) reported that the incorporation yields of epigallocatechin gallate (EGCG) 
with stearic acid, EPA and DHA was 56.9, 42.7 and 30.7%, respectively.  
4.3 Identification of resveratrol derivatives 
For the HPLC-MS ion source, atmospheric-pressure chemical ionization (APCI) was 
employed in this study, since APCI can be applied to small and low polarity molecules 
(Herderich et al., 1997). Wang et al. (2002) reported that resveratrol might be ionized in 
both positive and negative modes. In this study, only the positive mode was employed. 
The crude product of RC3:0 ester was subjected to HPLC-MS with methanol/ 5% 
acetonitrile in water (90:10, v/v) as the mobile phase. Intact resveratrol, monoester, 
diester, and triester were detected at m/z 229.1, 285.1, 341.1, and 397.3, respectively 
(spectra not shown). However, using TLC plates, the esters appeared as two monoesters, 
one diester, and one triester components. Although the HPLC chromatogram showed only 
a single peak for RC3:0 monoesters at 4.064 min, two monoesters were expected in 
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HPLC-MS (Figure 4.1). This might be due to the high proportion of methanol in the 
mobile phase, which made it difficult to stay in the column. Thus, the 5% acetonitrile in 
the water portion of the mobile phase of the HPLC-MS solvent was increased to 60:40 
(methanol/ 5% acetonitrile in water) to obtain better separation. Although RC3:0 
monoesters were not fully separated, two different retention times were noted at 8.958 
and 9.544 min with the same m/z at 285.1, which implies the presence of two monoesters 
of RC3 (Figure 4.1 and Figure 4.2). Interestingly, the diester appeared as only a single 
spot on the TLC; however, it was resolved into two spots with retention times at 26.640 
and 31.374 min, respectively (Figure 4.1 and Figure 4.2) by the HPLC-MS. RC3:0 triester 
was not detected by HPLC-MS (mobile phase 60:40, 70 min runtime), although it was 
detected with the mobile phase of 90:10 (v/v) and was visualized on the TLC plate under 
UV light (254 nm). This might be related to its increased lipophilicity of the molecule.  
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Figure 4.1. HPLC chromatogram of RC3:0 esters with mobile phase methanol/ 5% 
acetonitrile in water 90:10 (I) and 60:40 (II), respectively (a, resveratrol; b, RC3:0 
monoesters; c, RC3:0 diesters; and d, RC3:0 triester). 
a 
b 
a	  
c 
d 
a b 
a	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Figure 4.2. Mass spectra of RC3:0 esters (a, resveratrol; b, RC3:0 monoesters; and c, 
RC3:0 diesters). 
a 
b 
b 
c 
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In addition to the HPLC-MS analysis, it was necessary to investigate the location of 
esterification due to the presence of three hydroxyl groups in the resveratrol molecule. 
Meanwhile, the esterification positions of the phenolic compounds with different fatty 
acyl chlorides remained the same as it was also observed for EGCG (Zhong and Shahidi, 
2011). Therefore, RDHA, with the most complicated structure among the synthesised 
fatty acid esters, was selected for further structure elucidation. The crude RDHA product 
was separated by flash column chromatography using silica gel as the stationary phase 
and gradient elution with hexane, ethyl acetate, and formic acid as the mobile phase; each 
fraction was monitored using TLC (hexane/ ethyl acetate/formic acid at 3:3:0.12, v/v/v). 
The formulas of the esterified resveratrol were confirmed by different types of NMR (1H-
NMR, 13C-NMR, COSY, HSQC, NOESY, and HMBC) spectroscopy after being 
separated by flash column chromatography. The position of esterification was determined 
by comparison with the literature data and its parent resveratrol (Jayatilake et al., 1993; 
Mannila et al., 1993; Lancake and Pryce, 1977; Mattivi and Korhammer, 1995). The H-2 
and H-6, H-2' and H-6', and H-3' and H-5' of the parent resveratrol had the same chemical 
shifts at δ 6.38, δ 7.39, and δ 6.75 ppm, respectively (Table 4.1). This means they are 
chemically equivalent as resveratrol is a symmetric molecule (Torres et al., 2010; Figure 
4.3).  
R-4'-O-DHA was easily identified as the position of monoesterification (Figure 4.3 and 
Table 4.1). First of all, H-2 and H-6 still had the same chemical shift at δ 6.43 ppm, which 
means it remained a symmetric molecule. Moreover, large downfield shifts were 
observed at H-3' and H-5' (Δδ= 0.32 ppm) and H-2', H-6' (Δδ= 0.22 ppm). Because of the 
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distance from the acylation site, downfield shifts of H-2' and H-6' (Δδ= 0.22 ppm) were 
lower than those for H-3' and H-5' (Δδ= 0.32 ppm). In addition, the 4'-OH peak of 
resveratrol (δ 9.54 ppm) disappeared in the spectrum. 
 
Table 4.1. 1H chemical shifts (δ in ppm) of 
resveratrol (R), R-3 and R-4'-O-DHA (DHA signals 
omitted for clarity) 
1H positon resveratrol R-4'-O-DHA R-3-O-DHA 
2 6.38 6.43 6.79 
4 6.11 6.16 6.36 
6 6.38 6.43 6.72 
7 6.81 overlapping 6.90 
8 6.93 overlapping 7.05 
2' 7.39 7.61 7.40 
3' 6.75 7.07 6.76 
5' 6.75 7.07 6.76 
6' 7.39 7.61 7.40 
3-OH 9.19 9.25 
 5-OH 9.19 9.25 9.60 
4'-OH 9.54 
 
9.7 
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Figure 4.3. Structures of resveratrol and its esters. Red lines represent the symmetry in 
resveratrol itself. 
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For the R-3 or 5-O-DHA, there were several evidences indicating that either the 3-OH or 
5-OH group was esterified with the DHA (Figure 4.3 and Table 4.1). First, resveratrol 
originally showed one chemical shift for H-2 and H-6 because of the symmetry, however 
after esterification, the peak of H-2 and H-6 was split into two chemical shifts (δ 6.79 and 
δ 6.72 ppm). This means the compound was no longer symmetric due to mono-
esterification. In addition, large downfield shifts were observed at H-2 and H-6 (Δδ=0.34- 
0.41 ppm). In addition, there were two hydroxyl group peaks at δ 9.60 and 9.70 ppm in 
the spectrum. Integration of the peak at δ 9.60 was reduced to one, which means either 3-
OH or 5-OH was esterified. The 3-OH and 5-OH of resveratrol are chemically equivalent, 
hence both resveratrol-3-DHA and resveratrol-5-DHA are possibly the same. According 
to Lee et al. (2003), the specific substituted position can be determined by HMBC. In this 
study, 13C-NMR, COSY, HSQC, NOESY and HMBC were employed but none of them 
gave any information about the substitution at either H-3 or H-5. This could be caused by 
the difference between resveratrol-3-O-β-D-glucopyranoside and R-3-O-DHA. It could 
be determined by showing correlations between H-1'' of glucopyranose and C-3 of R-3-
O-β-D-glucopyranoside, however no hydrogen is attached at C-1 of DHA in R-3-O-DHA. 
Theoretically, HMBC detects correlations between protons and carbons within 2~3 bonds 
(Richards and Hollerton, 2011).  
The diesters of resveratrol could be confirmed as R-3,4'-O-DHA and R-3,5-O-DHA 
without NMR assignment due to their symmetric nature. The monoesters and the diesters 
were subsequently used in antioxidant activity studies.  
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4.4 Lipophilicity of resveratrol derivatives 
There are many relevant reported examples that increased lipophilicity of antioxidants 
leads not only to their better bioactivity but also improved performance in food systems. 
For example, ascorbic acid is one of the most powerful antioxidants, although it can 
hardly penetrate the phospholipid bilayers of membranes. However, ascorbyl palmitate, a 
lipophilic form of vitamin C, can be considered as a carrier of ascorbate into the tissues 
(Pokorski et al., 2003). Ascorbyl palmitate and ascorbyl stearate have already been used 
as antioxidant food additives. Furthermore, Zhong and Shahidi (2012) demonstrated that 
structurally modified EGCG showed not only excellent antioxidant activity but better 
performance in biological model systems. Thus, we also expected additional potential for 
use as nutraceuticals or even as pharmaceuticals for resveratrol esters.  
In this study, fatty acyl chlorides (C3:0-C22:6) were used to prepare esters to enhance the 
lipophilicity of resveratrol. This investigation may provide an ideal degree of lipophilicity 
for the best outcome of the test system. According to Medina et al. (2010), the 
lipophilicity of resveratrol was 1.85 ± 0.46. In addition, our preliminary data showed that 
lipophilicity of resveratrol was 1.84 ± 0.12, as determined by octanol-water partition 
coefficient measurement using a shake flask method. The shake flask method is the most 
classical method to measure partition coefficient (P). However, the lipophilicity of 
resveratrol derivatives was calculated by using a computer program in this work due to 
the difficulty of measuring the large value of partition coefficients by shake flask method 
(Ayouni et al., 2008; Giaginis and Tsantili-Kakoulidou, 2008; Finizio et al., 1997). 
Therefore, the lipophilicity calculator (ALOGPS 2.1.) was employed for reporting the 
lipophilicity of resveratrol derivatives. As expected, resveratrol derivatives showed higher 
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lipophilicity than resveratrol (Table 4.2) and their corresponding values increased 
according to their chain length extension. Tan et al. (2012) reported that the retention time 
of phytosteryl docosahexaneates was increased compared to the phytosterol itself. 
However, lipophilicity decreased as the degree of unsaturation of the fatty acids increased. 
A similar tendency was observed on TLC. This might be due to the property of the double 
bond with pi bond. Alkanes are made up of single-bonded carbon and hydrogen atoms 
and are nonpolar because carbon and hydrogen atoms have similar electronegativities. 
Alkenes also consist of carbon and hydrogen atoms, but they are slightly more polar than 
alkanes due to the high density of electrons, with a partial negative charge (Bruice, 2011).   
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Table 4.2. Lipophilicity of resveratrol and its monoestersa. 
Compounds Lipophilicity (Log P) 
Resveratrol(R) 2.57 
RC3:0 4.28 
RC4:0 4.55 
RC6:0 5.31 
RC8:0 5.85 
RC10:0 6.45 
RC12:0 7.28 
RC14:0 8.06 
RC16:0 8.72 
RC18:0 9.30 
RC18:1 9.07 
REPA 8.47 
RDHA 8.59 
DPPH radical 4.35 
ABTS radical cation 0.43 
aThe lipophilicity of resveratrol derivatives was 
calculated using ALOGPS 2.1. The structures of 
resveratrol derivatives in simplified molecular input line 
entry system (SMILE) were drawn by ChemDraw Std 
14.0.  
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4.5 DPPH radical scavenging assay 
The DPPH radical is a stable organic radical and is commercially available so that there 
are no preparation steps involved for its generation. The DPPH radical scavenging assay 
is frequently used as a first approach for evaluating antioxidant activity (Shahidi and 
Zhong, 2015). Antioxidants can neutralize the DPPH radical via electron and/or hydrogen 
atom donation (Prior et al., 2005). The purple colour of DPPH gets lighter (from purple to 
yellow) upon radical neutralization. The efficacy of antioxidant capacity can be measured 
by using UV-Vis spectrometry at 517 nm or electron paramagnetic resonance (EPR) 
spectroscopy.  
In this study, the resveratrol derivatives showed decreased DPPH scavenging capacity 
compared to resveratrol (Figure 4.4). It is possible that losing one or more hydroxyl group 
plays a major role in decreasing the antioxidant activity of resveratrol (Medina et al., 
2010; Torres et al., 2010). Chao et al. (2010) reported that antioxidant activity of 
methylated derivatives of resveratrol was in the order of R > R-3-C1 (monoester) > R-4'-
C1 (monoester) > R-3,4'-C1 (diester); the triester (R-3,5,4'-C1) lacked any antioxidant 
activity because it does not carry any free hydroxyl groups. In addition, RC10:0 showed 
the lowest antioxidant activity, whereas RC18:1 showed the highest antioxidant activity 
among all resveratrol derivatives tested. The short-chain and medium-chain fatty acid 
substituents (RC3:0 to RC12:0) exhibited scavenging of around 55~61% compared to the 
antioxidant activity of the parent resveratrol molecule, but this was increased up to 95% 
for RC12:0 to RC18:1. DPPH is a lipophilic compound which may have better affinity to 
the lipophilic compounds tested. Therefore, resveratrol with long-chain fatty acids, which 
	   84	  
have more lipophilicity than resveratrol with short-chain fatty acids, might have better 
accessibility to DPPH and this could lead to a better antioxidant activity. Zhong and 
Shahidi (2011) reported that EGCG esters showed better DPPH radical scavenging 
activity than EGCG itself and suggested that DPPH radical is lipophilic so that the 
substituted compounds have more accessibility/affinity to it than the parent compound. 
Moreover, the antioxidant activities of resveratrol substituted with C18:0, EPA and DHA 
showed a similar pattern (RC18:0 > RDHA > REPA) with the results for EGCG esters 
(EGCG-C18:0 > EGCG-DHA > EGCG-EPA). However, some studies have reported that 
the antioxidant activity increases with the increase of alkyl chain length to a maximum 
point and then begin to reverse with further chain extension. The maximum point is 
generally reached for medium chain fatty acids. This phenomenon is known as a 
nonlinear theory, or cutoff effect. Laguerre et al. (2009) observed collapse in antioxidant 
activity for longer chain esters than dodecyl ester of chlorogenic acid. In addition, Panya 
et al. (2012) observed a drastic decrease after dodecyl chain in DPPH radical scavenging 
activity using rosmarinic acid and its alkyl esters. 
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Figure 4.4. DPPH radical scavenging capacity in micromoles of trolox equivalents (TE) 
per micromole of resveratrol (R) or its derivatives. All determinations were repeated three 
times using the same combined starting materials and mean values and standard 
deviations reported. Bars with different letters are significantly different at P <0.05 
performed by Tukey’s HSD test. Bars with same letters such as “a” and “ab” are not 
significantly different.  
 
4.6 ABTS radical cation scavenging assay  
The ABTS radical cation scavenging assay was developed by Miller et al. (1993) and 
then improved by Re et al. (1999) and van den Berg et al. (1999). The ABTS radical 
cation was prepared by heating with the azo compound AAPH and measuring the 
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absorbance of the blue-green colour can be read at 734 nm. The ABTS radical cation 
scavenging assay is based on single electron transfer (SET) as well as hydrogen atom 
transfer (HAT) mechanisms. The extent of decreasing absorbance can be monitored either 
every few minutes or at an endpoint (Chandrasekara and Shahidi, 2010; Ambigaipalan et 
al., 2015; Shahidi and Zhong, 2015). 
In this study, the ABTS radical cation scavenging effect of resveratrol derivatives was 
lower than that of resveratrol, similar to that observed for DPPH radical scavenging 
activity (Figure 4.5). As mentioned earlier, substitution of hydroxyl group(s) appears to 
negatively affect the antioxidant activity of resveratrol derivatives. The compound RC4:0 
showed the highest ABTS radical cation scavenging effect among all resveratrol 
derivatives tested by exhibiting 83.8% scavenging compared to that of resveratrol. 
Meanwhile, RC8:0 and RC16:0 showed the lowest ABTS radical cation scavenging effect 
among all resveratrol derivatives tested and exhibited scavenging of 34.8 and 33.6%, 
respectively, compared to the scavenging activity of resveratrol. In the DPPH radical 
scavenging assay, resveratrol with long-chain fatty acids showed better radical 
scavenging activity than with short-chain fatty acids. On the other hand, resveratrol with 
short-chain fatty acids showed better antioxidant capacity than other derivatives in the 
ABTS radical cation scavenging assay. The result of the ABTS radical cation scavenging 
assay was similar to that reported by Torres et al. (2010). These author reported that the 
ABTS radical cation scavenging effect of resveratrol (R), its acetate ester (RC2) and 
resveratrol esterified with stearic acid (RC18:0) was in the order of R > RC2 > RC18:0. 
This finding might also be due to the increased lipophilicity of the resveratrol derivatives. 
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According to lipophilicity calculations conducted in this work, the lipophilicity of DPPH 
radical was 4.35, whereas the lipophilicity of ABTS radical cation was 0.43 (Table 4.2). 
Therefore, resveratrol with short-chain fatty acids might have a better affinity towards the 
ABTS radical cation than the other ester derivatives with long-chain fatty acids. The 
ABTS radical cation scavenging effects of resveratrol derivatives with short- (C3:0 to 
C6:0), medium- (C8:0 to C12:0), and long- (C14:0 to C18:0) chain fatty acids decreased 
as their lipophilicity increased. The average ABTS radical cation scavenging effects of 
resveratrol with short-, medium-, long-, and unsaturated fatty acids (C18:1 to DHA) were 
78.4, 45.5, 41.2, and 46.4%, respectively. Reyes-Duarte et al. (2011) studied the ABTS 
radical cation scavenging effects of ascorbyl esters and reported that ascorbic acid 
showed a better ABTS radical cation scavenging effect than ascorbyl esters (in the order 
of ascorbic acid > ascorbyl palmitate > ascorbyl oleate). However, some studies showed 
an opposite trend (enhanced ABTS radical cation scavenging effects as lipophilicity 
increased). Wang et al. (2016) studied the ABTS radical cation scavenging effects of 
EGCG derivatives and reported that EGCG derivatives showed increased ABTS radical 
cation scavenging effects as alkyl chain length increased (EGCG-C18 > EGCG-C8 > 
EGCG-C6 > EGCG-C12, EGCG-C2 > EGCG-C3, EGCG). Saito et al. (2004) studied the 
ABTS radical cation scavenging effects of protocatechuic acid and its alkyl esters. They 
reported that the esterification reaction increased their ABTS radical cation scavenging 
effects, whereas ABTS radical cation scavenging effects of protocatechuic alkyl esters 
decreased as alkyl chain length increased (protocatechuyl methyl ester > protocatechuyl 
ethyl ester > protocatechuyl buthyl ester > protocatechuyl isopropyl ester > 
protocatechuyl tert-butyl ester > protocatechuic acid). In addition, some studies have 
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demonstrated that the 4'-OH group of resveratrol is necessary for its antioxidant activity 
(Caruso et al., 2004; Stivala et al., 2001). Stivala et al. (2001) reported that 4'-OH is 
required more than 3-OH and 5-OH for antioxidant activity. They suggested that the 
electronic structure and the formation enthalpy caused by three different radicals losing 
hydrogen atoms at the 3, 5, and 4'-OH groups in resveratrol might account for this 
behaviour. 
 
 
 
 
 
 
 
Figure 4.5. ABTS radical cation scavenging assay in micromoles of trolox equivalents 
(TE) per micromole of resveratrol (R) or its derivatives. All determinations were repeated 
three times using the same combined starting materials and mean values and standard 
deviations reported. Bars with different letters are significantly different at P <0.05 
performed by Tukey’s HSD test. Bars with same letters such as “a” and “ab” are not 
significantly different.  
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4.7 Summary  
Esterification of resveratrol with 12 different fatty acyl chlorides afforded monoesters as 
the main products. The monoesters, determined by NMR, were both resveratrol-3-
monoester and resveratrol-4'-monoester. Resveratrol was successfully lipophilised via 
esterification as calculated using ALOGPS 2.1. In the DPPH radical and ABTS radical 
cation scavenging assays, resveratrol showed the highest antioxidant activity. Among 
resveratrol derivatives, RC18:0 and RC18:1 showed a higher DPPH radical scavenging 
activity than the other derivatives tested at 87 and 95%, respectively. On the other hand, 
RC3:0, RC4:0, and RC6:0 showed higher ABTS radical cation scavenging activity than 
other derivatives at 74, 84, and 77%, respectively. In this context, it may be of interest to 
carry out more research using RC3:0, RC4:0, RC18:0, and RC18:1. Moreover, it is 
hypothesised that resveratrol with PUFA may have synergistic effect in biological 
systems. Therefore, these molecules may also deserve to be studied further. This suggests 
that some resveratrol derivatives may have the potential of serving as antioxidants in 
lipophilic systems.  
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CHAPTER 5 
Antioxidant activity of resveratrol ester derivatives in food and biological model 
systems 
 
This chapter has been published in Food Chem. (2018), 261, 267-273.  
5.1 Introduction  
Lipid oxidation is a major deteriorative process in food. It is responsible for off-flavour 
formation, a decrease of nutritional value, and generation of potentially toxic compounds 
(Frankel, 1980). The most common lipid oxidation process encountered in food is 
autoxidation in which the free radicals formed lead to further adverse effects once 
consumed (Choe and Min, 2006).  Concerns about lipid oxidation are not limited to food, 
because the free radicals formed can also attack different cells in the body, thus causing 
ageing and a myriad of diseases such as cancer, cardiovascular ailments, and immune 
system deficiencies (Percival, 1998). Therefore, many attempts have been made to 
improve the oxidative stability of foods by using antioxidants as a most effective means 
(Shahidi and Ambigaipalan, 2015). Antioxidants are generally phenolic compounds that 
can interfere with free radical chain reactions by donating a hydrogen atom or an electron 
to the free radicals (Frankel, 1980; Shahidi and Ambigaipalan, 2015). By retarding 
oxidation, they can also prevent certain diseases related to oxidative stress such as skin 
lesions, atherosclerosis, pulmonary dysfunction, cancer, and inflammatory disorders, 
among others (Percival, 1998). 
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Resveratrol is a phenolic stilbenoid compound with powerful antioxidant activity. It also 
has preventive effects on inflammation, cardiovascular disease, and cancer (Jang et al., 
1997; Wang et al., 2002; Donnelly et al., 2004). However, some studies have failed to 
reflect these beneficial effects, possibly due to its high absorption but low bioavailability 
(Baur and Sinclair, 2006; Bove et al., 2002; Walle et al., 2004). In addition, like some 
other phenolic compounds, application of resveratrol could be compromised due to its 
hydrophilicity when used in lipophilic systems (Zhong and Shahidi, 2011). However, this 
problem could be overcome by structural modification. In fact, there are several studies 
reporting maximizing antioxidant activities via structure modification, such as those for 
chlorogenic acid (Laguerre et al., 2011), epigallocatechin gallate (EGCG) (Zhong and 
Shahidi, 2011), caffeic acid (Alemán, et al., 2015), and rosmarinic acid (Laguerre et al., 
2010), among others. Moreover, EGCG esterified with polyunsaturated fatty acids 
(PUFA), especially docosahexaenoic acid (DHA) provided a novel bioactive product that 
was a composite of the two bioactive compounds since DHA itself possesses health 
benefits (Zhong et al., 2012; Zhong and Shahidi, 2012). For this reason, resveratrol was 
esterified with 12 different acyl chlorides (propionyl chloride, butyryl chloride, caproyl 
chloride, capryloyl chloride, capryl chloride, lauroyl chloride, myristoyl chloride, 
palmitoyl chloride, stearoyl chloride, oleoyl chloride, eicosapentaenoyl chloride, and 
docosahexaenoyl chloride) as described in Chapter 3 (see sections 3.2.1.1 and 3.2.1.2; Oh 
and Shahidi, 2017).  
Vlachogianni et al. (2015) demonstrated that 4'-acetylated resveratrol (R) had a better 
DPPH radical scavenging activity than its 3-acetylated isomer (R > 4'-acetylated R > 3-
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acetylated R > 3,5-diacetylated R). However, in the non-enzymatic linoleic acid 
peroxidation assay, they reported a better antioxidant activity for 3-acetylated R than that 
for 4'-acetylated R (3,5-diacetylated R > 3-acetylated R > R > 4'-acetylated R > 3,4'-
diacetylated R) isomer. Moreover, they reported that 3,5-diacetylated R exhibited the 
most powerful effect in the non-enzymatic linoleic acid peroxidation assay even though it 
had lost two of its hydroxyl groups. The effect of esterification position and degree of 
esterification is still unknown. Since the resultant esters still have antioxidant activity, it 
is of interest to see whether the mixture of mono- and diesters show an additive, 
synergistic, or antagonistic effect. In the case of oral administration of ester compounds, 
the ester bond might undergo hydrolysis. Biasutto et al. (2007) studied the bioavailability 
of ester-based quercetin using Madin-Darby Canine Kidney (MDCK)-1, MDCK-2, and 
human colon adenocarcinoma (Caco-2) cells. They reported that some quercetin esters 
underwent partial hydrolysis when they passed through a monolayer of MDCK-1, 
MDCK-2, and Caco-2 cells. Hydrolysis of the ester was dependent on the particular ester 
examined. Pokorski et al. (2003) compared the amount of ascorbate in the brain of cats 
when they were untreated (control), treated with ascorbyl acid, or treated ascorbyl 
palmitate. They could not recover ascorbyl palmitate as is; they found accumulation of 
ascorbate in the brain of the ascorbyl palmitate-treated cat. According to Pokorski et al. 
(2003), ascorbyl palmitate-treated cats showed more recovery of ascorbate in their brain 
tissues compared to ascorbic acid-treated cats. Therefore, it might be hypothesised that 
resveratrol esters would show a beneficial effect even if they underwent hydrolysis. 
In this work, selected food and biological model systems were used to fill the existing 
knowledge gap in the literature on antioxidant potential of resveratrol derivatives in food 
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and for potential health promotion and disease risk reduction. Potential synergistic effects 
of resveratrol with PUFA were also examined in this contribution. 
5.2 Antioxidant activity of resveratrol derivatives in oil-in-water emulsion (β-
carotene bleaching assay) 
A β-carotene bleaching assay was used to evaluate the antioxidant activity of resveratrol 
and its derivatives (Figure 5.1) in an oil-in-water emulsion. When two immiscible liquids 
exist together, one liquid can form a dispersion of small droplets in the other liquid, 
known as emulsion (McClements, 2007). Tween 40 and linoleic acid, used in this assay, 
are amphiphilic with a hydrophilic head and a lipophilic tail, thus can form small 
spherical micelles in the water (McClements, 2002). Meanwhile, β-carotene, a lipophilic 
compound, stays inside the micelle. Heat induces oxidation, and linoleic acid forms 
hydroperoxides and free radicals as a result of losing a hydrogen atom (Chandrasekara 
and Shahidi, 2010). Beta-carotene is attacked by those oxidative products, therefore it 
loses its yellow-orange colour (Ambigaipalan and Shahidi, 2015). The change of colour 
could be monitored spectrometrically at 470 nm.  
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Figure 5.1. Structures of resveratrol derivatives.  
 
In this study, all test compounds prevented decolouration of β-carotene compared to the 
control (Figure 5.2). RC3:0 and RC4:0 exhibited a better inhibition of oxidation than 
resveratrol after 30 min of incubation, but this started to decrease and showed a lower 
inhibition than resveratrol from 45 to 105 min. While resveratrol had the highest 
antioxidant activity among all tested compounds from 60 to 105 min, RC14:0 showed the 
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lowest effect over the same period (Figure 5.2A). Figure 5.2B indicates that resveratrol 
and its derivatives inhibited the decolouration of β-carotene by 11.4-71.2 % over the 105 
min incubation period. Resveratrol had the highest inhibition among all resveratrol-based 
compounds. Among derivatives, resveratrol with short-chain fatty acids (RC3:0 and 
RC4:0) showed better antioxidant activities than other derivatives which were tested. The 
antioxidant activity of resveratrol derivatives in the oil-in-water emulsion was well 
correlated with ABTS radical cation scavenging activity with a correlation coefficient of 
0.84 (Oh and Shahidi, 2017). The antioxidant activity of resveratrol derivatives in the oil-
in-water system did not correspond with the polar paradox. According to the polar 
paradox, nonpolar antioxidants tend to be more effective than polar ones in the oil-in-
water emulsion systems. This is because nonpolar antioxidants may stay around the lipid 
droplet where oxidation occurs (Shahidi and Zhong, 2011). However, several studies have 
demonstrated that not all antioxidants follow the trend that can be explained by the polar 
paradox (Torres de Pinedo et al., 2007; Stöckmann et al., 2000). Torres de Pinedo et al. 
(2007) studied antioxidant activity of phenolic compounds containing alcohols with 
different alkyl chain lengths such as protocatechuic alcohol (C1), hydroxytyrosol (C2), 
and dihydrocaffeoyl alcohol (C3). They found an increase in antioxidant activity in bulk 
oil (C3 > C2 > C1), which contradicts the polar paradox theory. Stöckmann et al. (2000) 
observed different trends of antioxidant activity using various emulsifiers in the oil-in-
water system and suggested that the application of the polar paradox hypothesis might 
need to be narrowed down to the emulsions containing phospholipids as emulsifiers.  
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Figure 5.2. Antioxidant activities of resveratrol and its derivatives against β-carotene 
bleaching over a 105 min period (a) and inhibition against β-carotene bleaching after 105 
min incubation (b) by resveratrol and its derivatives. All determinations were repeated 
three times using same combined starting materials and the mean values and standard 
deviation values were reported. Bars with different letters mean significantly different at 
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P < 0.05 performed by Tukey’s HSD test. Bars with same letters such as “a” and “ab” 
mean insignificantly different.  
 
5.3 Antioxidant activity in bulk oil 
 In the food industry, many different techniques such as degumming, refining, bleaching, 
and deodorization have been used to refine oils by removing a variety of minor 
compounds that influenced the oxidative stability of oils (McClements and Decker, 2007). 
For example, the refining process effectively removes FFAs accelerate lipid oxidation of 
oils, leading to an enhancement of oxidative stability (Choe and Min, 2006). However, 
purified oils are highly susceptible to oxidation. Thus, one may recover the tocols and put 
them back into oils, since tocols can improve the oxidative stability of oils by acting as 
electron or hydrogen atom donors, therefore retarding lipid oxidation (Choe and Min, 
2006). Thus, commercial oils generally contain some tocols. In order to use the oils 
(either bought from the market or extracted in the laboratory) for experimental work, 
further processing to remove their minor components is needed, and this is known as 
stripping. 
Corn oil used in this study was stripped of its endogenous antioxidants in order to 
eliminate their influence on oxidative stability of the oil containing the test compounds. 
Major fatty acids in corn oil are oleic acid (C18:1, 34.1 %) and linoleic acid (C18:2, 47.9 
%) (Ferrari et al., 1996). Generally, oxidation is initiated by the abstraction of a hydrogen 
atom attached to an allylic or a bis-allylic carbon atom (carbon next to the double bond) 
due to their low dissociation energy (Zhong and Shahidi, 2009). After losing its hydrogen 
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atom, the alkyl radical formed is stabilised by delocalisation, along with possible 
formation of trans isomers as well as conjugated dienes (polyunsaturated fatty acids) 
(Choe and Min, 2006; McClements and Decker, 2007). The conjugated diene content was 
measured at 233 nm. However, conjugated dienes could dissociate to secondary oxidation 
products, such as aldehydes, ketones, alcohols and hydrocarbons (Choe and Min, 2006). 
For secondary oxidation products, the p-anisidine assay was employed. The p-anisidine 
can react with aldehydes (2-alkenals and 2,4-alkadienals) and form a yellowish 
chromophore, which can be measuread at 350 nm (Shahidi and Wanasundara, 2002).  
Conjugated diene formation of corn oil in this study is shown in Table 5.1. The oils with 
test compounds exhibited a similar lag phase of 3 days. On day 6, most of the test 
compounds were able to retard the formation of conjugated dienes significantly except for 
RC3:0 and RDHA (p < 0.05). Although resveratrol derivatives lost their hydroxyl groups 
due to esterification, some derivatives (RC6:0, RC8:0, RC10:0, RC12:0, RC16:0) showed 
significantly better antioxidant activity than resveratrol itself (p < 0.05). This result also 
contradicts polar paradox, as polar antioxidants generally are expected to be more 
efficacious than nonpolar ones in bulk oil systems. In addition, we hypothesised that 
resveratrol with polyunsaturated fatty acids (PUFA), namely EPA and DHA might 
produce the same or even a higher level of conjugated dienes than the control because 
PUFA connected to resveratrol could also be oxidized and form conjugated dienes. 
However, REPA inhibited the oxidation to nearly the same extent as resveratrol itself (no 
significant difference). RC3:0 had very little effect on antioxidant activity but the 
antioxidant activity of other resveratrol derivatives from RC4:0 to RC8:0 increased as the 
lipophilicity increased, but after reaching a maximum point (RC8:0), a decrease was 
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noted. This has been observed in several studies; this phenomenon was coined as the 
cutoff effect, or nonlinear theory (Laguerre et al., 2009; Panya et al., 2011; Laguerre et 
al., 2015). Laguerre et al. (2009) studied the antioxidant activities of chlorogenic acid and 
its alkyl esters in emulsion systems in order to examine the effect of chain length on 
antioxidant activity. They observed a drastic decrease in antioxidant activity after the 
dodecyl chain (C12:0). Furthermore, Panya et al. (2011) observed a nonlinear 
phenomenon in DPPH radical scavenging assay using rosmarinic acid and its alkyl esters. 
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Table 5.1.  Conjugated dienes formation of stripped corn oil over a 6-day period in the 
presence of resveratrol and its derivatives. 
 Storage period 
Sample Day 0  Day 1  Day 3  Day 6  
Control 0.21 ± 0.02 e 0.50 ± 0.01 bcd 0.62 ± 0.01 ab 5.46 ± 0.03 a 
R 0.22 ± 0.01 e 0.48 ± 0.02 de 0.57 ± 0.00 d 4.42 ± 0.08 ef 
RC3:0 0.24 ± 0.00 e 0.48 ± 0.02 cde 0.63 ± 0.00 a 5.44 ± 0.02 a 
RC4:0 0.22 ± 0.01 e 0.49 ± 0.01 bcde 0.61 ± 0.00 bc 4.95 ± 0.02 b 
RC6:0 0.23 ± 0.00 e 0.49 ± 0.02 bcde 0.55 ± 0.00 de 4.04 ± 0.01 g 
RC8:0 0.25 ± 0.03 de 0.48 ± 0.00 de 0.57 ± 0.01 d 3.78 ± 0.01 h 
RC10:0 0.29 ± 0.02 cd 0.48 ± 0.01 bcde 0.56 ± 0.01 de 3.99 ± 0.03 g 
RC12:0 0.31 ± 0.01 bc 0.46 ± 0.01 e 0.54 ± 0.00 e 4.02 ± 0.08 g 
RC14:0 0.35 ± 0.03 ab 0.49 ± 0.02 bcde 0.57 ± 0.01 d 4.57 ± 0.01 cd 
RC16:0 0.37 ± 0.01 a 0.50 ± 0.01 abcd 0.56 ± 0.01 de 4.08 ± 0.01 g 
RC18:0 0.36 ± 0.01 a 0.51 ± 0.01 abcd 0.54 ± 0.01 e 4.34 ± 0.03 f 
RC18:1 0.35 ± 0.02 ab 0.52 ± 0.00 abc 0.56 ± 0.01 de 4.64 ± 0.01 c 
REPA 0.37 ± 0.00 a 0.52 ± 0.01 ab 0.55 ± 0.01 de 4.53 ± 0.01 de 
RDHA 0.36 ± 0.00 a 0.54 ± 0.01 a 0.59 ± 0.01 c 5.53 ± 0.04 a 
All determinations were repeated three times using the same combined starting materials 
and mean values and standard deviations reported. Values in the same column with 
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different letters are significantly different at P < 0.05 performed by Tukey’s HSD test. 
Columns with same letters such as “a” and “ab” are not significantly different.  
 
The p-anisidine value of the oils with test compounds (RC6:0, RC8:0, RC10:0, RC12:0, 
RC16:0, RC18:0) on day 6 showed a significantly better antioxidant activity than the 
parent molecule (P < 0.05, Table 5.2). RC8:0 showed the highest antioxidant activity 
among all compounds tested while RC3:0 and RDHA had no effect compared to the 
control. This result correlated well with conjugated dienes and their correlation 
coefficient was 0.96. 
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Table 5.2. p-Anisidine values of stripped corn oil over a 6-day period in the presence of 
resveratrol and its derivatives. 
 Storage period 
Sample Day 0 Day 1  Day 3 Day 6  
Control 22.4 ± 9.1 a 11.8 ± 0.2 cde 17.7 ± 0.4 bcd 165 ± 0.8 a 
R 16.9 ± 6.5 ab 12.0 ± 0.3 cd 16.5 ± 0.3 d 84.8 ± 0.3 e 
RC3:0 10.0 ± 1.5 bc 12.6 ± 1.1 bc 17.0 ± 0.3 cd 163.0 ± 1.2 a 
RC4:0 10.9 ±1.5 b 11.1 ± 0.2 cde 17.0 ± 0.3 cd 112.9 ± 0.7 b 
RC6:0 9.5 ± 0.4 bcd 10.6 ± 0.4 de 16.8 ± 0.3 d 70.2 ± 0.4 g 
RC8:0 14.6 ± 1.1 ab 10.4 ± 0.3 e 17.5 ± 0.1 bcd 65.0 ± 0.6 h 
RC10:0 10.3 ± 0.2 bc 10.7 ± 0.2 de 17.0 ± 0.7 cd 71.6 ± 0.7 g 
RC12:0 9.1 ± 0.4 bcd 10.4 ± 0.2 e 18.6 ± 0.3 ab 66.7 ± 1.5 h 
RC14:0 8.7 ± 0.8 bcd 10.9 ± 0.2 de 19.6 ± 0.3 a 87.5 ± 0.6 d 
RC16:0 8.9 ± 0.7 bcd 13.7 ± 1.0 ab 18.9 ± 0.2 ab 70.5 ± 0.8 g 
RC18:0 1.5 ± 0.8 cd 14.2 ± 0.6 a 17.8 ± 0.7 bcd 78.0 ± 0.5 f 
RC18:1 0.8 ± 0.2 d 13.8 ± 0.4 ab 18.4 ± 0.9 abc 91.4 ± 0.5 c 
REPA 1.4 ± 0.1 cd 14.5 ± 0.5 a 18.3 ± 0.4 abc 85.0 ± 0.3 e 
RDHA 1.6 ± 0.4 cd 15.0 ± 0.3 a 18.3 ± 0.9 abc 163.8 ± 1.1 a 
All determinations were repeated three times means and standard deviations were 
reported. Values in the same column with different letters are significantly different at P 
< 0.05 performed by Tukey’s HSD test. Columns with same letters such as “a” and “ab” 
are not significantly different.  
	   103	  
5.4 Antioxidant activity in a meat model system (thiobarbituric acid reactive 
substances, TBARS) 
The thiobarbituric acid (TBA) method was employed to assess the effect of resveratrol 
and its derivatives in the control of oxidation in a meat model system. The secondary 
oxidative products, mainly aldehydes and ketones, are responsible for off-flavour 
development and loss of nutrients in muscle foods (Cesa, 2004). MDA, one of 
degradation products from polyunsaturated fatty acids, reacts with TBA. The MDA-TBA 
so produced has a pink colour, which can be measured at 530-535 nm, therefore TBARS 
are usually reported as MDA equivalents (Shahidi and Zhong, 2015). In this study, BHT 
was employed as a positive control. As shown in Table 5.3, all samples showed an 
increasing trend of TBARS during cold storage (4 °C). The ground pork system 
containing resveratrol with unsaturated fatty acids (C18:1, EPA, DHA) had the lowest 
TBARS values at the beginning of the storage after cooking (day 0). From day 3 to day 7, 
most of the test compounds except RC14:0 displayed lower TBARS values compared to 
the control. RC3:0 and RC6:0 had the lowest TBARS value among all tested compounds 
after 3 days of storage, significantly lower than resveratrol itself (p < 0.05). Meanwhile 
RC3:0, RC6:0, REPA, and RDHA showed some, but insignificant differences with 
resveratrol after 5 days of storage (in the following order RC3:0 > R > RDHA > RC6:0 > 
REPA, p > 0.05).  However, REPA and RDHA were able to inhibit the production of 
TBARS significantly compared to resveratrol after 7 days of storage (p < 0.05). 
According to Zhong and Shahidi (2012), inhibition of β-carotene bleaching by EGCG and 
its derivatives was correlated with the inhibition of TBARS production and their 
lipophilicity (EGCG-C18:0 > EGCG-DHA > EGCG-EPA > EGCG). However, there was 
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no correlation between TBARS values and lipophilicity in this study. There was a 
possibility that the ester bonds could be hydrolysed during the cooking (80 °C), which 
might lead to the insignificant differences with resveratrol itself. Moreover, REPA and 
RDHA carrying PUFA, are able to produce aldehydes that could increase TBARS. 
However, REPA and RDHA showed the lowest TBARS values among all tested 
compounds after 7 days of storage (p < 0.05). Moreover, most of the test compounds, 
except resveratrol with medium chain fatty acids, exhibited a better inhibition of the 
formation of TBARS when compared with BHT during 7 days of storage. The amount of 
BHT used was low (equivalent to 5 ppm) compared to other similar studies 
(Ambigaipalan and Shahidi, 2015), therefore the positive control might show lower 
antioxidant activity than other studies. However, some of the resveratrol esters were able 
to inhibit TBARS formation and this was stronger statistically than the positive control at 
the same concentration. Therefore, the results so obtained suggest that resveratrol 
derivatives might be used as potential antioxidants in cooked muscle foods in order to 
provide better oxidative stability to the products. 
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Table 5.3. TBARS values of pork model system over a 7-day period in the presence of 
resveratrol and its derivatives (MDA eq. /kg). 
 Storage period 
Sample Day 0 Day 3 Day 5 Day 7 
Control 1.03 ± 0.00b 2.25 ± 0.05ab 2.84 ± 0.09ab 2.94 ± 0.09a 
BHT 1.19 ± 0.06a 2.10 ± 0.04bc 2.74 ± 0.04b 2.74 ± 0.04b 
R 0.86 ± 0.01c 1.56 ± 0.02h 1.86 ± 0.07fg 2.35 ± 0.05cde 
RC3:0 0.46 ± 0.01fg 1.25 ± 0.06j 1.89 ± 0.05fg 2.19 ± 0.03ef 
RC4:0 0.62 ± 0.01de 1.60 ± 0.04h 2.12 ± 0.03e 2.27 ± 0.05cde 
RC6:0 0.68 ± 0.01d 1.35 ± 0.03ij 1.78 ± 0.03g 2.24 ± 0.06def 
RC8:0 0.89 ± 0.03c 1.76 ± 0.02fg 2.34 ± 0.03d 2.74 ± 0.09b 
RC10:0 0.83 ± 0.05c 1.62 ± 0.04gh 2.10 ± 0.05e 2.81 ± 0.04ab 
RC12:0 1.04 ± 0.01b 1.95 ± 0.03cde 2.41 ± 0.10cd 2.80 ± 0.03ab 
RC14:0 0.86 ± 0.02c 2.26 ± 0.05a 2.99 ± 0.7a 2.70 ± 0.06b 
RC16:0 1.01 ± 0.04b 2.26 ± 0.03cd 2.99 ± 0.08c 2.70 ± 0.02b 
RC18:0 0.53 ± 0.03ef 1.94 ± 0.06de 2.47 ± 0.07cd 2.39 ± 0.08cd 
RC18:1 0.36 ± 0.03h 1.47 ± 0.08hi 2.03 ± 0.03ef 2.44 ± 0.07c 
REPA 0.42 ± 0.00gh 1.79 ± 0.02ef 1.71 ± 0.03g 2.00 ± 0.06g 
RDHA 0.42 ± 0.04gh 1.56 ± 0.12h 1.82 ± 0.05g 2.08 ± 0.05fg 
All determinations were repeated three times using the same combined starting materials 
and mean values and standard deviations reported. Values in the same column with 
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different letters are significantly different at P < 0.05 performed by Tukey’s HSD test. 
Columns with same letters such as “a” and “ab” are not significantly different.  
	  
5.5 Hydrogen peroxide (H2O2) scavenging activity 
Superoxide dismutase in the human body can generate H2O2 in order to remove 
superoxide radical (O2•-) (Halliwell, 1991). In addition, activated phagocytes can produce 
H2O2 to protect the body from invading microorganisms (Chandrasekara and Shahidi, 
2011). Although H2O2 is one of the non-radical reactive oxygen species (ROS), it can be 
very toxic to the cells due to its ability to cause DNA damage and membrane disruption 
(Halliwell, 1991). It is also known that in the presence of iron or copper ions, H2O2 can 
form hydroxyl radical (HO•) which is a highly reactive radical (Halliwell and Aruoma, 
1991). Therefore, it is important to keep the level of H2O2 in balance. In this study, the 
H2O2 scavenging activity of resveratrol and its derivatives was determined and the results 
are shown in Figure 5.3. Some resveratrol derivatives (RC3:0 to RC14:0) showed better 
activity than the parent resveratrol. RC3:0 and RC4:0 were 3- to 3.2-fold and RC6:0 to 
RC14:0 were 1.6- to 2.4-fold more effective than resveratrol itself. Konyalioglu et al. 
(2013) reported that resveratrol might be effective against hydrogen peroxide-induced 
oxidation stress on embryonic neural stem cells. Jang and Surh (2001) stated that 
pheochromocytoma (PC12) cells in rats may be protected by resveratrol from hydrogen 
peroxide-induced apoptosis. This study suggests that resveratrol derivatives could render 
enhanced effects on H2O2 scavenging activity so that they may lead to better activities 
than resveratrol itself in various diseases caused by H2O2. Meanwhile, except for RC3:0 
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and RC4:0, the compounds beginning with resveratrol to RC10 exhibited an increasing 
trend of activity in the order of RC10:0 > RC8:0 > RC6:0 > R. However, RC12:0 to 
RC18:0 followed an opposite trend. Moreover, unsaturated esters showed no H2O2 
scavenging activity. This might also be related to the so-called nonlinear or cutoff effect. 
Several studies have reported a cutoff effect in emulsions as well as with other systems 
(Devínsky et al., 1990; Locatelli et al., 2008; Sugandhi et al., 2007). Devínsky et al. 
(1990) found a cutoff effect on antimicrobial activity of the homologous series of N,N-
dimethylalkylamine oxides for Staphylococcus aureus and Escherichia coli. Locatelli et 
al. (2008) observed a cutoff effect on the cytotoxic effect toward L1210 leukemia cells.  
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Figure 5.3. Hydrogen peroxide scavenging activities in micromoles of ascorbic acid 
equivalents (AAE) per micromoles of resveratrol and its derivatives. Resveratrol (R) or 
its derivatives. All determinations were repeated three times using the same combined 
starting materials and mean values and standard deviations reported. Bars with different 
letters mean significantly different at P < 0.05 performed by Tukey’s HSD test. Bars with 
same letters such as “a” and “ab” are not significantly different.  
	  
5.6 Inhibition of copper-induced low-density lipoprotein oxidation 
LDL is an essential particle for transporting cholesterol to cells in the human body. Since 
LDL is composed of lipids such as phospholipids, cholesterols, and triacylglycerols, 
among others, it is susceptible to oxidation. The oxidation of LDL might start with 
phospholipids located on the surface of the LDL and then propagate to the core lipids 
causing modification of phospholipids, lipids, cholesterols, as well as apolipoprotein B 
(Witztum, 1994). The oxidized LDL, known as modified LDL, can lead to atherosclerosis. 
 de     
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    abc       
	  	  	  e	  	  	  	  	  	  	  	  e	  
	   109	  
Therefore, inhibition of LDL oxidation is of interest to many scientists. There are two 
ways to initiate LDL oxidation outside of the body, one is using transition metal ions such 
as copper ion (Cu2+) and the other is using AAPH to generate peroxyl radical (Magalhães, 
2008). In this study, LDL oxidation was induced by CuSO4, and the resulting LDL 
oxidation (formation of conjugated dienes) was monitored spectrophotometrically at 234 
nm. Resveratrol is known to be an inhibitor of human LDL oxidation (Frankel et al. 
1993). Frankel et al. (1993) measured hexanal formation by copper-catalyzed oxidation, 
in which resveratrol was able to inhibit LDL oxidation by 70-81%. However, resveratrol 
and resveratrol with EPA showed a prooxidative activity in this study (Figure 5.4). There 
are several studies suggesting resveratrol as being responsible for DNA cleaving due to 
its prooxidant effect (Fukuhara and Miyata, 1998; Fukuhara et al., 2006; Zheng, et al., 
2006). Fukuhara and Miyata (1998) reported that resveratrol was able to convert 
supercoiled DNA to nicked DNA effectively at neutral pH in the presence of O2 and Cu2+. 
On the other hand, resveratrol could not damage the DNA in the presence of other metal 
ions such as Mg2+, Mn2+, Zn2+, Ni2+, Co2+ or Fe3+. Although Frankel et al. (1993) did not 
report the specific conditions for their experiment reporting the inhibitory effect of LDL 
oxidation, the pro-oxidative activity of resveratrol in this work might originate from 
different conditions such as pH and presence of O2. The behaviour of resveratrol 
(antioxidant or prooxidant) in LDL oxidation induced by copper needs to be further 
investigated. Interestingly, most resveratrol derivatives were able to inhibit LDL 
oxidation. Among resveratrol derivatives, RC16:0 and RC18:0 showed the highest 
inhibition of LDL oxidation. Structural modification might affect the inhibition ability of 
test materials. Fukuhara et al. (2006) studied the structural basis of resveratrol and its 
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analogues for DNA-cleaving activity in the presence of Cu2+. Among hydroxyl groups of 
resveratrol, the 4'-hydroxyl group was most important for DNA cleavage due to its ability 
to bind with Cu2+. Therefore, loss of hydroxyl groups via esterification could affect their 
binding ability with Cu2+, which leads to a better inhibition of LDL oxidation. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.4. Inhibition (%) of resveratrol and its derivatives against LDL oxidation 
induced by copper. Resveratrol (R) or its derivatives. All determinations were repeated 
three times using the same combined starting materials and mean values and standard 
deviations reported. Bars with different letters mean significantly different at P < 0.05 
performed by Tukey’s HSD test. Bars with same letters such as “a” and “ab” are not 
significantly different.  
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5.7 Inhibition of hydroxyl radical-induced DNA scission 
It is well known that damaged DNA that may occur upon the action of reactive oxygen 
species (ROS), can lead to mutation and potentically to carcinogenesis. However, ROS is 
not avoidable to living cells because it is continuously generated via biochemical 
reactions and external factors (Loft and Poulsen, 1996). For example, hydroxyl radical, 
one of the ROS, can be generated from degradation of hydrogen peroxide through Fenton 
reaction and from interaction between superoxide and hydrogen peroxide via a Haber-
Weiss reaction (Yu, 1994). Although hydroxylradical is the most reactive radical of the 
ROS, it has low diffusion capability due to its short half-life. Antioxidative defense 
systems to protect from ROS in our body such as superoxide dismutase, GSH peroxidase, 
and catalase are frequently inadequate to neutralize them (Yu, 1994; Loft and Poulsen, 
1996). Therefore, it is of interest to find external sources of antioxidants to serve as 
critical barriers against free radical and oxidative damage. In this study, hydroxyl radical 
was employed to determine the inhibition of DNA scission by resveratrol and its 
derivatives. Hydrogen peroxide and Fe2+ were used to generate hydroxyl radical. As 
shown in Figure 5.5, supercoiled DNA in the control was fully converted into open 
circular DNA by hydroxyl radicals, however the linear form was not observed. 
Resveratrol esters were able to inhibit DNA scission, similar to resveratrol itself (p > 0.05, 
Table 5.4). The esterification did not affect the inhibition of DNA scission in this work. 
However, Zhou et al. (2017) reported that esterification of tyrosol increased the inhibition 
of DNA scission induced by hydroxyl radical, whereas esterification of hydroxytyrosol 
decreased the inhibition of DNA scission. According to Zhong and Shahidi (2012), 
inhibition against DNA scission of EGCG and its derivatives might be due to a 
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combination of radical scavenging and Fe2+ chelation. Some studies have reported that 
resveratrol also has Fe2+ chelating ability (Hussein, 2011; Gülçin, 2010). Hence, 
inhibition against DNA scission induced by hydroxyl radical might also be due to a 
cumulative result of radical scavenging, Fe2+ chelating ability, and H2O2 scavenging 
ability. Although resveratrol derivatives (RC3:0 to RC14:0) showed a significantly better 
H2O2 scavenging activity than resveratrol, inhibition against DNA scission induced by 
hydroxyl radical was to various extent, but not significantly different. This might be due 
to its compromised radical scavenging ability. Resveratrol derivatives showed a lower 
radical scavenging activity in both DPPH radical and ABTS radical cation scavenging 
assays (Oh and Shahidi, 2017), suggesting that losing one or more hydroxyl group might 
compromise their radical scavenging activity. Therefore, decreased radical scavenging 
activity might counteract the better effect of resveratrol derivatives (RC3:0 to RC14:0) on 
H2O2 scavenging ability. While unsaturated derivatives of resveratrol (RC18:1, REPA, 
and RDHA) showed no H2O2 scavenging activity, their inhibition of DNA scission 
induced by hydroxyl radical was similar to resveratrol. This might be due to the structural 
nature (bent structure) of unsaturated fatty acids that might positively influence the metal 
chelation activity (Zhong and Shahidi, 2012). 
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Figure 5.5. Inhibition (%) of hydroxyl radical induced DNA scission by (a) R, RC3:0, 
RC4:0, RC6:0, RC8:0, RC10:0, and RC12:0 and (b) RC14:0, RC16:0, RC18:0, RC18:1, 
REPA, and RDHA (B: DNA only, C: DNA + FeSO4 + H2O2). The visualisation of DNA 
bands was obtained using the Alpha-Imager gel documentation system (Cell Biosciences, 
Santa Clara, CA, USA) and the data processing was performed with the Chemi-Imager 
4400 software (Cell Biosciences). 
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Table 5.4. Inhibition of hydroxyl radical-induced DNA scission by 
resveratrol and its derivatives. 
 Inhibition (%) 
R 79.75 ± 1.86 abc 
RC3:0 86.94 ± 1.40 a 
RC4:0 79.76 ± 1.49 abc 
RC6:0 80.92 ± 1.31 abc 
RC8:0 86.15 ± 3.58 ab 
RC10:0 84.46 ± 3.63 abc 
RC12:0 81.03 ± 1.77 abc 
RC14:0 77.94 ± 2.49 abc 
RC16:0 75.94 ± 0.70 c 
RC18:0 79.07 ± 3.71 abc 
RC18:1 77.55 ± 7.67 bc 
REPA 77.23 ± 1.18 bc 
RDHA 79.38 ± 1.04 abc 
All determinations were repeated three times using same 
combined starting materials and mean values and standard 
deviations reported. Values with different letters mean 
significantly different at P <0.05 performed by Tukey’s HSD 
test. Columns with same letters such as “a” and “ab” are not 
significantly different.  
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5.8 Summary 
This study demonstrated the potential extended use of lipophilised resveratrol derivatives 
in food and biological systems in order to control oxidative processes. The derivatives 
showed a range of antioxidant activities depending on the model system employed. We 
observed disagreement with the polar paradox hypothesis in both oil-in-water emulsion 
and bulk oil systems. Moreover, a nonlinear phenomenon was observed in the bulk oil 
system and hydrogen peroxide scavenging activity. The test compounds, except for 
resveratrol and REPA, were able to inhibit LDL oxidation induced by copper ion 
effectively. In addition, all test compounds inhibited DNA scission induced by hydroxyl 
radical. The results clearly demonstrated that resveratrol derivatives might serve as 
potential antioxidants in food and biological systems.  
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CHAPTER 6 
Effect of lipophilisation of resveratrol on reactive nitrogen/oxygen species 
generation in murine macrophages and human cancer cell lines 
6.1 Introduction 
Inflammation, such as redness, warmth, and swelling, is a normal reaction to injuries or 
infections. However, prolonged inflammation can progress further to various chronic 
diseases such as cardiovascular disease and cancer (Zhong et al., 2012). Reactive oxygen 
species (ROS) and reactive nitrogen species (RNS) may explain the link between 
inflammation and other chronic diseases (Wiseman and Halliwell, 1996). It is well known 
that ROS and RNS can continuously be generated in vivo as a by-product of biological 
reactions (Halliwell, 1996, Fransen et al., 2012). Superoxide (O2•−), hydrogen peroxide 
(H2O2), and nitric oxide (ON•) are the primary ROS/RNS species in a cell and they can 
readily form other ROS/RNS (Fransen et al., 2012). At a low level, ROS/RNS can serve 
as mediators for various biological responses such as gene expression and cell 
proliferation. However, at high levels, they can also cause harmful effects, including 
inflammation, cardiovascular disease, and cancer (Fransen et al., 2012; Zhong et al., 
2012). Antioxidative defense systems are frequently insufficient in our body to keep 
ROS/RNS level in balance, therefore external sources of antioxidants are needed (Yu, 
1994; Loft and Poulsen, 1996). 
Resveratrol is a powerful antioxidant and has been found in more than 70 plant species, 
especially grape skins. Red wine also contains resveratrol that originates from grapes 
(Dercks and Creasy, 1989; King et al., 2006). Resveratrol had received increasing 
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attention since red wine was first shown to display cardioprotection (Baur and Sinclair, 
2006). In addition, resveratrol has been known to prevent oxidation, cancer, coronary 
heart disease and inflammation (Jang et al., 1997; Wang et al., 2002; Donnelly et al., 
2004). Although it has beneficial health properties, there are limitations to its bioactivity 
due to its hydrophilic nature and fast metabolism in the body (Zhong and Shahidi, 2011; 
Walle et al., 2004). Structural modification may be considered to overcome its limitations 
in this respect (Torres et al., 2010; Baur and Sinclair, 2006). Several studies on lipophilic 
derivatives of phenolic compounds, including resveratrol, have demonstrated their better 
performance in biological model systems. Acetylated resveratrol showed better inhibition 
of platelet activating factor (1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine, PAF)-
induced washed rabbit platelet aggregation and DU-145 human prostate cancer cell-
growth than resveratrol itself (Fragopoulou et al., 2007; Cardile et al., 2005). In addition, 
Cichocki et al. (2008) reported that pterostilbene, similar to resveratrol, acted as an 
inhibitor of tumour promotion biomarker. Moreover, esterification of resveratrol with 
polyunsaturated fatty acids (PUFAs) may provide a synergistic effect due to their own 
individual bioactivities. In addition, our preliminary data showed that some of the 
resveratrol esters have a potential effect on ROS/RNS generation in murine macrophages. 
For this reason, resveratrol was esterified with propionyl chloride (C3:0) and 
docosahexaenoyl chloride (DHA, C22:6) as described in Chapter 3 (sections 3.2.1.1 and 
3.2.1.2; Oh and Shahidi, 2017). In the study reported in this chapter, the monoesters 
(RC3:0 and RDHA) were evaluated for inhibition against NO production, and RDHA was 
evaluated further for cell viability and ROS generation in HepG2 cells.  
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6.2 Nitric oxide (NO) production 
Nitric oxide is an important molecule with known beneficial activities such as vascular 
relaxation and neurotransmission in mammals (Coleman, 2001). The solubility and 
diffusion properties of NO are similar to those of oxygen and it can freely cross cell 
membranes and has a long half-life (Coleman, 2001). It is a relatively stable radical, 
however it can form peroxynitrite anion (ONOO−) which is a more reactive form of RNS 
(Kruidenier and Verspaget, 2002). Moreover, an excessive amount of NO in activated 
immune cells leads to tissue damage during inflammation (Zhong et al., 2012). NO is 
generally synthesized from L-arginine by three different types of NO synthase (NOS), 
namely neural NO synthase (nNOS), endothelium NO synthase (eNOS), and inducible 
NO synthase (iNOS). Unlike nNOS and eNOS, iNOS is continuously active once 
expressed and produces NO at a sustained high level. Expression of iNOS can be induced 
by LPS or cytokines such as tumour necrosis factor (TNF)-α and interleukin (IL)-1 
(Coleman, 2001).  
In this study, inhibition of LPS-induced NO production in murine RAW 264.7 was 
examined for two different resveratrol esters (Figure 6.1) was evaluated and compared 
with resveratrol. The nitrite concentration in the culture medium was considered as NO 
production. As shown in Figure 6.2, the nitrite level of LPS treatment alone (LPS) 
increased greatly compared to that of the control (p < 0.005). All samples were able to 
attenuate NO production in murine RAW 264.7 cells. Resveratrol and RC3:0 showed a 
significant decrease of NO production at both 5 and 25 µg/mL (p < 0.05). However, 
RDHA at 5 µg/mL was able to attenuate the NO production slightly but an insignificant 
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difference was observed as compared to LPS; RDHA at 25 µg/mL was able to inhibit 
overproduction of NO effectively and it was as effective as resveratrol itself at the same 
concentration. Tsai et al. (1999) reported that resveratrol inhibited the generation of NO 
and reduced the level of iNOS protein. They also found almost complete suppression of 
iNOS mRNA by resveratrol, suggesting that the inhibition of iNOS generation might be 
due to suppression of iNOS mRNA. Bi et al. (2005) reported that resveratrol inhibited the 
release of NO as well as TNF-α induced by LPS. Zhong et al. (1999) stated that 
resveratrol showed inhibition of IL-6 release. TNF-α and IL-6 are involved in pro-
inflammatory responses. Resveratrol esters have not been studied on the generation of 
iNOS protein, iNOS gene expression, the release of IL-6 and TNF- α, however they are 
expected to exert an effect on pro-inflammatory agents due to possessing inhibitory 
activity on NO production. This implies that all tested compounds may render an 
inhibitory effect on NO production and possibly serve as anti-inflammatory agents, but 
this needs to be further investigated.  
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R:  C3H6O (C3:0) 
      C22H32O (C22:6; DHA) 
Figure 6.1. Structures of RC3:0 and RDHA monoesters. 
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Figure 6.2. Effect of resveratrol and its monoesters on NO production in LPS-induced 
RAW 264.7 macrophages (P < 0.001 compared with the control; P < 0.05, compared 
with the LPS treatment only). All determinations were repeated three times using the 
same combined starting materials and mean values and standard deviations reported. 
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6.3 Determination of cytotoxicity and ROS generation on human hepatoma 
carcinoma (HepG2) cells (cellular antioxidant assay) 
The cytotoxicity of resveratrol and its esters (10 µg/mL) on HepG2 cells was determined 
by using the MTT assay. The MTT assay is a colourimetric assay, which is fast and 
precise and is based on the reducing ability of mitochondria of living cells. Mitochondria 
can reduce tetrazolium salt MTT, a pale-yellow compound, to formazan, a dark-blue 
product. Formazan so obtained can be dissolved in dimethyl sulphoxide (DMSO) and 
measured at 570 nm and considered as the cell population (Mosmann, 1983). As shown in 
Table 6.1, the cells treated with resveratrol and its esters were incubated for 24 or 48 h.  
None of the compounds tested showed any cytotoxicity, thus the ROS generation assay 
was conducted. A cellular antioxidant assay (CAA), using 2',7'-dichlorofluorescin 
diacetate (DCFH-DA), was employed to assess ROS generation in cells. DCFH-DA is a 
stable, non-fluorescent and cell membrane permeable compound due to its 
hydrophobicity (Le Bras et al., 2005; Pan et al., 2005). When DCFH-DA is taken into the 
cultured HepG2 cells, cellular esterase forms DCFH by cleaving the acetate groups (Le 
Bras et al., 2005). DCFH is sensitive to ROS and RNS, thus it can be oxidized to a 
fluorescent DCF. The measured fluorescent intensity can be considered as an index of the 
overall oxidative stress in cells (Pan et al., 2005; Shahidi and Zhong, 2015).  
 
 
 
	   123	  
Table 6.1. Effect of resveratrol and its DHA ester on HepG2 cell viability 
Compound (10 µg/mL) Cell Viability % (24 h) Cell Viability % (48 h) 
Resveratrol 111.05 ± 9.16 Aa 111.58 ± 10.19 Aa 
RDHA 101.08 ± 5.54 Ba 89.47 ± 4.96 Bb 
 
Values in the same column with different uppercase letters were significantly different at 
P < 0.05 performed by a t-test. Values in the same row with different lowercase letters 
mean significantly different at P < 0.05 performed by the t-test. All determinations were 
repeated three times using the same combined starting materials and mean values and 
standard deviations reported. 
 
In this study, HepG2 cells were treated with various concentrations of resveratrol and 
RDHA for 4 h. As shown in Figure 6.3, ROS generation increased in 400 µM t-BOOH 
compared to the control. All concentrations of resveratrol were able to suppress ROS 
generation in a concentration-dependent manner. Although 0.5 µg/mL of RDHA showed 
a slightly higher ROS generation than t-BOOH, ROS generation decreased in the 
presence of 1-10 µg/mL RDHA in a concentration-dependent manner. Resveratrol 
showed a higher inhibition of ROS generation than RDHA in this study. However, 
limitations of using HepG2 should be realized as recently discussed by Kellett et al. 
(2018). They questioned the use of HepG2 cells because liver cells are not the most 
suitable for assessing antioxidant activity of dietary phenolics. They reported that 
catechin at 50 µM showed no cellular antioxidant activity in HepG2 cells, on the other 
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hand, it reduced fluorescence by 54.1% in Caco-2 cells. Furthermore, the intestinal barrier 
is the most critical factor because it can affect the function of phenolics in vivo. Hence the 
Caco-2 cell model was suggested as being better for measuring cellular antioxidant 
activity.  
ROS plays a crucial role in cancer cell growth and apoptosis (Juan et al., 2008) and is 
known to cause cancer by inducing DNA base changes, strand breaks, and 
rearrangements, among other effects (Wiseman and Halliwell, 1996). On the other hand, 
an excess amount of ROS in the damaged cell can initiate and execute apoptosis (Juan et 
al., 2008). Apoptosis of cancer cells can therefore be controlled by the level of ROS by 
overcoming the antioxidative defense systems (Wenzel et al., 2005). Resveratrol is known 
as an anticancer agent by inducing apoptosis via ROS generation. Jung and Woo (2016) 
studied ROS generation in A172 human glioma cells exposed to 100 µM of resveratrol 
and reported that ROS generation of the cell exposed to resveratrol greatly increased as 
compared to the control. Juan et al. (2008) studied the production of superoxide radicals 
in the mitochondria of HT-29 human colorectal carcinoma cells containing 150 µM of 
resveratrol and reported that superoxide radicals level increased compared to that of the 
control. Pan et al. (2007) studied ROS generation in human gastric carcinoma AGS cells 
treated with 80 µM of pterostilbene, and reported an increase in the ROS level. These 
reports contradict those found in this study, possibly due to the different concentration of 
resveratrol used. Antioxidant activity may depend on the concentration of antioxidants 
such as tocopherol (Jung and Min, 1990). According to Ahmad et al. (2003), 50-150 µM 
hydrogen peroxide-induced apoptosis was blocked by 4 and 8 µM resveratrol. They 
suggested that resveratrol could trigger or inhibit apoptosis in cancer cells, depending on 
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the concentration used.  
 
 
  
Figure 6.3. Effect of resveratrol and RDHA on intracellular reactive oxygen species (ROS) 
generation. The different letters mean significantly different (P < 0.05) performed by 
Tukey’s HSD test. Bars with same letters such as “a” and “ab” are not significantly 
different. Resveratrol and RDHA at same concentration showed significantly different (P 
< 0.05) performed by t-test except for control (C) and tert-butylhydroperoxide (t-BOOH). 
All determinations were repeated three times using the same combined starting materials 
and mean values and standard deviations reported. 
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6.4 Effect of resveratrol and its esters on the viability of human epidermoid 
carcinoma (A431) cells, human breast adenocarcinoma (MCF7) cells, human 
colorectal adenocarcinoma (HT-29) cells, and human gastric adenocarcinoma (AGS) 
cells 
The effect of resveratrol and its esters at various concentrations on the viability of A431, 
MCF7, HT-29, and AGS cells was determined by employing the MTT assay. As shown 
in Figure 6.4, resveratrol and its esters decreased the growth in cultured human cancer 
cells. Resveratrol at 5 µg/mL was able to decrease cell viability in all tested cancer cell 
lines except for A431 cells, whereas 5 µg/mL of RC3:0 showed cytotoxicity in A431, 
MCF7, AGS cells. Although 5-50 µg/mL of RC3:0 showed a lower cytotoxicity than that 
of resveratrol in HT29 cells, 75 µg/mL of RC3:0 showed a higher cytotoxicity than 
resveratrol. RDHA at all concentrations showed the lowest cytotoxicity in A431, HT29, 
and AGS cells compared to resveratrol and RC3:0. However, 50 and 75 µg/mL of RDHA 
in MCF7 cells showed no cell viability.  
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c) 
 
Figure 6.4. Effect of a) resveratrol, b) RC3:0, and c) RDHA on cell viability of various 
human cancer cells. All determinations were repeated three times and mean values and 
standard deviations reported. 
 
Several studies have demonstrated the anticancer activity of resveratrol and its derivatives. 
Jang et al. (1997) studied the anticancer activity of resveratrol in three major stages of 
carcinogenesis and found its chemopreventive effect due to acting as an antioxidant, 
antimutagen, anti-inflammatory, antipromotion, and antiprogression agent. In addition, 
resveratrol inhibited preneoplastic lesions in a mouse mammary glands culture model of 
carcinogenesis and inhibited tumorigenesis in a mouse skin cancer model. Pan et al. 
(2007) demonstrated that resveratrol ester also possessed effects on cancer cells. They 
studied the inhibition of cell proliferation in pterostilbene treated human cancer cells such 
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as COLO 205, AGS, HL-60, HepG2, and HT-29. They reported that pterostilbene (60 
µM) showed the largest sensitive inhibitory effect on AGS cell-growth compared to the 
other cell tested. Patel et al. (2010) revealed the concentration of resveratrol and its 
metabolites in the colorectal tissue of cancer patients and the potential benefit of 
resveratrol as a chemopreventive agent in colorectal cancer. They found that daily doses 
of 0.5 or 1.0 g resveratrol could reduce cancer cell proliferation by 5 %. However, some 
studies have failed to show such anticancer activity. For example, Bove et al. (2002) 
found resveratrol showed inhibitory effect on the growth of 4T1 breast cancer cell line (in 
vitro) in a dose- and time-dependent manner, however it showed no effect on the growth 
of 4T1 breast cancer in mice (in vivo). Baur and Sinclair (2006) suggested that this failure 
could be due to an inadequate dose of resveratrol, delivery method, and tumour origin. In 
pharmacokinetic perspective, resveratrol has extremely low bioavailability, and 
increasing the dose of resveratrol to overcome its low bioavailability might not be 
possible due to toxicity. Therefore, lipophilised resveratrols need to be evaluated further 
in vivo for their anticancer potential. 
6.5 Summary 
Two resveratrol esters demonstrated antioxidant and antiproliferative activities in this 
study. The test compounds were able to inhibit NO production in murine RAW 264.7 
cells, suggesting their potential anti-inflammatory effect, which needs to be further 
investigated on the generation of iNOS protein, iNOS gene expression, the release of IL-6 
and TNF-α. RDHA was studied further in HepG2 cells and showed decreased ROS 
generation. In addition, all test compounds in this chapter showed decreased cell viability 
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of A431, MCF7, HT-29, and AGS. The results suggest that resveratrol esters need to be 
further investigated for their anti-inflammatory and antiproliferative potential. 
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CHAPTER 7 
Preparation of esterified quercetin derivatives and effects on antioxidant activity 
7.1 Introduction 
Quercetin, another flavonoid, serves as a robust antioxidant with numerous reported 
health benefits such as cardioprotection, anti-inflammatory, and anticancer activities 
(Pace-Asciak et al., 1995; Kaidama and Gacche, 2015; Lu et al., 2006). Despite its 
potential beneficial effects, its low absorption does not allow the body to take full 
advantage of it. Some 90% of intake of phenolic compounds is transferred to the colon 
without being absorbed, and is fermented by the gut microflora (Clifford, 2004). In 
addition, the hydrophilicity of the compound may limit its antioxidant potential in 
lipophilic systems such as lipid-based food and cosmetic formulations. The hydrophilicity 
may also affect absorption of quercetin due to the limited permeability of lipophilic cell 
membranes. Hence, many attempts have been made to maximise its efficiency by 
different means, including structure modification. Esterification of phenolic compounds 
has been extensively studied. Zhong and Shahidi (2011, 2012) studied the antioxidant 
activities of esterified epigallocatechin gallate (EGCG); EGCG derivatives showed a 
better antioxidant activity than EGCG itself. Moreover, Zhong et al. (2012) reported that 
EGCG derivatives exhibited anticarcinogenic activity on colon cancer. Zhou et al. (2017) 
studied the antioxidant activity of tyrosol derivatives and observed an unsaturation-
dependent antioxidant trend in a DNA scission assay. Pokorski et al. (2003) found that 
commercially available ascorbyl palmitate might serve as an ascorbate carrier to brain 
tissues. Esterification with fatty acids would increase the lipophilicity of phenolic 
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compounds. Hence, quercetin derivatives may also show an improved application in food, 
cosmetics, and even biological environments. Besides the potential health benefit of 
quercetin, fatty acids have their own advantages. For example, short-chain fatty acids 
such as propionic acid and butyric acid are generally produced via fermentation by gut 
microbes (Wong et al., 2006). Propionic acid, which can be used for hepatic 
gluconeogenesis, has been shown to inhibit cholesterol synthesis (Brüssow and Parkinson, 
2014; Wong et al., 2006). On the other hand, butyric acid, an energy source for colonic 
mucosa, can prevent colon cancer (Brüssow and Parkinson, 2014; Wong et al., 2006). In 
addition, the beneficial effect of polyunsaturated fatty acids (PUFA) towards health has 
been well documented. PUFA such as eicosapentaenoic acid (EPA) and docosahexaenoic 
acid (DHA) have been known to have anti-inflammatory, cardioprotective, and anticancer 
activities (Tapiero et al., 2002). Hence, it is of interest to see the effects in the case of 
joining two biologically active components such as EPA and DHA with quercetin. For 
this reason, quercetin was esterified with 12 different acyl chlorides varying in chain 
length as well as the degree of unsaturation. 
 
7.2 Preparation of quercetin derivatives    
The quercetin derivatives were prepared chemically using quercetin and fatty acyl 
chlorides. The esterification was monitored by thin-layer chromatography (TLC). After 
completion of the reaction, the selected crude products were subjected to HPLC-MS with 
methanol/5% acetonitrile in water (90:10, v/v) as the mobile phase. As shown in Table 
7.1, the HPLC-MS analysis of quercetin with caproic acid (Q-C6:0) showed that there 
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were intact quercetin (9.4%), monoesters (35.7%), diesters (38.7%), triesters (14.2%), and 
tetraester (2%). The yield of crude product of Q-C6:0 was 90.6%. Oh and Shahidi (2017) 
reported that the yields of resveratryl propionate and resveratryl docosahexaenoate were 
74 and 37.7%, respectively. Zhong and Shahidi (2011) prepared EGCG derivatives using 
stearic acid (C18:0), EPA, and DHA and reported that the yields of EGCG-C18:0, 
EGCG-EPA, and EGCG-DHA were 56.9, 42.7, 30.7%, respectively. They also reported 
that esterification by chemical method had less selectivity and specificity. Both studies 
suggested that structural properties might affect the esterification reaction. Indeed, the 
resultant crude product of quercetin with propionic acid (Q-C3:0) did not show any 
remaining intact quercetin by HPLC-MS analysis. On the other hand, the crude resultant 
product of the reaction with quercetin and DHA (Q-DHA) showed around 56.7% of intact 
quercetin (triesters and tetraester were not considered). The elongation of the carbon 
chain and kink characteristics might cause steric hindrance in the case of DHA.   
 
Table 7.1. Composition of quercetin (Q) and Q-C6:0 derivatives in crude products. 
 Q monoester diester triester tetraester 
Composition (%) 9.4 35.7 38.7 14.2 2 
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7.3 Identification of quercetin derivatives 
The HPLC-MS analysis was carried out with Q-C6:0, because the isomers of quercetin 
with shorter chain fatty acids could not be separated in the column due to their similar 
lipophilicity. Quercetin with longer chain fatty acids, on the other hand, could be 
separated in the column. However, substitution of more than 3 hydroxyl groups could not 
be detected due to its extremely increased lipophilicity. Zhong and Shahidi (2011) 
reported that although the yield of EGCG-C18:0, EGCG-EPA, and EGCG-DHA might be 
different due to the structural characteristics, the main resultant products remained the 
same (tetraester). The crude product of Q-C6:0 was subjected to HPLC-MS with 
methanol/ 5% acetonitrile in water 90:10 (v/v) as the mobile phase (Figure 7.1). Intact 
quercetin (2.907-3.32 min), monoesters (3.32-4.44 min), diesters (4.44-6.293 min), 
triesters (8.133-12.113 min), and tetraester (19.26-20.68 min) were detected at their 
expected m/z of 303.05, 401.12, 499.20, 597.27, and 695.35, respectively (Figure 7.2). 
After that, the crude product of Q-C6:0 was subjected to HPLC-MS with methanol/ 5% 
acetonitrile in water 80:20, v/v) as the mobile phase to achieve better separation. Since 
quercetin has five hydroxyl groups, the number of different esterification products or the 
products with the same number of esterification products in the different positions could 
vary. In this study, four monoesters (4.427, 5.067-5.2, and 6.787 min), four diesters 
(10.873, 13.307, 15.18, and 18.947 min), and three triesters (43.42, 51.5, and 75.527 min) 
were detected (Table 7.2) by HPLC-MS. The monoesters from 5.067 to 5.2 min were not 
fully resolved and the peak had a small shoulder, which could be expected as two 
compounds existed. In this analysis (methanol/ 5% acetonitrile in water, 80:20, v/v), 
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tetraester was not detected due to increased lipophilicity. Two monoesters (15.8 and 
15.5%) and three diesters (10.8, 11.2, and 15.4%) were predominant products. 
 
 
Figure 7.1. HPLC chromatogram of Q-C6:0 with methanol/ 5% acetonitrile in water, 
90:10 as the mobile phase (a, quercetin (Q); b, Q-C6:0 monoesters; c, Q-C6:0 diesters; d, 
Q-C6:0 triesters; and e, Q-C6:0 tetraester).   
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Figure 7.2. Mass spectra of quercetin (Q) and Q-C6:0 derivatives (a, quercetin (Q); b, Q-
C6:0 monoesters; c, Q-C6:0 diesters; and d, Q-C6:0 triesters).    
a	  
b	  
c	  
d	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Table 7.2. Composition of each Q-C6:0 derivatives.a  
Peak number Monoesters (%) Diesters (%) Triesters (%) 
1 6.0 10.8 4.5 
2 15.8 5.2 7.1 
3 15.5 11.2 4.9 
4 3.6 15.4 N/A* 
a Intact quercetin and tetraester were not considered. * Not available. 
 
7.4 1H-NMR assignment of quercetin derivatives 
The predominant products of quercetin derivatives identified by HPLC-MS were two 
monoesters and three diesters. Since there were many possibilities to form the different 
degrees of substitution and isomers, information of the specific location of substitution 
was required. This was conducted using 1H-NMR by comparing the parent molecule as 
well as literature values. Although the yields of esterification with different fatty acids 
were different, the esterification pattern for all fatty acid esters remained the same. 
Therefore, one compound was selected for further investigation. For this study, Q-DHA 
was selected due to its complex structure and its high lipophilicity. The crude product of 
Q-DHA was separated by TLC (hexane/ ethyl acetate/ formic acid, 3:3:0.12, v/v/v). Then 
each compound was subjected to 1H-NMR. The chemical shifts of the parent molecule 
were very similar to those in the literature values (Bukhari et al., 2008; Galati et al., 2001). 
Since the separation of two monoesters was unsuccessful due to extremely similar 
lipophilicity, two spectral assignments of two monoesters were carried out as a mixture. 
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The chemical shifts of two unknown monoesters (QM1 and QM2) and three unknown 
diesters (QD1, QD2, and QD3) are summarized in Table 7.3. For QM1, H-6 showed a 
similar chemical shift (δ 6.19 ppm) compared to that of quercetin (δ 6.20 ppm), which 
indicated esterification did not occur on A ring. While H-2' and H-6' of QM1 showed 
downfield shifts (Δδ= 0.07 and 0.14 ppm, respectively), H-5' showed similar chemical 
shifts (δ 6.92 ppm) compared to quercetin (δ 6.89 ppm). There were two possible 
substitution positions which were either 3'-OH or 4'-OH. Since chemical shift did not 
occur on H-5', the substitution position could be concluded on 3'-OH. This was similar to 
that given by Moalin et al. (2011) who reported chemical shifts of 3'-methylated quercetin 
as 6.21 (H-6), 6.49 (H-8), 6.95 (H-5'), 7.70 (H-6'), and 7.77 (H2') ppm. For QM2, H-6 
slightly shifted to downfield (Δδ= 0.05). Interestingly, H-2' and H-6' of QM2 showed 
large upfield shifts (Δδ= -0.37 and -0.30 ppm, respectively), whereas H-5' showed similar 
chemical shifts (δ 6.92 ppm) compared to quercetin (δ 6.89 ppm); this might be explained 
by anisotropy (Richards and Hollerton, 2011). Therefore, the possible substitution 
position of QM2 was expected to be on 3-OH. This was also similar to Moalin et al. 
(2011). Hydrogens in positions 6 and 8 of QD1 showed large downfield chemical shifts 
(Δδ= 0.38 and 0.56 ppm, respectively). Thus, one of the substitutions could be on 7-OH. 
The other substitution of QD1 occurred on B ring. The chemical shift of H-2', H-5', and 
H-6' was similar to QM1, the other substitution could be expected on 3'-OH. For these 
reasons, QD1 could be Q-7,3'-O-diester. For QD2, the chemical shifts of H-6 (δ 6.20 ppm) 
and H-8 (δ 6.44 ppm) were similar to those of H-6 (δ 6.20 ppm) and H-8 (δ 6.42 ppm) of 
quercetin, which meant substitution did not occur on A ring. However, large downfield 
chemical shifts (Δδ= 0.15 and 0.41 ppm) were observed on H-2' and H-6' of QD2 
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compared to quercetin. In addition, H-5' of QD2 also showed large downfield shift (Δδ= 
0.19 ppm) compared to quercetin. Hence, the substitution positions of QD2 could occur 
on 3'-OH and 4'-OH. For QD3, the H-6 and H-8 of QD3 showed downfield shifts (Δδ 
0.06 and 0.08, respectively) compared to quercetin. While H-2' of QD3 showed upfield 
shift (Δδ -0.06), H-5' and H-6' showed downfield shifts (Δδ= 0.21 and 0.11 ppm, 
respectively). Therefore, QD3 could be concluded as Q-3,4'-O-diester. In summary, QM1, 
QM2, QD1, QD2, and QD3 were identified as being Q-3'-O-monoester, Q-3-O-
monoester, Q-7,3'-O-diester, Q-3',4'-O-diester, and Q-3,4'-O-diester, respectively (Figure 
7.3). 
 
Table 7.3. 1H chemical shift (δ in ppm) of quercetin and Q-C6:0 derivatives. 
1H position Quercetin (Q) QM1 QM2 QD1 QD2 QD3 
6 6.20 6.19 6.25 6.58 6.20 6.26 
8 6.42 n/a* n/a* 6.99 6.44 6.50 
2' 7.69 7.76 7.32 7.76 7.84 7.54 
5' 6.89 6.92 6.92 6.92 7.08 7.10 
6' 7.55 7.69 7.25 7.66 7.96 7.66 
* Not available. The compounds were identified as Q-3'-O-monoester (QM1), Q-3-O-
monoester (QM2), Q-7,3'-O-diester (QD1), Q-3',4'-O-diester (QD2), and Q-3,4'-O-diester 
(QD3). 
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Figure 7.3. Structure of quercetin. Red circles present substitution occurring position.  
 
7.5 Lipophilicity of quercetin derivatives 
Esterifications between quercetin and the fatty acyl chlorides were carried out in order to 
increase the lipophilicity of quercetin. The shake-flask method, a traditional method for 
measuring lipophilicity, was not employed because it was not suitable for measuring the 
lipophilicity of highly lipophilic compounds (Ayouni et al., 2008; Giaginis and Tsantili-
Kakoulidou, 2008; Finizio et al., 1997). Thus, the lipophilicity was instead calculated 
using the lipophilicity calculator program, ALOGPS 2.1. The lipophilicity of quercetin 
was 1.81. As shown in Table 7.4, the lipophilicity of the quercetin derivatives was 
increased compared to that of quercetin as the chain length and the number of substitution 
increased. The increased lipophilicity was also observed in the HPLC analysis. However, 
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unsaturation disturbed the lipophilicity pattern. While the monoester and diester of Q-
C18:0 had lipophilicity values of 7.89 and 10.26, respectively, that of Q-C18:1 had 
lipophilicity values of 7.87 and 10.14, respectively. Moreover, Q-EPA showed a drastic 
decrease of its lipophilicity compared to Q-C18:0 and Q-C18:1, despite the elongation of 
chain length. This might be due to the nature of unsaturation. Carbon double bonds have 
higher density of electrons than carbon single bonds, thus carbon double bonds possesses 
slight polarity (Bruice, 2011). Hence, the large number of unsaturation of EPA (C20:5) 
could enhance electron density so that the lipophilicity of Q-EPA might decrease, 
compared to Q-C18:0. The extent of decreased lipophilicity of Q-EPA was increased as 
the number of substitution increased (diester > monoester). Others also observed similar 
patterns. Zhong and Shahidi (2011) reported that the lipophilicities of EGCG with stearic 
acid (SA), EPA, and DHA were in the order EGCG-SA > EGCG-EPA > EGCG-DHA, 
EGCG-EPA and EGCG-DHA with a nonsignificant difference (P > 0.05); this was 
evaluated by shake flask method. They also reported that the retention time obtained from 
HPLC analysis was in the order EGCG-SA > EGCG-DHA > EGCG-EPA. A similar 
sequence of lipophilicity was exhibited when resveratrol was esterified (Oh and Shaidi, 
2017). The lipophilicity of resveratrol (R) esterified with SA (9.30) showed the highest 
value followed by R-DHA (8.59) and R-EPA (8.47).  
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Table 7.4. Lipophilicity of quercetin and its derivatives. 
  Monoester Diester 
Quercetin 1.81   
Q-C3:0  2.88 
 
3.70 
 
 
Q-C4:0  3.13 4.27 
Q-C6:0  3.81 5.51 
 
Q-C8:0  4.65 6.65 
Q-C10:0  5.38 7.92 
Q-C12:0  6.08 8.97 
Q-C14:0  6.78 9.66 
Q-C16:0  7.38 10.00 
Q-C18:0  7.89 10.26 
Q-C18:1  7.87 10.14 
 
Q-EPA  7.23 8.87 
Q-DHA  7.48 8.89 
The lipophilicity of quercetin and its derivatives was 
calculated using ALOGPS 2.1. The SMILE structures of the 
compounds were drawn using ChemDraw Standard 16.0. 
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7.6 ABTS radical cation scavenging assay  
Quercetin is known to be a very powerful antioxidant. Esterification could affect its 
antioxidant activity either positively or negatively. To evaluate antioxidant activity of 
quercetin and its derivatives, ABTS radical cation scavenging assay was employed. As 
shown in Figure 7.4, quercetin showed the highest ABTS radical cation scavenging 
activity among all tested compounds. Among derivatives, Q-C3:0 and Q-C4:0 showed 
better ABTS radical cation scavenging activity than other derivatives. Oh and Shahidi 
(2017) reported a similar behaviour for resveratrol and its derivatives. Resveratrol showed 
the highest ABTS radical cation scavenging activity among all compounds examined. In 
addition, resveratrol with short-chain fatty acids showed better antioxidant activity than 
other derivatives. According to Mainini et al. (2013), quercetin esters showed weaker 
DPPH and ABTS radical cation scavenging activity compared to the parent molecule. 
This might be due to their loss of hydroxyl groups by esterification. In addition, the 
powerful antioxidant activity of quercetin has been known to originate from a 
combination of the 3',4'-dihydroxyl structure (catechol) in the B ring, 3- and 5-hydroxyl 
groups in the A and B rings, and the 2,3-double bond and 4-oxo group in the C ring (Bors 
et al., 1990; Rice-Evans et al., 1996; Pulido et al., 2000). The quercetin derivatives which 
were tested here might not have the 3',4'-dihydroxy structure in the B ring due to their 
esterification. Hence this could be another reason why quercetin showed the highest 
antioxidant activity in this study.  
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Figure 7.4. ABTS radical cation scavenging activity of quercetin (Q) and its derivatives 
expressed as trolox equivalents. All determinations were repeated three times using the 
same combined starting materials and mean values and standard deviations reported. The 
different letters are significantly different (P < 0.05). Columns with same letters such as 
“a” and “ab” are not significantly different.  
 
7.7 Summary 
Esterification of quercetin with the fatty acyl chlorides of different chain length and 
degree of unsaturation provided derivatives whose structures were confirmed by HPLC-
MS and 1H NMR. These were mainly the Q-3'-O-monoester, Q-3-O-monoester, Q-7,3'-O-
diester, Q-3',4'-O-diester, and Q-3,4'-O-diester. As expected, the lipophilicity of quercetin 
derivatives was successfully increased. The antioxidant activity of quercetin and its 
derivatives was evaluated using ABTS radical cation scavenging assay. In this work, 
quercetin exhibited the highest ABTS radical scavenging activity among all tested sample. 
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Quercetin with short-chain fatty acids (Q-C3:0 and Q-C4:0) possessed a better 
antioxidant activity than others. Although ABTS radical cation scavenging assay 
provided important information about antioxidant activity, this needs to be further 
extended to include both in vitro and in vivo studies. 
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CHAPTER 8 
Antioxidant activity of quercetin derivatives in food and biological model systems 
8.1 Introduction 
Quercetin is widely distributed in the plant kingdom and some commodities such as 
onions, kale, grapes, and apples contain a high level of it (Formica and Regelson, 1995; 
Shahidi and Ambigaipalan, 2015). Quercetin is a flavonoid, which is made of a three-ring 
structure with five hydroxyl groups. This includes a 3',4'-dihydroxyl structure in the B 
ring, a 2,3-double bond and 4-oxo in heterocycle (C ring), which make it a more powerful 
antioxidant than other phenolic compounds (Bors et al., 1990; Rice-Evans et al., 1996; 
Pulido et al., 2000). The antioxidant activity of quercetin has been demonstrated in ferric 
reducing/antioxidant power (FRAP) assay (Pulido et al., 2000), trolox equivalent 
antioxidant capacity (TEAC) (Re et al., 1999), reducing activity and metal chelation 
ability (Mira et al., 2002). Quercetin exhibited antioxidation activity in food model 
systems such as the oil-in-water emulsion system and bulk fish oil (Huber et al., 2009). It 
has been documented that quercetin inhibited LDL cholesterol oxidation (Frankel et al., 
1993) and reduced NO and ROS production induced by LPS in human acute monocytic 
leukemia cell (Zhang et al., 2011). Despite its unlimited potential use as an 
antioxidant, the application of quercetin can be limited due to its hydrophilicity, like 
other phenolic compounds. It is a well-known fact that phenolic compounds as 
antioxidants cannot exert their full effects in lipophilic systems which are highly 
prone to oxidation. Therefore, lipophilicity of phenolic compounds plays an important 
role with respect to the antioxidant activity in the food industry (Laguerre et al., 2015). 
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However, this problem is not limited to food and also affects biological systems. Most of 
the phenolic compounds are excreted without absorption, which may also relate to 
hydrophilicity. The hydrophilic compounds may be unable to penetrate cell membranes, 
which are lipid bilayers. In recent studies, structure modification has been carried out to 
improve lipophilicity of different molecules. One possible way to increase lipophilicity is 
esterification with fatty acids. In addition, it is of interest to explore the best lipophilicity. 
For this reason, in this work, quercetin was esterified with 12 different fatty acids as acyl 
chlorides (propionyl chloride, butyryl chloride, caproyl chloride, capryloyl chloride, 
capryl chloride, lauroyl chloride, myristoyl chloride, palmitoyl chloride, stearoyl chloride, 
oleoyl chloride, eicosapentaenoyl chloride, and docosahexaenoyl chloride). Following 
their preparation, the esters so produced were subjected to the selected antioxidant 
capacity test as well as being used in food and biological model systems.   
 
 
 
 
 
 
	   148	  
 
 
 
 
 
 
 
 
 
 
Figure 8.1. Structure of quercetin derivatives. 
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8.2 DPPH radical scavenging assay  
The DPPH radical scavenging capacity of quercetin and its derivatives (Figure 8.1) was 
carried out to determine their electron and/or hydrogen donation (Prior et al., 2005).  
DPPH radical is commercially available without any preparation to generate the radical, 
thus it is generally used as an initial step in the evaluation of antioxidant activity (Shahidi 
and Zhong, 2015). As shown in Figure 8.2, quercetin showed the highest DPPH radical 
scavenging activity among all tested samples. This might be due to the decreased number 
of hydroxyl groups, which can donate their hydrogen and/or electron. Mainini et al. (2013) 
also observed that quercetin showed the highest DPPH radical scavenging activity, 
compared to quercetin esters tested. In addition, quercetin with short-chain fatty acids 
exhibited a better DPPH radical scavenging activity compared to quercetin with long-
chain fatty acids except for Q-C16:0. Moreover, Q-C18:0 and Q-C18:1 showed the lowest 
DPPH radical scavenging activity. On the other hand, resveratrol with C18:0 and C18:1 
showed the highest DPPH radical scavenging activity in Chapter 4. DPPH radical is a 
lipophilic species, thus it was hypothesised that quercetin with long-chain fatty acids 
would show better radical scavenging activity due to their increased affinity to  lipophilic 
DPPH. Sun et al. (2018) reported that tyrosol with short- and medium-chain fatty acids 
also showed better DPPH radical scavenging activity than tyrosol with long-chain fatty 
acids, except for tyrosol with DHA. However, Oh and Shahidi (2017) reported that 
resveratrol with short- and medium-chain fatty acids exhibited lower DPPH radical 
scavenging activity than resveratrol with long-chain fatty acids. Furthermore, Zhong and 
Shahidi (2011) observed that DPPH radical scavenging activity of epigallocatechin 
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gallate (EGCG) derivatives was enhanced dramatically due to the esterification and 
EGCG derivatives, which showed better DPPH radical scavenging activity compared to 
EGCG itself. The effect of esterification on antioxidant activity was compound-dependent, 
which requires further evaluation. 
 
 
Figure 8.2. DPPH radical scavenging activity of quercetin (Q) and its derivatives 
expressed as trolox equivalents. All determinations were repeated three times using the 
same combined starting materials and mean values and standard deviations reported. The 
different letters are significantly different (P < 0.05). Bars with the same letters such as “a” 
and “ab” are not significantly different.  
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produced during lipid oxidation when hydroperoxide breaks down to alkoxyl radical 
(RO•). It can also be generated in the body via both Fenton and Haber-Weiss reactions 
(Yu, 1994). Thus hydroxyl radical scavenging activity was employed in this study. As 
shown in Figure 8.3, Q-C3:0 showed the highest hydroxyl radical scavenging activity 
among the tested compounds. In addition, Q-C4:0, Q-C8:0, Q-C10:0, Q-C12:0, and Q-
C18:0 showed an insignificant difference compared to quercetin itself. Hydroxyl radical 
scavenging activity was measured using EPR. Ambigaipalan et al. (2015) reported that 
the signals of EPR spectrum with intensities at a ratio of 1:2:2:1. Indeed, blank (only PBS 
and hydroxyl radical) showed the same spectrum (result not shown). However, another 
blank (only ethanol and hydroxyl radical) did not show any signal. Since quercetin 
derivatives could not be fully dissolved in PBS, possibly due to varied lipophilicity, PBS 
was used to dilute the samples in ethanol. The blank (ethanol without sample) was also 
diluted with PBS. The EPR spectrum of diluted samples showed signals, however, the 
number of signals and the intensity ratio was different compared to PBS with hydroxyl 
radical (Figure 8.4). The formation of hydroxyl radical might be affected by the solvent 
used. Hiramoto et al. (1996) studied the effect of phenolic compounds on DMPO-OH 
adduct and DNA scission. 
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Figure 8.3. Hydroxyl radical scavenging activity of quercetin (Q) and its derivatives 
expressed as trolox equivalents. All determinations were repeated three times using the 
same combined starting materials and mean values and standard deviations reported. The 
different letters are significantly different (P < 0.05). Bars with the same letters such as “a” 
and “ab” are not significantly different.  
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Figure 8.4. DMPO-OH adduct of blank, catechin (standard, 400 µM), and quercetin. 
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In addition, they compared the electron spin resonance (ESR) signals between DMPO-
OH produced in the presence of the phenolic compounds (result A) and production of 
DMPO-OH then the addition of phenolic compounds (result B). They reported that the 
hydroxyl radical scavenging activity of result A showed relatively concentration-
dependent manner, on the other hand, result B showed a lack of consistency. Moreover, 
some of the phenolic compounds from result B enhanced the intensity of signals. They 
suggested that this method might not be reliable and DNA scission induced by hydroxyl 
radical might be a better method to evaluate the antioxidant activity of phenolics towards 
hydroxyl radical. In this study, DNA scission induced by hydroxyl radical also studied, as 
it will be discussed later.   
8.4 Reducing power  
The antioxidant activities of quercetin and its derivatives were determined according to 
their reducing power. An antioxidant can retard the oxidation via donating its hydrogen 
atom and/or transferring an electron. Unlike DPPH radical scavenging activity, this assay 
is for determining its electron transfer ability because this is measuring from ferric ion 
(Fe3+)-ligand complex to ferrous ion (Fe2+) complex, which is blue colour (Shahidi and 
Zhong, 2015). As shown in Figure 8.5, quercetin showed the highest reducing power 
among tested samples. Among derivatives, Q-C3:0, Q-C4:0, and Q-C8:0, in the order 
shown, had higher reducing power than other derivatives in this study. The reducing 
power assay was highly correlated to ABTS radical cation scavenging activity 
(correlation coefficient: 0.97) (see results in Chapter 7, section 7.6). According to Mira et 
al. (2002), the reducing ability of quercetin might come from the presence of catechol 
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structure in the B ring and 3-OH, 2,3-double bond, and 4-oxo group in the C ring. Thus, 
the esterification might compromises the reducing power of quercetin derivatives, 
compared to quercetin itself. Danihelová et al. (2013) reported that quercetin (IC50 12.5 ± 
0.9) and monochloropivaloyl quercetin (substitution on 3-OH; IC50 12.5 ± 0.3) showed a 
similar reducing power, however tri(monochloropivaloyl) quercetin and 
monoacetylferuloyl quercetin (substitution on 3-OH) was more than IC50 of 200. Zhong 
and Shahidi (2012) reported that reducing power of EGCG dramatically decreased 
compared to EGCG derivatives, although free radical scavenging activity of EGCG 
derivatives was better than EGCG itself. This disagreement was thought to be possibly 
due to the different mechanisms of action.  
 
 
 
 
 
 
 
Figure 8.5. Reducing power of quercetin (Q) and its derivatives as ascorbic acid 
equivalents. All determinations were repeated three times using the same starting 
materials and mean values and standard deviations reported. The different letters are 
significantly different (P < 0.05). Bars with the same letters such as “a” and “ab” are not 
significantly different.  
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8.5 Antioxidant activity of quercetin derivatives in oil-in-water emulsion (β-carotene 
bleaching assay)  
Emulsion, a mixture of two immiscible liquids, is commonly encountered in food. In 
order to evaluate the possible application in an oil-in-water emulsion system, a β-carotene 
bleaching assay was employed to determine antioxidant activity of quercetin and its 
derivatives. Tween 40 was used for stabilising the emulsions. Linoleic acid in the surface 
of the micelle is first oxidized by induced heat, which is then producing oxidation 
products. These will attack β-carotene, which is inside the micelle. When β-carotene is 
oxidized, it will lose its colour and this can be monitored by monitoring the absorbance at 
470 nm (Ambigaipalan and Shahidi, 2015). The antioxidant activity of quercetin and its 
derivatives in the oil-in-water emulsion over a 105-minute period is shown in Figure 8.6A. 
Quercetin showed the highest antioxidant activity over a 105-minute period for quercetin 
and its esters. Among quercetin derivatives, Q-C3:0 and Q-C4:0 exhibited a better 
antioxidant activity than other derivatives, whereas Q-C16:0, Q-C18:0, and Q-EPA 
showed a lower antioxidant activity than other tested compounds over a 105-minute 
period. Inhibition against β-carotene bleaching after 105 min incubation is shown in 
Figure 8.6B. While quercetin was the most potent in the inhibition of β-carotene 
bleaching, Q-C16:0 was the least effective among all after 105 min incubation. Quercetin 
with short-chain fatty acids showed a better inhibition compared to other derivatives; the 
inhibition then slowly decreased as alkyl chain increased. This result was well correlated 
with ABTS radical cation scavenging activity (see results in Chapter 7, section 7.6) and 
reducing power (the correlation coefficient was 0.82 and 0.87, respectively). This might 
be due to their increased lipophilicity. Oh and Shahidi (2018) reported that resveratrol 
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with short-chain fatty acids was more effective in the oil-in-water emulsion systems than 
other derivatives. In addition, resveratrol derivatives showed a better antioxidant activity 
than the parent compound in a bulk oil system. Those results, both quercetin derivatives 
and resveratrol derivatives, contradicted polar paradox. The polar paradox stated that the 
nonpolar antioxidants possessed better antioxidant potent than polar antioxidants in the 
oil-in-water emulsions, whereas polar antioxidants were more effective than nonpolar 
antioxidants in water-in-oil emulsions and/or bulk oil system (Shahidi and Zhong, 2011). 
For example, Zhong and Shahidi (2012) reported that EGCG derivatives showed better 
inhibition in β-carotene bleaching assays than EGCG itself. However, many studies have 
provided evidence that not all antioxidants correspond with polar paradox and researchers 
suggested that polar paradox might need to be revisited (Torres de Pinedo et al., 2007; 
Stöckmann et al., 2000; Laguerre et al., 2015; Shahidi and Zhong, 2011).   
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(a) 
(b) 
Figure 8.6. Antioxidant activities of quercetin (Q) and its derivatives against β-carotene 
bleaching over a 105 min period (a) and inhibition against β-carotene bleaching after 105 
min incubation (b) by Q and its derivatives. All determinations were repeated three times 
using the same starting materials and mean values and standard deviations reported. The 
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different letters are significantly different (P < 0.05). Bars with the same letters such as “a” 
and “ab” are not significantly different.  
 
8.6 Antioxidant activity of quercetin derivatives in bulk oil 
Corn oil is generally used for cooking purposes and its composition is well known. In 
addition, linoleic acid (C18:2, 47.9 %), one of the major fatty acids in corn oil, accounted 
for almost half of the fatty acids composition and this could generate sufficient amount of 
conjugated dienes (Ferrari et al., 1996). In such context, corn oil was selected in this 
study. The minor components in corn oil were removed by a stripping process to 
minimise their effect on oil oxidation. Conjugated dienes could be considered as primary 
oxidation products, like hydroperoxides, and these compounds could be broken down to 
form secondary oxidation products. Therefore, conjugated dienes and p-anisidine value 
were measured for both primary and secondary oxidative products, respectively. Figure 
8.7 indicates the conjugated dienes formation of stripped corn oil over an 8-day period in 
the presence of quercetin and its derivatives. All test compounds were able to inhibit the 
formation of conjugated dienes throughout the entire 8-day period compared to the 
control. On day 2, while quercetin showed the highest inhibition among all, Q-C18:0 
exhibited the least inhibition. On day 4, quercetin was still most effective in inhibiting the 
formation of conjugated dienes. In contrast, Q-DHA showed an insignificant difference 
compared to the control. However, quercetin with medium- and long-chain fatty acids 
showed a better inhibition of the conjugated dienes formation compared to the parent 
molecule on day 6. On day 8, Q-C18:1 and Q-DHA showed a similar inhibition compared 
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to quercetin. This might be due to the increased lipophilicity, which could improve the 
affinity to the oil. Although the quercetin derivatives had lower concentration due to the 
heavier molecular weight compared to quercetin, the enhanced affinity might overcome 
the concentration gap. In addition, quercetin with long-chain fatty acids displayed a better 
inhibition compared to quercetin with short-chain fatty acids on days 6 and 8. This was an 
opposite trend compared to the antioxidant activity in the oil-in-water emulsion system. 
Furthermore, this result also contradicted the polar paradox.  
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Figure 8.7. Conjugated dienes formation of stripped corn oil over an 8-day period in the 
presence of quercetin and its derivatives. All determinations were repeated three times 
using the same starting materials and mean values and standard deviations reported. The 
different letters are significantly different (P < 0.05). Bars with the same letters such as “a” 
and “ab” are not significantly different.  
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Figure 8.8. p-Anisidine values of stripped corn oil over an 8-day period in the presence of 
quercetin and its derivatives. All determinations were repeated three times and mean 
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values and standard deviations reported. The different letters are significantly different (P 
< 0.05). Bars with the same letters such as “a” and “ab” are not significantly different.  
 
Meanwhile, Figure 8.8 indicates p-anisidine values of stripped corn oil over an 8-day 
period in the presence of quercetin and its derivatives. The p-anisidine values exhibited a 
lag phase of 2 days (data not shown). On day 4, all test compounds showed an 
insignificant different compared to the control. On day 6, the test compounds showed 
lower p-anisidine values than the control. Among the test compounds, Q-C18:1 had the 
lowest p-anisidine value. On day 8, quercetin with long-chain fatty acids showed lower p-
anisidine values than quercetin with short-chain fatty acids and this was as effective as the 
quercetin itself. The correlation coefficients between the formation of conjugated dienes 
and p-anisidine values on days 4, 6, and 8 were 0.63, 0.82, and 0.98, respectively.  
8.7 Inhibition of copper-induced low-density lipoprotein (LDL) oxidation  
The oxidized LDL has been in the spotlight due to the association with coronary heart 
disease. It can be involved in different steps of atherosclerosis such as accumulating in 
the endothelium cells and forming foam cells (Young and McEneny, 2001). In addition, 
circulating oxidized LDL has been proposed as a marker for coronary artery disease 
(Holvoet et al., 2001) and prediction of the risk of heart attack (Holvoet, 2004). Hence, 
controlling the oxidation of LDL has been very important to decrease the incidence of 
heart disease. The antioxidant activity of quercetin towards LDL oxidation has well been 
reported (Frankel et al., 1993; Frémont et al., 1999; Aviram and Fuhrman, 2002). Hence, 
it was of interest to evaluate how the esterification affects the inhibition of quercetin 
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against LDL oxidation. In this study, copper was used to induce the LDL oxidation. As 
shown in Figure 8.9, quercetin showed the highest inhibition among all tested samples (P 
> 0.05). Other studies have been demonstrated that quercetin showed radical scavenging 
activity as well as metal chelating activity (Rice-Evans et al., 1996; Mira et al., 2002, 
Frémont et al., 1999). Therefore, the inhibition of quercetin against LDL oxidation might 
be through a combination of radical scavenging and metal chelating activities. Among 
quercetin derivatives, quercetin with short-chain fatty acids exhibited lower inhibition 
than other quercetin derivatives. In addition, although there were big drops (Q-C12:0 and 
Q-C18:0), quercetin derivatives showed increased inhibition of LDL oxidation as carbon 
chain length increased. Moreover, quercetin with long-chain fatty acids (Q-C14:0, Q-
C16:0, Q-C18:1, Q-EPA, and Q-DHA) showed an insignificant difference compared to 
quercetin itself (P > 0.05). In fact, inhibition of quercetin against LDL oxidation was 
expected to be higher than quercetin derivatives because quercetin derivatives lost their 
hydroxyl groups and hence favourable structure for metal chelation, due to esterification. 
In addition, the samples were prepared by weight (5 µg/mL), therefore quercetin 
derivatives, which have heavier molecular weight than quercetin itself due to the 
esterification, had lower molar concentration and this could lead to a lower inhibition 
compared to that of the parent molecule. Despite the lower number of the hydroxyl 
groups and lower concentration of quercetin derivatives, the improved inhibition might be 
due to the increased lipophilicity. Phenolic compounds esterified with fatty acids showed 
better inhibition of LDL oxidation compared to that of the parent molecule (Zhong and 
Shahidi, 2012; Oh and Shahidi, 2018). According to Zhong and Shahidi (2012), the 
increased lipophilicity might improve the affinity to the surface of LDL, which are 
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phospholipids. It seemed the improved lipophilicity was strong enough to compromise the 
factors, namely number of hydroxyl groups and different concentration, which could 
lower the antioxidant activity of quercetin derivatives in this study. 
 
 
 
 
Figure 8.9. Inhibition (%) of quercetin and its derivatives against LDL oxidation induced 
by copper. All determinations were repeated three times and mean values and standard 
deviations reported. The different letters are significantly different (P < 0.05). Bars with 
the same letters such as “a” and “ab” are not significantly different.  
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8.8 Inhibition of hydroxyl radical-induced DNA scission  
Damaged DNA is a well-known cause of mutations which can lead to cancer. There are 
several ways to cause damaged DNA, one of which is because of the reactive oxygen 
species (ROS). Among ROS, hydroxyl radical, which is constantly produced in the body, 
is the most powerful oxidant (Yu, 1994). Thus, there is an interest to prevent oxidation of 
DNA. Inhibition against hydroxyl radical-induced DNA scission was carried out to 
evaluate the inhibitory capacity of quercetin and its derivatives. As shown in Figure 8.10, 
all test compounds showed 68.5-88.3% inhibition of DNA oxidation, among which Q-
C3:0 exhibited the highest inhibition. However, there was an insignificant difference of 
this compared with quercetin, Q-C4:0, Q-C6:0, and Q-C16:0 (p > 0.05). Interestingly, Q-
C3:0 showed the highest radical scavenging activity among all tested samples for 
hydroxyl radical scavenging effect with significant difference (see section 8.3). The 
correlation coefficient between the hydroxyl radical scavenging activity and inhibition of 
hydroxyl radical-induced DNA scission was 0.695. According to Mukaka (2012), a 
correlation coefficient from 0.7 to 0.9 could be interpreted as being highly positive. 
Although hydroxyl radical scavenging activity of quercetin and its derivatives showed a 
different type of signals from EPR spectrum in hydroxyl radical scavenging assay and the 
method was deemed unreliable by Hiramoto et al. (1996) (see section 8.3); the results 
between hydroxyl radical scavenging activity and inhibition of DNA scission induced by 
hydroxyl radical showed a positive correlation. In addition, the inhibition against 
hydroxyl radical-induced DNA scission showed a decreasing pattern as chain length 
increased. This could be due to the varying concentration, which was already mentioned 
above. A similar pattern was observed by Oh and Shahidi (2018) who studied the  
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(a) 
 
(b) 
 
Figure 8.10. (a) DNA scission induced by hydroxyl radical (B, DNA only; C, DNA + 
FeSO4 + H2O2; Q, quercetin; 1, Q-C3:0; 2, Q-C4:0; 3, Q-C6:0; 4, Q-C8:0; 5, Q-C10:0; 6, 
Q-C12:0; 7, Q-C14:0; 8, Q-C16:0; 9, Q-C18:0; 10, Q-C18:1; 11, Q-EPA; 12, Q-DHA) 
and (b) their inhibition (%). All determinations were repeated three times using the same 
combined starting materials and mean values and standard deviations reported. The 
different letters are significantly different (P < 0.05). Bars with the same letters such as “a” 
and “ab” are not significantly different. The visualisation of DNA bands was obtained 
using the Alpha-Imager gel documentation system (Cell Biosciences, Santa Clara, CA, 
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USA) and the data processing was performed with the Chemi-Imager 4400 software (Cell 
Biosciences). 
 
inhibition of resveratrol and its derivatives against DNA scission induced by hydroxyl 
radical and resveratrol with short-chain fatty acids were better than resveratrol with long-
chain fatty acids. Sun et al. (2018) also reported that hydroxytyrosol with short-chain 
fatty acids showed better inhibition of DNA scission than other derivatives except for that 
of hydroxytyrosol with stearic acid. However, they reported that the inhibition of tyrosol 
with medium-chain fatty acids was higher than the other derivatives.  
8.9 Summary 
The application of quercetin and its derivatives was evaluated in selected food and 
biological model systems. The test compounds showed the antioxidant activity in a 
system-dependent manner. Quercetin showed the highest antioxidant activity in DPPH 
radical scavenging activity, reducing power, and an oil-in-water emulsion system. 
Moreover, quercetin with short-chain fatty acids exhibited a better antioxidant activity 
than other derivatives in those assays. On the other hand, some quercetin derivatives 
displayed a similar or better antioxidant activity than the parent molecule in hydroxyl 
radical scavenging activity, bulk oil system, inhibition of LDL oxidation, and inhibition 
of DNA scission. In this study, both oil-in-water emulsion and bulk oil systems 
contradicted the polar paradox theory. These results demonstrate that quercetin and its 
derivatives may be used as possible antioxidants in food and biological systems.  
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CHAPTER 9 
Summary and recommendations 
 This study evaluated the effect of lipophilisation of two selected phenolic compounds, 
namely resveratrol and quercetin, for their potential extended application in food, 
nutraceuticals, cosmetics, and possibly pharmaceuticals.  
The resveratrol derivatives were prepared via esterification with 12 different fatty acids 
with the corresponding acyl chlorides. The main products were resveratrol-3- and 
resveratrol-4'-monoesters and this was confirmed by HPLC-MS and NMR spectroscopy 
(1H-NMR, 13C-NMR, COSY, HSQC, NOESY, and HMBC). The lipophilicity of 
resveratrol derivatives was better than the parent molecule which also exhibited the 
highest DPPH and ABTS radical scavenging activities among all derivatives. However, 
the radical scavenging activities of resveratrol with long-chain fatty acids (RC18:0 and 
RC18:1) in the assay, using the lipophilic DPPH, were 87 and 95%, respectively, 
compared to resveratrol. Thus, resveratrol derivatives could be used as powerful 
antioxidants in lipophilic systems. Therefore, we expanded our investigation to food and 
biological model systems. The results were varied depending on the test system employed. 
Some resveratrol derivatives showed a similar and/or better antioxidant activity than 
resveratrol in hydrogen peroxide scavenging activity, bulk oil, cooked ground pork model 
system, inhibition of LDL oxidation, and inhibition of DNA scission. This work 
demonstrated that resveratrol derivatives could serve as possible antioxidants in food and 
biological systems. Two selected resveratrol derivatives, namely RC3:0 and RDHA were 
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evaluated further for their potential antioxidant, anti-inflammatory, and antiproliferative 
activities in A431, MCF7, HT-29, and AGS cell lines.  
Resveratrol, RC3:0, and RDHA were able to attenuate NO production in murine RAW 
264.7 cells. Moreover, these compounds could decrease the cell viability of A431, MCF7, 
HT-29, and AGS. Resveratrol and RDHA were investigated further, and they were found 
to decrease ROS generation in HepG2 cells. These findings implied that some of the 
resveratrol derivatives might be used as antioxidants, possibly anti-inflammatory and 
anticancer agents but this needs to be further confirmed in future studies.   
Meanwhile, quercetin derivatives were also prepared with the fatty acyl chlorides of 
different chain lengths and degrees of unsaturation. The quercetin derivatives produced 
were mainly Q-3'-O-monoester, Q-3-O-monoester, Q-7,3'-O-diester, Q-3',4'-O-diester, 
and Q-3,4'-O-diester and this was confirmed by HPLC-MS and 1H NMR. The 
lipophilicity of quercetin derivatives was superior to that of quercetin itself. In terms of 
antioxidant activity, quercetin showed the highest antioxidant activity among all tested 
samples in ABTS radical scavenging activity, DPPH radical scavenging activity, reducing 
power, and an oil-in-water emulsion system. In addition, quercetin with short-chain fatty 
acids showed a better antioxidant activity than other quercetin derivatives in those assays. 
On the other hand, some quercetin derivatives exhibited a similar and/or better 
antioxidant activity than quercetin itself in hydroxyl radical scavenging activity, bulk oil 
system, inhibition of LDL oxidation, and inhibition of DNA scission. The results 
suggested that quercetin derivatives might serve as potential antioxidants in food and 
biological systems. 
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Taking all together, the findings of this work suggest that lipophilisation of resveratrol 
and quercetin could potentially enhance their application in lipophilic media of food and 
biological systems. It is also expected that the lipophilisation can also improve their 
bioavailability because it can increase the affinity to the cell membrane. In such context, 
they may be used as functional food ingredients and nutraceuticals for health promotion 
and disease risk reduction. To that end, more studies should be carried out on 1) 
bioactivities both ex vivo and in vivo; 2) toxicities; 3) bioavailabilities, including 
absorption and metabolism. Moreover, practical aspects such as the economy of the 
process need further evaluation. 
This study will provide a better understanding of the antioxidant behaviour of lipophilised 
resveratrol and quercetin in different systems. Moreover, to the best of our knowledge, 
this is the first work incorporating short-, medium-, and long-chain fatty acids, especially 
the omega-3 PUFA into the resveratrol and quercetin molecules. This can also fill the 
existing gap in the knowledge about the effect of fatty acid chain length and degree of 
unsaturation of lipophilised resveratrol and quercetin on their antioxidant properties. 
Moreover, this study provides an opportunity for the expanded use of polyphenols tested 
which will add value to food and nutraceutical industry. 
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